Nothing Special   »   [go: up one dir, main page]

CN112813049B - Fusion protein for live cell RNA marking and application - Google Patents

Fusion protein for live cell RNA marking and application Download PDF

Info

Publication number
CN112813049B
CN112813049B CN201911127456.3A CN201911127456A CN112813049B CN 112813049 B CN112813049 B CN 112813049B CN 201911127456 A CN201911127456 A CN 201911127456A CN 112813049 B CN112813049 B CN 112813049B
Authority
CN
China
Prior art keywords
lys
leu
glu
asp
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911127456.3A
Other languages
Chinese (zh)
Other versions
CN112813049A (en
Inventor
陈玲玲
杨良中
王洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Center for Excellence in Molecular Cell Science of CAS
Original Assignee
Center for Excellence in Molecular Cell Science of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Center for Excellence in Molecular Cell Science of CAS filed Critical Center for Excellence in Molecular Cell Science of CAS
Priority to CN201911127456.3A priority Critical patent/CN112813049B/en
Publication of CN112813049A publication Critical patent/CN112813049A/en
Application granted granted Critical
Publication of CN112813049B publication Critical patent/CN112813049B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention belongs to the field of research on RNA living cell markers, and particularly provides a fusion protein of dCas13 protein and fluorescent protein with RNA nuclease activity deletion or reduction, and a method and application of RNA markers in living cells. The RNA marking method has the characteristics of short experimental period, simple operation, high sensitivity, high specificity and the like. The rapid endogenous RNA labeling can be realized by using the labeling method.

Description

Fusion protein for RNA (ribonucleic acid) marking of living cells and application
Technical Field
The invention belongs to the field of nucleic acid labeling, and particularly relates to a fusion protein for labeling cell RNA and application thereof.
Background
RNA, one of important biological macromolecules, is widely involved in various cell life activities. Research on RNA has long previously focused primarily on the study of cellular biological functions and biophysical properties of RNA using biochemical and molecular biological means. However, it was reported in 1983 that transcripts were not randomly distributed in the egg cells of ascidians petioli and that the distribution of transcripts was constantly changing during embryonic development (Jeffery et al, 1983), suggesting that subcellular localization of mRNA under different spatiotemporal conditions plays an important role during development. Since noncoding RNA, especially long noncoding RNA (incrna), does not have the ability to encode functional protein, incrna functions by determining its own sequence properties to locate in a cell, and functions directly or by interacting with a related RNA binding protein to form a complex. Therefore, it is very important to study the function of RNA whether it is mRNA encoding protein or non-coding RNA and to understand its subcellular localization and spatiotemporal changes under different conditions.
For the research on the localization of RNA, RNA Fluorescence In Situ Hybridization (FISH) is mainly used, but since RNA FISH is hybridized in fixed cells, the use of a fixative may cause cell deformation or affect the original localization of molecules in cells, which may cause the observed phenomenon to be different from the real situation, and FISH may lose some important information because it cannot reflect the dynamic change of RNA in the state of living cells (Schnell et al, 2012). The method of fluorescence probe labeling of live cell RNA is similar to RNA FISH technology (Raj et al, 2008, santangelo et al, 2009, simon et al, 2010), and due to the integrity of the live cell membrane and the preservation of cell activity, fluorescence probe labeling of live cells inevitably creates several problems: (1) The fluorescent probe is difficult to deliver to living cells, and the current methods mainly comprise methods such as liposome transfection, electrotransformation and microinjection; microinjection can inject an accurate and quantitative probe into cells, but the operation is complex, the transfection and electrotransformation efficiency of liposome is low, and the toxicity to cells is high; (2) The probe can be degraded and unstable by nuclease after entering a living cell, and the existence time is short. When the probe is manufactured, the problem that the probe is degraded can be effectively solved by using 2' -O-methylation modified ribonucleotide to replace oligodeoxyribonucleotide or preparing the probe with a stable skeleton structure, but the corresponding preparation cost of the probe is also greatly increased (Molenaar et al, 2001, okabe et al, 2011); (3) A relatively high background signal is also a relatively large problem that needs to be faced with fluorescence labeling of live cell RNA. After the fluorescent probe enters into a living cell and is combined with target RNA, a large amount of free probes which are not combined with the target RNA still exist, and the free probes inevitably cause high background signals to influence the detection and observation of the target RNA. Although the fluorescent probe labeling method has been subjected to multiple modifications and improvements, so that there may be some advantages in labeling RNA, the higher manufacturing cost becomes a great limitation to its popularization and application. The RNA aptamer labeling method based on a specific structure can be classified into a fluorescent protein labeling method and a fluorescein labeling method. Although no RNA capable of automatically generating fluorescence can directly mark target RNA like labeled protein, a class of RNA with a special structure such as Spinach2 has been found to be capable of combining with fluorescein DFHBI and improving the quantum efficiency of DFHBI so as to be detected, so that Spinach2 is inserted into the target RNA and the target RNA can be detected by DFHBI staining, but the fluorescence intensity is very low, the signal is difficult to detect, and the application of the RNA is greatly limited (Strack and Jaffrey, 2015). In addition, based on the specific binding of some RNA binding proteins to some RNAs with stem-loop structures, fluorescently labeled RNA binding proteins can be recruited to label the RNA of interest after insertion of the RNA into the RNA of interest (Beach et al, 1999 horvatova et al, 2017. However, this RNA aptamer-based approach requires the insertion of a sequence into the RNA of interest, which may affect the structure and function of RNA, particularly lncRNA, which functions mainly depending on its structure, even if the marker is in the untranslated region of mRNA (Heinrich et al, 2017).
In summary, although many different methods have been developed for the labeling of live cells of RNA, these labeling methods are either too costly to be affordable in the laboratory or cannot label endogenous RNA that has not been modified by sequence insertions. Therefore, it is necessary to develop a simple and convenient RNA labeling technique that can realize the detection and observation of endogenous RNA in living cells.
Disclosure of Invention
In order to overcome the problems of the prior art, the present invention aims to provide a fusion protein for RNA labeling of living cells and application thereof.
One aspect of the invention provides a fusion protein comprising a dCas protein having a deleted or reduced RNA nuclease activity, one or more marker sequences and optionally one or more intracellular localization sequences.
In one or more embodiments, the dCas protein is N-terminal to the one or more marker sequences.
In one or more embodiments, the dCas protein is dCas13 protein. Preferably, the dCas13 protein is derived from the following species: lachnospiraceae bacteria, leptotrichia wadei, prevotella sp.P5-125, porphyromonas gulae, eubacterium siaeum DSM15702, anaerobic digesterter metagenome 15706, ruminococcus flavefaciens XPD3002.
In one or more embodiments, the dCas13 protein is selected from one or more of a deletion or a reduced mutant of RNA nuclease activity of: lbaCas13a, lwaCas13a, pspCas13b, pguCas13b, ranCas13b, admCas13d, esCas13d, rfxCas13d. In one or more embodiments, the mutation is located in one or both HEPN domains of the Cas13 protein.
In one or more embodiments, the dCas13 protein has one or more of the following sequences or a sequence having at least 70% identity thereto: position 18-1456 of SEQ ID NO.1, position 18-1171 of SEQ ID NO.2, position 9-1089 of SEQ ID NO.3, position 9-1183 of SEQ ID NO.4, position 9-1103 of SEQ ID NO. 5, position 18-966 of SEQ ID NO. 6, position 18-974 of SEQ ID NO. 7, position 18-986 of SEQ ID NO. 8, or a combination thereof. Preferably, the sequence of the dCas13 protein is shown in SEQ ID NO.3 at positions 9-1089 or SEQ ID NO.4 at positions 9-1183.
In one or more embodiments, the fusion protein comprises a plurality of tag sequences.
In one or more embodiments, the marker sequence is an optically active polypeptide, preferably a fluorescent protein.
In one or more embodiments, the marker sequence has one or more of the following sequences or a sequence having at least 70% identity thereto: 1, 1123-1360 of SEQ ID NO.9, 1111-1345 of SEQ ID NO.11, or a combination thereof.
In one or more embodiments, the fusion protein comprises a plurality of intracellular localization sequences.
In one or more embodiments, the intracellular localization sequence is a nuclear localization signal.
In one or more embodiments, the intracellular localization sequence has one or more of the following sequences or a sequence having at least 70% identity thereto: positions 2-17 of SEQ ID NO.1 or positions 1363-1369 of SEQ ID NO.9, or a combination thereof.
In one or more embodiments, the nuclear localization signal is located N-terminal to dCas and/or C-terminal to the marker sequence.
In one or more embodiments, the fusion protein has, from N-terminus to C-terminus, one or more nuclear localization signals, dCas protein, one or more marker sequences, and one or more nuclear localization signals.
In one or more embodiments, the fusion protein has or consists of a sequence set forth in any one of SEQ ID NOs 1-18 or a sequence having at least 70% identity thereto.
In another aspect, the invention provides a polynucleotide selected from: (1) a polynucleotide encoding a fusion protein described herein; (2) the complement of (1); and (3) a fragment of (1) or (2). Preferably, the polynucleotide sequence is shown in SEQ ID NO. 46.
The invention also provides a nucleic acid construct comprising a polynucleotide as described herein. In one or more embodiments, the nucleic acid construct is a cloning vector or an expression vector.
The invention also provides a host cell that (1) expresses a fusion protein described herein; (2) comprising a polynucleotide as described herein; (3) comprising a nucleic acid construct as described herein; (4) optionally comprising a gRNA directed against the target. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and fusion protein.
Also provided herein is a detection composition containing a fusion protein, a polynucleotide, a nucleic acid construct, a gRNA for a target, and reagents for detecting a marker sequence as described herein. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and the fusion protein.
Also provided herein is a detection kit comprising (1) the fusion protein described herein, or the coding sequence of said fusion protein or a complement thereof, or a nucleic acid construct comprising said coding sequence or a complement thereof, (2) reagents for detecting a marker sequence, and optionally (3) a gRNA directed against a target or a nucleic acid construct comprising the gRNA or a complement thereof. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and fusion protein.
In one or more embodiments, the kit can further comprise various reagents suitable for transfecting the polynucleotide or nucleic acid construct into a cell, and optionally instructions directing a person of skill in the art to transfect the nucleic acid construct into a cell.
The invention also provides for the use of the fusion proteins, polynucleotides, nucleic acid constructs, host cells described herein in detecting a target. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and the fusion protein. In one or more embodiments, the assay is an intracellular assay.
The invention also provides a method of detecting a target comprising (1) incubating cells that express the fusion protein described herein and comprise a gRNA for the target, and (2) detecting a marker sequence. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and fusion protein.
In one or more embodiments, the marker sequence is a fluorescent protein and detecting the marker sequence comprises detecting a fluorescent protein color.
The invention also includes a method of locating a target within a cell, comprising expressing in the cell a fusion protein described herein and a gRNA directed against the target, and detecting the location of a marker sequence in the cell. In one or more embodiments, the target is a target RNA. The gRNA recognizes dCas13 in the target RNA and the fusion protein.
The invention also provides a method of detecting a target RNA and a target DNA comprising (1) incubating a cell that expresses a fusion protein described herein and comprises a gRNA for the target RNA, and that expresses a protein in which dCas9 is fused to another marker sequence and comprises a sgRNA for the target DNA, and (2) detecting the marker sequence. The gRNA recognizes dCas13 in the target RNA and the fusion protein. The sgrnas recognize dCas9 in the target DNA and fusion protein.
The invention also includes a method of diagnosing a disease associated with the identification, amount, or location of a target comprising detecting or locating the target using the methods described herein and diagnosing based on the detection or location.
The invention has the following advantages and beneficial effects:
(1) dCas13b-FPs is a novel protein system for targeting RNA, which is different from the traditional RNA molecular probe and RNA aptamer method. The novel RNA protein system has the characteristics of specificity and stable combination with endogenous target RNA.
(2) The invention can mark the target RNA by a transfection method only after constructing the gRNA plasmid, and compared with the method that a period of weeks or even months is consumed by knocking in a section of aptamer into the gene sequence of the target RNA in advance, the invention greatly simplifies the steps of RNA marking and shortens the time required by RNA marking. The above innovations are beneficial to the quick and effective marking of target RNA, and provide a new tool for more conveniently and quickly researching the positioning and dynamic change of RNA and the relation with functions.
Drawings
FIG. 1: dCas13b-EGFP labels NEAT1 results in targeting the gRNA effect of NEAT 1.
FIG. 2: the result of labeling NEAT1 after optimization of the dspcas 13b fused fluorescent protein.
FIG. 3: the result of marking SaIII by dCas13b-3 xEGFP after 1 hour of thermal stimulation or 6 hours of treatment with sodium arsenite under the action of gRNA targeting SaIII.
FIG. 4: the result of labeling MUC4 by dPspCas13b-3 xEGFP under the action of gRNA targeting MUC 4.
FIG. 5: the result of labeling 24 XGCN 4 with dPspCas13b-3 XEGFP under the action of gRNA targeting GCN 4.
FIG. 6: and (3) labeling mRNA after optimizing the dPspCas13b fused fluorescent protein.
FIG. 7: results of CRISPR-Cas13 dual color labeling of RNA.
FIG. 8: results of CRISPR-Cas13 combined CRISPR-Cas9 dual-color labeling of RNA and DNA.
Detailed Description
The inventor carries out enzyme activity deletion mutation on a plurality of CRISPR-Cas13 proteins and then fuses the proteins with fluorescent protein to obtain the recombinant protein which can be used for living cell RNA labeling.
Before the present embodiments are further described, it is to be understood that the scope of the invention is not limited to the particular embodiments described below; it is also to be understood that the terminology used in the examples is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention. Test methods in which specific conditions are not specified in the following examples are generally carried out under conventional conditions or under conditions recommended by the respective manufacturers.
When numerical ranges are given in the examples, it is understood that both endpoints of each of the numerical ranges and any value therebetween can be selected unless the invention otherwise indicated. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In addition to the specific methods, devices, and materials used in the examples, the invention may be practiced using any method, device, and material that is similar or equivalent to the methods, devices, and materials described in examples herein, in addition to those described in prior art practice and the description herein.
Unless otherwise indicated, the experimental methods, detection methods, and preparation methods disclosed herein all employ techniques conventional in the art of molecular biology, biochemistry, chromatin structure and analysis, analytical chemistry, cell culture, recombinant DNA technology, and related arts.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In addition, any methods and materials similar or equivalent to those described herein can be used in the practice of the present invention. The preferred embodiments and materials described herein are intended to be exemplary only.
The fusion proteins of the invention comprise a dCas protein with a deleted or reduced RNA nuclease activity, a marker and optionally an intracellular localization sequence.
CRISPR-Cas systems are a class of acquired immune systems that are widely found in bacteria and archaea to protect hosts from foreign virus invasion. The CRISPR-Cas13 is a protein which can cut RNA in a targeted mode under the mediation of guide RNA or nonspecifically cut RNA after being activated by targeted RNA, and is developed and used for experiments such as the knockdown of cell RNA, the specific editing of RNA base, the detection of exogenous virus RNA and the like. The different Cas13 families comprise at least four known subtypes, including Cas13a (also referred to as C2), cas13b, cas13C and Cas13d. Cas13 proteins suitable for use herein include, but are not limited to: proteins derived from the following species: lachnospiraceae bacteria ((Lba) Cas13 a), leptotrichia wadei ((Lwa) Cas13 a), prevotella sp.P5-125 ((Psp) Cas13 b), porphyromonas gulae ((Pgu) Cas13 b), porphyromonas gulae ((Ran) Cas13 b), eubacterium siarum DSM15702 ((Es) Cas13 d), anaerobic digger swagenoome 15706 ((Adm) Cas13 d) and Ruminococcocus flavefaciens XPD3002 ((Rfx) Cas13 d).
Cas13 family members contain two HEPN domains that produce rnase activity. Cas13 proteins suitable for use herein also include dCas13 proteins with missing or reduced rnase activity. dCas13 can be obtained by mutating or modifying a Cas13 protein. In one or more embodiments, the mutation is located in one or both HEPN domains of the Cas13 protein. Such mutations include insertions, deletions or substitutions having one or more (e.g., within 20, within 15, within 10, within 8, within 5 or within 3) amino acids in the amino acid sequence, while the rnase activity of the sequence is deleted or reduced. While the rnase activity of dCas13 is deleted or reduced, other activities or functions are unaffected or substantially unaffected, such as activities of RNA recognition, recruitment of grnas, complex formation with grnas, binding to DNA, and the like. Alternatively, cas13 proteins suitable for use herein also include Cas13 protein mutants having at least 70%, preferably at least 80%, preferably at least 85%, preferably at least 90%, preferably at least 95%, or preferably at least 97% sequence identity to a wild-type Cas13 protein or to a dCas13 protein with deletion or reduction of rnase activity as described herein, which Cas13 protein mutants still have rnase activity deleted or reduced while retaining their function other than rnase activity; preferably, these Cas13 protein mutants are from the same species as their wild-type Cas13 protein. Exemplary dCas13 proteins are shown below: dLbaCas13a (position 18-1456 of SEQ ID NO: 1), dLwaCas13a (position 18-1171 of SEQ ID NO: 2), dPspCas13b (position 9-1089 of SEQ ID NO: 3), dPguCas13b (position 9-1183 of SEQ ID NO: 4), dRanCas13b (position 9-1103 of SEQ ID NO: 5), dAdmCas13d (position 18-966 of SEQ ID NO: 6), dEsCas13d (position 18-974 of SEQ ID NO: 7), dRfxCas13d (position 18-986 of SEQ ID NO: 8), and sequences having at least 70%, preferably at least 80%, preferably at least 85%, preferably at least 90%, preferably at least 95%, or preferably at least 97% sequence identity to these dCas13 proteins, the RNA enzyme activity being deleted or reduced but retaining its RNA enzyme activity function, preferably from the same species as the Cas13 protein from which it is derived from.
As used herein, a "marker sequence" or "marker" is a substance used to represent the results of an assay in a manner that facilitates detection or observation. The marker may be a polypeptide, protein, small molecule, or other molecule. Illustratively, the label may be an optically active polypeptide or a functional fragment thereof. A protein-based "optically active polypeptide" is a polypeptide that has the ability to emit fluorescence. Functional fragments of an optically active polypeptide include fragments that can undergo a change in the same or similar fluorescent properties as a parent optically active polypeptide. Examples of optically active polypeptides include "fluorescent proteins," which refer to proteins that fluoresce under irradiation with excitation light. Fluorescent proteins and sequences thereof useful in the present invention are known in the art. In an exemplary embodiment, EGFP (positions 1466-1704 of SEQ ID NO: 1), sfGFP (positions 1123-1360 of SEQ ID NO: 9), mNeonGreen (positions 1111-1345 of SEQ ID NO: 11) fluorescent proteins are used. In the fusion proteins of the invention, one or more optically active polypeptides (e.g., fluorescent proteins) are operably linked to dCas protein. Any of the optically active polypeptides may be located at the N-terminus, C-terminus or within dCas protein. In a preferred embodiment, the plurality of optically active polypeptides are located consecutively at the C-terminus of the dCas protein.
The fusion proteins herein may also optionally comprise intracellular localization sequences that serve to direct the fusion protein into a desired organelle. The organelles include cytoplasm, mitochondria, nucleus, endoplasmic reticulum, cell membrane, golgi apparatus, lysosomes, peroxisomes and the like. Intracellular localization sequences may be located at the N-terminus and/or C-terminus of the sequence to be expressed. In one or more embodiments, the intracellular localization sequence is a nuclear localization signal. Intracellular localization sequences suitable for various organelles are known in the art, and exemplary nuclear localization signals are shown at positions 2-17 of SEQ ID NO:1 or 1363-1369 of SEQ ID NO: 9. The nuclear localization signal may be located at the N-terminus or the C-terminus or both of the sequence to be expressed (e.g., a fusion polypeptide of dCas with a fluorescent protein).
The optically active polypeptide, dCas protein and nuclear localization signal forming the fusion protein herein may be linked to each other or to the plurality of optically active polypeptides directly or via linkers well known in the art. Herein, a linker is a polypeptide fragment that connects different proteins or polypeptides, with the purpose of maintaining the connected proteins or polypeptides in their respective spatial conformations, so as to maintain the function or activity of the proteins or polypeptides. Exemplary linkers include linkers containing G and/or S. In addition to glycine and serine, other known amino acid residues may be contained in the linker, such as alanine (a), leucine (L), threonine (T), glutamic acid (E), phenylalanine (F), arginine (R), glutamine (Q), and the like. The linker may be 1-25 amino acid residues in length, for example 1-15, 3-15, 5-20 amino acid residues. In certain embodiments, the proteins, polypeptides or sequences of the invention are linked by (GGGS) n, where n is an integer from 1 to 5. In one or more embodiments, the linker sequence is a short peptide chain of one or more flexible amino acids, such as LE, KL. Linkers suitable for use between functional polypeptides of the invention include, but are not limited to: LEALPAT, SGGRSG, GGGSGSM, SR, SNSKPGFHM, LE, SGLRSCLMH, SNSAVDGTM, EGALEGTSGGGSM, EGALEALPVAT, SGLRS, KL, GSIDGS, EALPVAT, SGLRS, SGLRSRRYRRYRHM, EGALEGS, SGLRSHM, GIVPHGAA, GSGSPKKKRKVSR.
The invention also includes mutants of said polypeptides or proteins. The mutant comprises: an amino acid sequence that has at least 70%, at least 80%, preferably at least 85%, preferably at least 90%, preferably at least 95%, preferably at least 97% sequence identity to a reference sequence and retains the biological activity (e.g., binding to a gRNA, fluorescence excitation, nuclear localization) of the reference sequence. Sequence identity between two aligned sequences can be calculated using, for example, BLASTp from NCBI. Mutants also include amino acid sequences that have one or several mutations (insertions, deletions, or substitutions) in the amino acid sequence while still retaining the biological activity of the reference sequence. The number of mutations typically means within 1-20, such as 1-15, 1-10, 1-8, 1-5, or 1-3. The substitution is preferably a conservative substitution. For example, conservative substitutions with amino acids that are similar or analogous in performance are not generally known in the art to alter the function of a protein or polypeptide. "amino acids with similar or analogous properties" include, for example, families of amino acid residues with analogous side chains, including amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine tryptophan, histidine). Thus, substitution of one or more sites with another amino acid residue from the same side chain species in the polypeptide of the invention will not substantially affect its activity.
The present invention includes polynucleotides encoding the polypeptides or proteins of the present invention. The polynucleotide of the present invention may be in the form of DNA or RNA. The form of DNA includes cDNA, genomic DNA or artificially synthesized DNA. The DNA may be single-stranded or double-stranded. The DNA may be the coding strand or the non-coding strand. The invention also includes degenerate variants of polynucleotides that encode a polypeptide or protein, i.e., polynucleotides that encode the same amino acid sequence but differ in nucleotide sequence.
Polynucleotides described herein include sequences that are altered by codon optimization, so long as the amino acid sequence encoded by the polynucleotide is not altered. Codon-optimized sequences may exhibit more suitable expressivity for a particular species. Methods for codon optimizing polynucleotide sequences are well known in the art.
The polynucleotide of the invention may be a fusion protein coding sequence as described herein or a complement thereof. Herein, a coding sequence refers to a portion of a nucleic acid sequence that directly determines the amino acid sequence of its protein product (e.g., CAR, single chain antibody, hinge region, transmembrane region, intracellular signal region, or anti-TCR antibody, etc.). The boundaries of the coding sequence are generally determined by a ribosome binding site (for prokaryotic cells) immediately upstream of the 5 'open reading frame of the mRNA and a transcription termination sequence immediately downstream of the 3' open reading frame of the mRNA. A coding sequence can include, but is not limited to, DNA, cDNA, and recombinant nucleic acid sequences. In certain embodiments, the coding sequence or expression cassette is integrated into the genome of the cell. Thus, in these embodiments, the cell described herein has stably integrated into its genome an expression cassette comprising a nucleic acid encoding a fusion protein described herein. An exemplary polynucleotide is shown in SEQ ID NO 46.
The invention also relates to nucleic acid constructs comprising a polynucleotide as described herein, and one or more control sequences operably linked to the sequences. The polynucleotides of the invention may be manipulated in a variety of ways to ensure expression of the polypeptide or protein. The nucleic acid construct may be manipulated prior to insertion into the vector, depending on the type of expression vector or requirements. Techniques for altering polynucleotide sequences using recombinant DNA methods are known in the art.
The control sequence may be an appropriate promoter sequence. The promoter sequence is typically operably linked to the coding sequence of the protein to be expressed. The promoter may be any nucleotide sequence which shows transcriptional activity in the host cell of choice including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular polypeptides either homologous or heterologous to the host cell. The control sequence may also be a suitable transcription terminator sequence, a sequence recognized by a host cell to terminate transcription. The terminator sequence is operably linked to the 3' terminus of the nucleotide sequence encoding the polypeptide. Any terminator which is functional in the host cell of choice may be used in the present invention. The control sequence may also be a suitable leader sequence, a nontranslated region of an mRNA which is important for translation by the host cell. The leader sequence is operably linked to the 5' terminus of the nucleotide sequence encoding the polypeptide. Any terminator which is functional in the host cell of choice may be used in the present invention.
In certain embodiments, the nucleic acid construct is a vector. The vector may be a cloning vector, an expression vector, or a homologous recombinant vector. The polynucleotides of the present invention can be cloned into many types of vectors, for example, plasmids, phagemids, phage derivatives, animal viruses, and cosmids. Cloning vectors may be used to provide the coding sequences for the fusion proteins of the invention. The expression vector may be provided to the cell in the form of a viral vector. Expression of a polynucleotide of the invention is typically achieved by operably linking the polynucleotide of the invention to a promoter and incorporating the construct into an expression vector. The vector may be suitable for replication and integration into eukaryotic cells. Typical expression vectors contain transcriptional and translational terminators, initiation sequences, and promoters that may be used to regulate the expression of the desired nucleic acid sequence. Viral vector technology is well known in the art and is described, for example, in Sambrook et al (2001, molecular cloning. Viruses that can be used as vectors include, but are not limited to, retroviruses, adenoviruses, adeno-associated viruses, herpes viruses, and lentiviruses. Homologous recombinant vectors are used to integrate the expression cassettes described herein into the host genome.
Generally, suitable vectors comprise an origin of replication functional in at least one organism, a promoter sequence, a convenient restriction enzyme site and one or more selectable markers. An example of a suitable promoter is the immediate early Cytomegalovirus (CMV) promoter sequence. However, other constitutive promoter sequences may be used, and promoter sequences suitable for expressing the fusion proteins of the present invention in a variety of cells are well known in the art.
To assess the expression of the polypeptide or protein, the expression vector introduced into the cells may also contain a selectable marker gene and/or a reporter gene to facilitate identification and selection of expressing cells from the population of cells sought to be transfected or infected by the viral vector. In other aspects, the selectable marker may be carried on a separate piece of DNA and used in a co-transfection procedure. Both the selectable marker and the reporter gene may be flanked by appropriate regulatory sequences to enable expression in a host cell. Useful selectable markers include, for example, antibiotic resistance genes, such as neo and the like. The reporter gene is used to identify potentially transfected cells and to evaluate the functionality of the regulatory sequences. After the DNA has been introduced into the recipient cell, the expression of the reporter gene is assayed at an appropriate time. Suitable reporter genes may include genes encoding luciferase, β -galactosidase, chloramphenicol acetyltransferase, secreted alkaline phosphatase, or green fluorescent protein. Suitable expression systems are well known and can be prepared using known techniques or obtained commercially.
The polynucleotides described herein can generally be obtained by PCR amplification. Specifically, primers can be designed based on the nucleotide sequences disclosed herein, particularly open reading frame sequences, and the relevant sequences can be amplified using commercially available cDNA libraries or cDNA libraries prepared by conventional methods known to those skilled in the art as templates. When the sequence is long, two or more PCR amplifications are often required, and then the amplified fragments are spliced together in the correct order. Alternatively, the nucleic acid molecules described herein can also be synthesized directly.
Methods for introducing and expressing genes into cells are known in the art. The polynucleotide can be readily introduced into a host cell by any method known in the art, for example, mammalian, bacterial, yeast or insect cells. Generally, polynucleotides can be transferred into host cells by physical, chemical, or biological means. Physical methods for introducing polynucleotides into host cells include calcium phosphate precipitation, lipofection, particle bombardment, microinjection, electroporation, and the like. Biological methods for introducing a polynucleotide of interest into a host cell include the use of DNA and RNA vectors. Chemical means of introducing polynucleotides into host cells include colloidal dispersion systems such as macromolecular complexes, nanocapsules, microspheres, beads; and lipid-based systems including oil-in-water emulsions, micelles, mixed micelles, and liposomes.
Biological methods for introducing polynucleotides into host cells include transfection with viral vectors or mRNA, particularly retroviral vectors. Other viral vectors may be derived from lentiviruses, poxviruses, herpes simplex virus I, adenoviruses, adeno-associated viruses, and the like. Many virus-based systems have been developed for gene transfer into mammalian cells, such as retrovirus-based systems. The selected gene can be inserted into a vector and packaged into a retroviral particle using techniques known in the art. The recombinant virus can then be isolated and delivered to the subject cells in vivo or ex vivo. Many retroviral systems are known in the art. Lentiviruses are a genus of the family retroviridae, and a lentivirus vector is a more complex retroviral vector. Reagents for lentiviral packaging are well known in the art, as are conventional lentiviral vector systems including pRsv-REV, pMDlg-pRRE, pMD2G and the desired interference plasmid. In one embodiment, the vector pHAGE-EF1 alpha-IRES-puro is used to express dCas13 fusion protein (which can be replaced by any protein eukaryotic expression plasmid such as pcDNA3, etc.), and the vector crRNA-backbone vector is used to express gRNA (which can be replaced by any RNA expression vector such as pLKO.1, etc.).
Herein, a host cell refers to a cell capable of receiving and containing a polynucleotide described herein. An ideal host cell would satisfy both the conditions of ease of acquisition and proliferation. The "host cell" of the present invention may be prokaryotic and eukaryotic cells, including bacterial cells, yeast cells, insect cells, mammalian cells, and the like. The host cell is preferably a variety of cells which facilitate expression of the gene product or fermentative production of such cells, which are well known and commonly used in the art. In certain embodiments, the invention provides a genetically modified cell comprising a polynucleotide as described herein, or comprising a nucleic acid construct as described herein, or prepared by a method as described herein, or stably expressing a fusion protein as described herein.
After transformation of the host cell, the resulting transformant can be cultured by conventional methods to allow expression of the fusion protein described herein. The medium used in the culture may be selected from various conventional media depending on the host cell used. The recombinant fusion proteins herein can be isolated and purified using various isolation methods known in the art. Such methods are well known to those skilled in the art and include, but are not limited to: conventional renaturation treatment, treatment with a protein precipitant (such as salt precipitation), centrifugation, cell lysis by osmosis, sonication, ultracentrifugation, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, high Performance Liquid Chromatography (HPLC), and other various liquid chromatography techniques and combinations thereof.
Thus, host cells containing the proteins described herein or their coding sequences or expression vectors are also included herein. Such host cells can constitutively express the proteins described herein, can also express the proteins described herein under certain induction conditions, and can also specifically express the proteins described herein in different host cell types. Methods of how to make host cells constitutively express, inducibly express, or specifically express the proteins of the invention are well known in the art. For example, in certain embodiments, inducible promoters are used to construct expression vectors of the invention to achieve inducible expression of the protein. In certain embodiments, tissue-specific expression of the protein is achieved using a tissue-specific expression promoter or associating the coding sequence of the protein with a tissue-specific gene.
The knock-in vector is used to knock the polynucleotide sequences described herein into a region of interest in the genome. Typically, the knock-in vector will contain, in addition to the polynucleotide sequence, a 5 'homology arm and a 3' homology arm required for homologous recombination of the genome. In certain embodiments, the nucleic acid constructs herein comprise a 5 'homology arm, a polynucleotide sequence described herein, and a 3' homology arm. When using knock-in vectors, the CRISPR/Cas9 technique can be simultaneously utilized to homologously recombine the polynucleotide sequence to the location of interest. The CRISPR/Cas9 technology is used for guiding Cas9 nuclease to modify a genome at an insertion position by designing a guide RNA aiming at a target gene, so that the homologous recombination efficiency of a gene modification region is increased, and a target fragment contained in a gene knock-in vector is subjected to homologous recombination to a target site.
Also provided herein is a detection composition comprising the fusion protein or polynucleotide described herein, a gRNA for a target, and a reagent for detecting a label. Also provided herein is a detection kit comprising (1) a fusion protein described herein, or a coding sequence of said fusion protein or a complement thereof, or a nucleic acid construct comprising said coding sequence or a complement thereof, (2) a gRNA directed against a target or a nucleic acid construct comprising said gRNA or a complement thereof, and (3) optionally reagents for detecting a marker. The kit may also contain various reagents suitable for transfecting the polynucleotide or nucleic acid construct into a cell, and optionally instructions directing a person of skill in the art to transfect the nucleic acid construct into a cell.
The gRNA is a guide RNA for guiding CRISPR-Cas13 targeting to a target RNA, comprising a Cas13 protein recognition region and a target RNA recognition region. Typically, the target RNA recognition region can be fully or partially paired with a spacer (spacer) in the target RNA. Methods of designing grnas from different Cas13 proteins and target RNAs are known in the art. Exemplary gRNA sequences are shown in SEQ ID NOS: 19-42.
The invention also includes a method of detecting a target RNA comprising expressing in a cell a fusion protein described herein and a gRNA directed against the target RNA, and detecting a marker. The target RNA can be any type of RNA including mRNA, tRNA, rRNA, and the like. In the cell, the protein recognition region of the gRNA recognizes dCas13 protein in the fusion protein, and the target RNA recognition region of the gRNA recognizes the target RNA, thereby forming a complex of the fusion protein, the target RNA, and the gRNA. And the real-time fluorescence detection of the target RNA is realized through the color development of the fluorescent protein in the fusion protein. Exemplary Cas proteins and protein recognition regions of grnas are shown in table 2.
The invention also includes a method of localizing a target RNA within a cell, comprising expressing a fusion protein described herein and a gRNA for the target RNA in the cell, and detecting the location of a marker in the cell.
The invention also includes a method of diagnosing a disease associated with the identification, amount, or location of a target RNA, comprising detecting or locating the target RNA using the methods described herein, and diagnosing based on the detection or location.
The present invention is described in further detail by referring to the following experimental examples. These examples are provided for illustrative purposes only and are not intended to be limiting unless otherwise specified. Accordingly, the present invention should in no way be construed as limited to the following examples, but rather should be construed to include any and all variations which become apparent in light of the teachings provided herein. The methods and reagents used in the examples are, unless otherwise indicated, conventional in the art.
Examples
Example 1 construction of gRNA expression plasmid
Designing a gRNA primer, wherein a forward primer is as follows: 5'CACC + spacer sequence, and the reverse primer is 5' CAAC + spacer reverse complementary sequence, the preferred spacer sequence is in the length range of 20-30nt, and is in reverse complementary pairing with the binding site of the target RNA sequence. In the examples, the selected target RNAs are respectively long non-coding RNA NEAT1, non-coding RNA SaIII, endogenous mRNA MUC4 and exogenous overexpression mRNA GCN4, and the sequences of the spacer are shown in Table 1. The protein recognition regions of the grnas corresponding to each dCas13 protein are shown in table 2.
TABLE 1
Figure BDA0002277297520000151
TABLE 2
Figure BDA0002277297520000161
Annealing of gRNA primers, wherein the annealing system is as follows: forward primer (10. Mu.M) 10. Mu.L, reverse primer (10. Mu.M) 10. Mu.L, ddH 2 O30. Mu.L, 50. Mu.L in total. Annealing conditions: after denaturation at 95 ℃ for 5 min, slowly cool to room temperature.
The plasmid was digested with BbsI-HF (NEB) for 4 hours, and then recovered by agarose gel electrophoresis. And annealing double chains with gRNA and connecting the double chains with a gRNA by using T4 DNA ligase (NEB), wherein the reaction system is as follows:
TABLE 3
Figure BDA0002277297520000162
Figure BDA0002277297520000171
After 10 minutes of ligation at room temperature, trans-T1 competence (Beijing holotype gold organisms) was transformed and plated with LB plates containing ampicillin. After 10 hours of culture at 37 ℃, the single clone was picked up in 1mL of medium, and after positive clones were identified by sanger sequencing, 100mL of LB liquid medium containing 100. Mu.g/mL was inoculated, cultured at 37 ℃ for 16-20 hours, and extracted using a plasmid Large extraction kit (MACHEREY-NAGEL).
Example 2 Cas13 marker protein screening
In order to achieve specific labeling of target RNA in living cells, the inventors constructed recombinant proteins comprising 8 Cas13 proteins and green fluorescent protein EGFP from different sources, and the sequences of the recombinant proteins were as follows: dLbaCas13a-EGFP (SEQ ID NO: 1), dLwaCas13a-EGFP (SEQ ID NO: 2), dPspCas13b-EGFP (SEQ ID NO: 3), dPguCas13b-EGFP (SEQ ID NO: 4), dRanCas13b-EGFP (SEQ ID NO: 5), dAdmCas13d-EGFP (SEQ ID NO: 6), dEsCas13d-EGFP (SEQ ID NO: 7), dRfxCas13d-EGFP (SEQ ID NO: 8). The sequences of gRNAs targeting NEAT1 are shown in SEQ ID NOS: 19-34. Under the mediation of gNEAT1, the corresponding dCas13-EGFP can specifically bind to the objective NEAT1, thereby generating a specific labeling signal. Therefore, dCas13-EGFP and gRNA are transferred to a cell of HeLa-NONO-KI, and dCas13 protein capable of effectively marking target RNA is screened out through the strength of a signal marked by the dCas13-EGFP on the target RNA. Transfection was performed using Lipo3000 transfection reagent (Thermo Fisher scientific) in the following protocol:
TABLE 4
Cell culture 12-hole plate
Opti-MEM (2 tubes) Each 50 mu L
dCas13-EGFP (tube 1) 0.2μg
gNEAT1-1 (tube 1) 0.4μg
gNEAT1-2 (tube 1) 0.4μg
P3000 (pipe 1) 2μL
Lipo3000 (tube 2) 2μL
24 hours after transfection, cells were transferred to 35mm glass plates (Cellvis), and 36-48 hours later, they were changed to serum-free live cell culture medium, and signals were observed under a Delta-vision microscope at 60-fold mirror and photographed at 50% exposure intensity and 0.2 second exposure time, processed, and analyzed for results. As shown in FIG. 1, only dPspCas13b-EGFP and dPguCas13b-EGFP showed significant labeling effect on NEAT1, and the labeling effect of dPspCas13b-EGFP was better. However, the reported dLwaCas13a (Abudayyeh et al, 2017) and dRfxCas13d (Wang et al, 2019) for RNA labeling have no obvious labeling effect or cannot non-specifically label the target RNA.
Example 3 fluorescent protein optimization for the dPspCas13b-EGFP labeling System
To increase the fluorescence intensity of the marker signal, the inventors adopted the replacement of other more efficient luminescent proteins for optimization, including sfGFP protein, mneon green protein with fluorescence intensity nearly 3-fold higher than EGFP, 2 xmeon green, 3 × sfGFP and 3 × EGFP proteins in tandem, which can promote efficient folding of the fusion protein. The sequence of the recombinant protein is as follows; dPspCas13b-sfGFP (SEQ ID NO. 9); dPspCas13b-3 XSfGFP (SEQ ID NO. 10); dPspCas13b-mNeonGreen (SEQ ID NO. 11); dPspCas13b-2 XmNeonGreen (SEQ ID NO. 12); dPspCas13b-3 × EGFP (SEQ ID NO. 13). The gRNAs targeting NEAT1 (SEQ ID NO. 23-24), the cell culture conditions and methods, the transfection mode and imaging conditions were the same as in example 2. Through microscope shooting and calculation of signal to noise ratio, the result is shown in figure 2, and the dPspCas13b system fused with 3 xEGFP can mark better signals.
Example 4 labeling of other RNAs with dPspCas13b-3 xEGFP
To further prove the universality of the dPspCas13b-3 xEGFP labeled RNA, the inventors further selected three RNAs including a non-coding RNA SatIII, an endogenous mRNA MUC4, and an exogenous over-expression mRNA GCN4 as labeled objects, and designed two to three gRNAs respectively for them. The sequence of gRNA is shown in SEQ ID NO 35-42, wherein the spacer sequence is shown in Table 1.
dCas13-3 xEGFP and gRNA were transfected into HeLa cells using Lipo3000 transfection reagent (Thermo Fisher scientific) as follows:
Figure BDA0002277297520000181
Figure BDA0002277297520000191
wherein pmRuby3-HSF1 is a marker protein expression plasmid of substructure nSBs in the nucleus of the cell where SatIII is located, pmRuby3-24 xGCN 4 is an expression plasmid of exogenous GCN4 RNA, and the sequence of GCN4 RNA is shown as SEQ ID NO. 43. 24 hours after transfection, cells were transferred to 35mm glass plates (Cellvis) and, 36-48 hours later, replaced with serum-free live cell culture medium. For the labeling of MUC4 and GCN4, the signals were observed and imaged directly under a Delta-vision microscope at a 60-fold mirror, and the results were processed and analyzed. For the marker of SatIII, the signal is observed and imaged under a Delta-vision microscope at 60 times after being thermally stimulated at 42 ℃ for 1 hour and then revived at 37 ℃ for 1 hour, and the result is processed and analyzed, or the signal is observed and imaged under the Delta-vision microscope at 60 times after being treated with 0.1mM sodium arsenite for 6 hours, and the result is processed and analyzed. As shown in FIGS. 3, 4 and 5, respectively, the dPspCas13b-3 xEGFP has good labeling effect on non-coding RNA SatIII, endogenous mRNA MUC4, exogenous over-expression mRNA GCN4 and the like under the mediation effect of gRNA.
Example 5 mRNA tagging after optimization of the dPspCas13b fused fluorescent protein
To more efficiently label the RNA of the cytoplasmic distribution, the inventors further optimized the dPspCas13b fused fluorescent protein as well as the nuclear localization signal, including dPspCas13b-3 XSfGFP-3 XNLS fused with 3 XSfGFP and 3 nuclear localization signals (SEQ ID NO: 10), dPspCas13b-3 XSfGFP-2 XNLS fused with 3 XSfGFP and 2 nuclear localization signals (SEQ ID NO: 14), dPsas 13b-2 XmNeon Green-NLS fused with 2 XmNeon Green and 1 nuclear localization signal (SEQ ID NO: 15), dPsas 13b-2 XmNeon Green-2 XNLS fused with 2 XmNeon Green and 2 nuclear localization signals (SEQ ID NO: 12). By using grnas: gGCN4-2 (SEQ ID NO. 41) and gMUC4-2 (SEQ ID NO. 38) labeled GCN4 and MUC4 mRNAs, and as a result, as shown in FIG. 6, the dPspCas13b-3 XsfGFP-3 XNLS and dPsas 13b-2 XmNeon Green-NLS recombinant proteins can effectively label RNA localized in cytoplasm, and the dPspCas13b-3 XsfGFP-3 XNLS recombinant proteins have better labeling effect on RNA localized in cytoplasm and nucleus. The conditions and methods for culturing the above cells, the transfection method and the imaging conditions were the same as in example 4.
Example 6 Simultaneous two-color labeling of intracellular RNA with dPspCas13b and dPguCas13b
Using green fluorescent protein-labeled dPspCas13b (dPspCas 13b-3 xEGFP, SEQ ID NO. 13) and red fluorescent protein-labeled dPguCas13b (dPguCas 13b-3 xmRuby 3, SEQ ID NO. 16), NEAT1 and SatIII were labeled, respectively, so that these two RNAs were labeled with different colors, or simultaneously labeled SatIII so that this RNA was labeled with different colors at the same time. The grnas used were as follows: psp-gNEAT1-1 (SEQ ID NO. 19), gSatIII-1 and gSatIII-2 (SEQ ID NO. 35-36). Two sets of marker system plasmids were transfected into HeLa cells using Lipo3000 transfection reagent (Thermo Fisher scientific) in the following protocol:
Figure BDA0002277297520000201
24 hours after transfection, cells were transferred to 35mm glass plates (Cellvis), and 36-48 hours later, they were changed to serum-free live cell culture medium, and signals were observed under a Delta-vision microscope at 60-fold mirror and photographed at 50% exposure intensity and 0.2 second exposure time, processed, and analyzed for results. The results are shown in figure 7, where a green signal for tag NEAT1 and a red signal for tag SatIII can be seen using the doppcs 13b system targeting NEAT1 and the dppgusas 13b system targeting SatIII, respectively. Co-localized green and red signals were seen when dppcas 13b and dppguscas 13b were targeted to SatIII simultaneously.
Example 7 Simultaneous labeling of intracellular DNA and RNA with the CRISPR-dCas13 and CRISPR-dCas9 systems
DNA and RNA from MUC4 or SatIII were labeled with red fluorescent protein labeled dPspCas13b-mScarlet, SEQ ID NO:17 and green fluorescent protein labeled dCas9 (dCas 9-mEmerald, SEQ ID NO: 18), respectively. sgRNA used: sgMUC4 targeting MUC4 DNA (SEQ ID NO. 44), sgSatIII targeting SatIII DNA (SEQ ID NO. 45). gRNA used: gMUC4-2 targeting MUC4 RNA (SEQ ID NO. 38), gSatIII-1 targeting SatIII RNA (SEQ ID NO. 35). Two sets of marker system plasmids were transfected into HeLa cells using Lipo3000 transfection reagent (Thermo Fisher scientific) as follows:
Figure BDA0002277297520000211
24 hours after transfection, cells were transferred to 35mm glass plates (Cellvis), and 36-48 hours later, they were changed to serum-free live cell culture medium, and signals were observed under a Delta-vision microscope at 60-fold mirror and photographed at 50% exposure intensity and 0.2 second exposure time, processed, and analyzed for results. As a result, as shown in fig. 8, a green signal of labeled MUC4 DNA and a red signal of labeled MUC4 RNA were seen using the dCas9 system targeting MUC4 DNA and the dspcas 13b system targeting MUC4 RNA. The green signal for labeled MUC4 DNA and the red signal for labeled MUC4 RNA can be seen using the dCas9 system targeting SatIII DNA and the dPspCas13b system targeting SatIII RNA
The experiment shows that the living cell RNA marking method provided by the invention has the following characteristics: the detection efficiency and accuracy are high, the detection is convenient, and the RNA positioned in cytoplasm and cell nucleus can be marked simultaneously.
The advantages are favorable for the popularization and the application of the method in the research of RNA living cells, and provide a convenient and quick tool for the research of the dynamic change and the functional relationship of RNA by the living cells.
While the invention has been described with respect to a preferred embodiment, it will be understood by those skilled in the art that the foregoing and other changes, omissions and deviations in the form and detail thereof may be made without departing from the scope of this invention. Those skilled in the art can make various changes, modifications and equivalent arrangements, which are equivalent to the embodiments of the present invention, without departing from the spirit and scope of the present invention, and which may be made by utilizing the techniques disclosed above; meanwhile, any changes, modifications and variations of the above-described embodiments, which are equivalent to those of the technical spirit of the present invention, are within the scope of the technical solution of the present invention.
Sequence listing
<110> Shanghai Living sciences research institute of Chinese academy of sciences
<120> fusion protein for RNA labeling of living cells and application thereof
<130> 198413
<141> 2019-11-15
<160> 46
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1757
<212> PRT
<213> Artificial Sequence
<400> 1
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Met Lys Ile Ser Lys Val Arg Glu Glu Asn Arg Gly Ala
20 25 30
Lys Leu Thr Val Asn Ala Lys Thr Ala Val Val Ser Glu Asn Arg Ser
35 40 45
Gln Glu Gly Ile Leu Tyr Asn Asp Pro Ser Arg Tyr Gly Lys Ser Arg
50 55 60
Lys Asn Asp Glu Asp Arg Asp Arg Tyr Ile Glu Ser Arg Leu Lys Ser
65 70 75 80
Ser Gly Lys Leu Tyr Arg Ile Phe Asn Glu Asp Lys Asn Lys Arg Glu
85 90 95
Thr Asp Glu Leu Gln Trp Phe Leu Ser Glu Ile Val Lys Lys Ile Asn
100 105 110
Arg Arg Asn Gly Leu Val Leu Ser Asp Met Leu Ser Val Asp Asp Arg
115 120 125
Ala Phe Glu Lys Ala Phe Glu Lys Tyr Ala Glu Leu Ser Tyr Thr Asn
130 135 140
Arg Arg Asn Lys Val Ser Gly Ser Pro Ala Phe Glu Thr Cys Gly Val
145 150 155 160
Asp Ala Ala Thr Ala Glu Arg Leu Lys Gly Ile Ile Ser Glu Thr Asn
165 170 175
Phe Ile Asn Arg Ile Lys Asn Asn Ile Asp Asn Lys Val Ser Glu Asp
180 185 190
Ile Ile Asp Arg Ile Ile Ala Lys Tyr Leu Lys Lys Ser Leu Cys Arg
195 200 205
Glu Arg Val Lys Arg Gly Leu Lys Lys Leu Leu Met Asn Ala Phe Asp
210 215 220
Leu Pro Tyr Ser Asp Pro Asp Ile Asp Val Gln Arg Asp Phe Ile Asp
225 230 235 240
Tyr Val Leu Glu Asp Phe Tyr His Val Arg Ala Lys Ser Gln Val Ser
245 250 255
Arg Ser Ile Lys Asn Met Asn Met Pro Val Gln Pro Glu Gly Asp Gly
260 265 270
Lys Phe Ala Ile Thr Val Ser Lys Gly Gly Thr Glu Ser Gly Asn Lys
275 280 285
Arg Ser Ala Glu Lys Glu Ala Phe Lys Lys Phe Leu Ser Asp Tyr Ala
290 295 300
Ser Leu Asp Glu Arg Val Arg Asp Asp Met Leu Arg Arg Met Arg Arg
305 310 315 320
Leu Val Val Leu Tyr Phe Tyr Gly Ser Asp Asp Ser Lys Leu Ser Asp
325 330 335
Val Asn Glu Lys Phe Asp Val Trp Glu Asp His Ala Ala Arg Arg Val
340 345 350
Asp Asn Arg Glu Phe Ile Lys Leu Pro Leu Glu Asn Lys Leu Ala Asn
355 360 365
Gly Lys Thr Asp Lys Asp Ala Glu Arg Ile Arg Lys Asn Thr Val Lys
370 375 380
Glu Leu Tyr Arg Asn Gln Asn Ile Gly Cys Tyr Arg Gln Ala Val Lys
385 390 395 400
Ala Val Glu Glu Asp Asn Asn Gly Arg Tyr Phe Asp Asp Lys Met Leu
405 410 415
Asn Met Phe Phe Ile His Arg Ile Glu Tyr Gly Val Glu Lys Ile Tyr
420 425 430
Ala Asn Leu Lys Gln Val Thr Glu Phe Lys Ala Arg Thr Gly Tyr Leu
435 440 445
Ser Glu Lys Ile Trp Lys Asp Leu Ile Asn Tyr Ile Ser Ile Lys Tyr
450 455 460
Ile Ala Met Gly Lys Ala Val Tyr Asn Tyr Ala Met Asp Glu Leu Asn
465 470 475 480
Ala Ser Asp Lys Lys Glu Ile Glu Leu Gly Lys Ile Ser Glu Glu Tyr
485 490 495
Leu Ser Gly Ile Ser Ser Phe Asp Tyr Glu Leu Ile Lys Ala Glu Glu
500 505 510
Met Leu Gln Arg Glu Thr Ala Val Tyr Val Ala Phe Ala Ala Arg His
515 520 525
Leu Ser Ser Gln Thr Val Glu Leu Asp Ser Glu Asn Ser Asp Phe Leu
530 535 540
Leu Leu Lys Pro Lys Gly Thr Met Asp Lys Asn Asp Lys Asn Lys Leu
545 550 555 560
Ala Ser Asn Asn Ile Leu Asn Phe Leu Lys Asp Lys Glu Thr Leu Arg
565 570 575
Asp Thr Ile Leu Gln Tyr Phe Gly Gly His Ser Leu Trp Thr Asp Phe
580 585 590
Pro Phe Asp Lys Tyr Leu Ala Gly Gly Lys Asp Asp Val Asp Phe Leu
595 600 605
Thr Asp Leu Lys Asp Val Ile Tyr Ser Met Ala Asn Asp Ser Phe Ala
610 615 620
Tyr Ala Thr Glu Asn His Asn Asn Gly Lys Trp Asn Lys Glu Leu Ile
625 630 635 640
Ser Ala Met Phe Glu His Glu Thr Glu Arg Met Thr Val Val Met Lys
645 650 655
Asp Lys Phe Tyr Ser Asn Asn Leu Pro Met Phe Tyr Lys Asn Asp Asp
660 665 670
Leu Lys Lys Leu Leu Ile Asp Leu Tyr Lys Asp Asn Val Glu Arg Ala
675 680 685
Ser Gln Val Pro Ser Phe Asn Lys Val Phe Val Arg Lys Asn Phe Pro
690 695 700
Ala Leu Val Arg Asp Lys Asp Asn Leu Gly Ile Glu Leu Asp Leu Lys
705 710 715 720
Ala Asp Ala Asp Lys Gly Glu Asn Glu Leu Lys Phe Tyr Asn Ala Leu
725 730 735
Tyr Tyr Met Phe Lys Glu Ile Tyr Tyr Asn Ala Phe Leu Asn Asp Lys
740 745 750
Asn Val Arg Glu Arg Phe Ile Thr Lys Ala Thr Lys Val Ala Asp Asn
755 760 765
Tyr Asp Arg Asn Lys Glu Arg Asn Leu Lys Asp Arg Ile Lys Ser Ala
770 775 780
Gly Ser Asp Glu Lys Lys Lys Leu Arg Glu Gln Leu Gln Asn Tyr Ile
785 790 795 800
Ala Glu Asn Asp Phe Gly Gln Arg Ile Lys Asn Ile Val Gln Val Asn
805 810 815
Pro Asp Tyr Thr Leu Ala Gln Ile Cys Gln Leu Ile Met Thr Glu Tyr
820 825 830
Asn Gln Gln Asn Asn Gly Cys Met Gln Lys Lys Ser Ala Ala Arg Lys
835 840 845
Asp Ile Asn Lys Asp Ser Tyr Gln His Tyr Lys Met Leu Leu Leu Val
850 855 860
Asn Leu Arg Lys Ala Phe Leu Glu Phe Ile Lys Glu Asn Tyr Ala Phe
865 870 875 880
Val Leu Lys Pro Tyr Lys His Asp Leu Cys Asp Lys Ala Asp Phe Val
885 890 895
Pro Asp Phe Ala Lys Tyr Val Lys Pro Tyr Ala Gly Leu Ile Ser Arg
900 905 910
Val Ala Gly Ser Ser Glu Leu Gln Lys Trp Tyr Ile Val Ser Arg Phe
915 920 925
Leu Ser Pro Ala Gln Ala Asn His Met Leu Gly Phe Leu His Ser Tyr
930 935 940
Lys Gln Tyr Val Trp Asp Ile Tyr Arg Arg Ala Ser Glu Thr Gly Thr
945 950 955 960
Glu Ile Asn His Ser Ile Ala Glu Asp Lys Ile Ala Gly Val Asp Ile
965 970 975
Thr Asp Val Asp Ala Val Ile Asp Leu Ser Val Lys Leu Cys Gly Thr
980 985 990
Ile Ser Ser Glu Ile Ser Asp Tyr Phe Lys Asp Asp Glu Val Tyr Ala
995 1000 1005
Glu Tyr Ile Ser Ser Tyr Leu Asp Phe Glu Tyr Asp Gly Gly Asn Tyr
1010 1015 1020
Lys Asp Ser Leu Asn Arg Phe Cys Asn Ser Asp Ala Val Asn Asp Gln
1025 1030 1035 1040
Lys Val Ala Leu Tyr Tyr Asp Gly Glu His Pro Lys Leu Asn Arg Asn
1045 1050 1055
Ile Ile Leu Ser Lys Leu Tyr Gly Glu Arg Arg Phe Leu Glu Lys Ile
1060 1065 1070
Thr Asp Arg Val Ser Arg Ser Asp Ile Val Glu Tyr Tyr Lys Leu Lys
1075 1080 1085
Lys Glu Thr Ser Gln Tyr Gln Thr Lys Gly Ile Phe Asp Ser Glu Asp
1090 1095 1100
Glu Gln Lys Asn Ile Lys Lys Phe Gln Glu Met Lys Asn Ile Val Glu
1105 1110 1115 1120
Phe Arg Asp Leu Met Asp Tyr Ser Glu Ile Ala Asp Glu Leu Gln Gly
1125 1130 1135
Gln Leu Ile Asn Trp Ile Tyr Leu Arg Glu Arg Asp Leu Met Asn Phe
1140 1145 1150
Gln Leu Gly Tyr His Tyr Ala Cys Leu Asn Asn Asp Ser Asn Lys Gln
1155 1160 1165
Ala Thr Tyr Val Thr Leu Asp Tyr Gln Gly Lys Lys Asn Arg Lys Ile
1170 1175 1180
Asn Gly Ala Ile Leu Tyr Gln Ile Cys Ala Met Tyr Ile Asn Gly Leu
1185 1190 1195 1200
Pro Leu Tyr Tyr Val Asp Lys Asp Ser Ser Glu Trp Thr Val Ser Asp
1205 1210 1215
Gly Lys Glu Ser Thr Gly Ala Lys Ile Gly Glu Phe Tyr Arg Tyr Ala
1220 1225 1230
Lys Ser Phe Glu Asn Thr Ser Asp Cys Tyr Ala Ser Gly Leu Glu Ile
1235 1240 1245
Phe Glu Asn Ile Ser Glu His Asp Asn Ile Thr Glu Leu Ala Asn Tyr
1250 1255 1260
Ile Glu Ala Phe Arg Tyr Tyr Ser Ser Phe Asp Arg Ser Phe Leu Gly
1265 1270 1275 1280
Ile Tyr Ser Glu Val Phe Asp Arg Phe Phe Thr Tyr Asp Leu Lys Tyr
1285 1290 1295
Arg Lys Asn Val Pro Thr Ile Leu Tyr Asn Ile Leu Leu Gln His Phe
1300 1305 1310
Val Asn Val Arg Phe Glu Phe Val Ser Gly Lys Lys Met Ile Gly Ile
1315 1320 1325
Asp Lys Lys Asp Arg Lys Ile Ala Lys Glu Lys Glu Cys Ala Arg Ile
1330 1335 1340
Thr Ile Arg Glu Lys Asn Gly Val Tyr Ser Glu Gln Phe Thr Tyr Lys
1345 1350 1355 1360
Leu Lys Asn Gly Thr Val Tyr Val Asp Ala Arg Asp Lys Arg Tyr Leu
1365 1370 1375
Gln Ser Ile Ile Arg Leu Leu Phe Tyr Pro Glu Lys Val Asn Met Asp
1380 1385 1390
Glu Met Ile Glu Val Lys Glu Lys Lys Lys Pro Ser Asp Asn Asn Thr
1395 1400 1405
Gly Lys Gly Tyr Ser Lys Arg Asp Arg Gln Gln Asp Arg Lys Glu Tyr
1410 1415 1420
Asp Lys Tyr Lys Glu Lys Lys Lys Lys Glu Gly Asn Phe Leu Ser Gly
1425 1430 1435 1440
Met Gly Gly Asn Ile Asn Trp Asp Glu Ile Asn Ala Gln Leu Lys Asn
1445 1450 1455
Ser Leu Glu Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu
1460 1465 1470
Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val
1475 1480 1485
Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr
1490 1495 1500
Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro
1505 1510 1515 1520
Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys
1525 1530 1535
Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser
1540 1545 1550
Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp
1555 1560 1565
Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr
1570 1575 1580
Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly
1585 1590 1595 1600
Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val
1605 1610 1615
Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys
1620 1625 1630
Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr
1635 1640 1645
Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn
1650 1655 1660
His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys
1665 1670 1675 1680
Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr
1685 1690 1695
Leu Gly Met Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His
1700 1705 1710
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1715 1720 1725
Lys Gln Arg Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr
1730 1735 1740
Lys Asp His Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1745 1750 1755
<210> 2
<211> 1471
<212> PRT
<213> Artificial Sequence
<400> 2
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Lys Val Thr Lys Val Asp Gly Ile Ser His Lys Lys Tyr
20 25 30
Ile Glu Glu Gly Lys Leu Val Lys Ser Thr Ser Glu Glu Asn Arg Thr
35 40 45
Ser Glu Arg Leu Ser Glu Leu Leu Ser Ile Arg Leu Asp Ile Tyr Ile
50 55 60
Lys Asn Pro Asp Asn Ala Ser Glu Glu Glu Asn Arg Ile Arg Arg Glu
65 70 75 80
Asn Leu Lys Lys Phe Phe Ser Asn Lys Val Leu His Leu Lys Asp Ser
85 90 95
Val Leu Tyr Leu Lys Asn Arg Lys Glu Lys Asn Ala Val Gln Asp Lys
100 105 110
Asn Tyr Ser Glu Glu Asp Ile Ser Glu Tyr Asp Leu Lys Asn Lys Asn
115 120 125
Ser Phe Ser Val Leu Lys Lys Ile Leu Leu Asn Glu Asp Val Asn Ser
130 135 140
Glu Glu Leu Glu Ile Phe Arg Lys Asp Val Glu Ala Lys Leu Asn Lys
145 150 155 160
Ile Asn Ser Leu Lys Tyr Ser Phe Glu Glu Asn Lys Ala Asn Tyr Gln
165 170 175
Lys Ile Asn Glu Asn Asn Val Glu Lys Val Gly Gly Lys Ser Lys Arg
180 185 190
Asn Ile Ile Tyr Asp Tyr Tyr Arg Glu Ser Ala Lys Arg Asn Asp Tyr
195 200 205
Ile Asn Asn Val Gln Glu Ala Phe Asp Lys Leu Tyr Lys Lys Glu Asp
210 215 220
Ile Glu Lys Leu Phe Phe Leu Ile Glu Asn Ser Lys Lys His Glu Lys
225 230 235 240
Tyr Lys Ile Arg Glu Tyr Tyr His Lys Ile Ile Gly Arg Lys Asn Asp
245 250 255
Lys Glu Asn Phe Ala Lys Ile Ile Tyr Glu Glu Ile Gln Asn Val Asn
260 265 270
Asn Ile Lys Glu Leu Ile Glu Lys Ile Pro Asp Met Ser Glu Leu Lys
275 280 285
Lys Ser Gln Val Phe Tyr Lys Tyr Tyr Leu Asp Lys Glu Glu Leu Asn
290 295 300
Asp Lys Asn Ile Lys Tyr Ala Phe Cys His Phe Val Glu Ile Glu Met
305 310 315 320
Ser Gln Leu Leu Lys Asn Tyr Val Tyr Lys Arg Leu Ser Asn Ile Ser
325 330 335
Asn Asp Lys Ile Lys Arg Ile Phe Glu Tyr Gln Asn Leu Lys Lys Leu
340 345 350
Ile Glu Asn Lys Leu Leu Asn Lys Leu Asp Thr Tyr Val Arg Asn Cys
355 360 365
Gly Lys Tyr Asn Tyr Tyr Leu Gln Val Gly Glu Ile Ala Thr Ser Asp
370 375 380
Phe Ile Ala Arg Asn Arg Gln Asn Glu Ala Phe Leu Arg Asn Ile Ile
385 390 395 400
Gly Val Ser Ser Val Ala Tyr Phe Ser Leu Arg Asn Ile Leu Glu Thr
405 410 415
Glu Asn Glu Asn Asp Ile Thr Gly Arg Met Arg Gly Lys Thr Val Lys
420 425 430
Asn Asn Lys Gly Glu Glu Lys Tyr Val Ser Gly Glu Val Asp Lys Ile
435 440 445
Tyr Asn Glu Asn Lys Gln Asn Glu Val Lys Glu Asn Leu Lys Met Phe
450 455 460
Tyr Ser Tyr Asp Phe Asn Met Asp Asn Lys Asn Glu Ile Glu Asp Phe
465 470 475 480
Phe Ala Asn Ile Asp Glu Ala Ile Ser Ser Ile Ala His Gly Ile Val
485 490 495
Ala Phe Asn Leu Glu Leu Glu Gly Lys Asp Ile Phe Ala Phe Lys Asn
500 505 510
Ile Ala Pro Ser Glu Ile Ser Lys Lys Met Phe Gln Asn Glu Ile Asn
515 520 525
Glu Lys Lys Leu Lys Leu Lys Ile Phe Lys Gln Leu Asn Ser Ala Asn
530 535 540
Val Phe Asn Tyr Tyr Glu Lys Asp Val Ile Ile Lys Tyr Leu Lys Asn
545 550 555 560
Thr Lys Phe Asn Phe Val Asn Lys Asn Ile Pro Phe Val Pro Ser Phe
565 570 575
Thr Lys Leu Tyr Asn Lys Ile Glu Asp Leu Arg Asn Thr Leu Lys Phe
580 585 590
Phe Trp Ser Val Pro Lys Asp Lys Glu Glu Lys Asp Ala Gln Ile Tyr
595 600 605
Leu Leu Lys Asn Ile Tyr Tyr Gly Glu Phe Leu Asn Lys Phe Val Lys
610 615 620
Asn Ser Lys Val Phe Phe Lys Ile Thr Asn Glu Val Ile Lys Ile Asn
625 630 635 640
Lys Gln Arg Asn Gln Lys Thr Gly His Tyr Lys Tyr Gln Lys Phe Glu
645 650 655
Asn Ile Glu Lys Thr Val Pro Val Glu Tyr Leu Ala Ile Ile Gln Ser
660 665 670
Arg Glu Met Ile Asn Asn Gln Asp Lys Glu Glu Lys Asn Thr Tyr Ile
675 680 685
Asp Phe Ile Gln Gln Ile Phe Leu Lys Gly Phe Ile Asp Tyr Leu Asn
690 695 700
Lys Asn Asn Leu Lys Tyr Ile Glu Ser Asn Asn Asn Asn Asp Asn Asn
705 710 715 720
Asp Ile Phe Ser Lys Ile Lys Ile Lys Lys Asp Asn Lys Glu Lys Tyr
725 730 735
Asp Lys Ile Leu Lys Asn Tyr Glu Lys His Asn Arg Asn Lys Glu Ile
740 745 750
Pro His Glu Ile Asn Glu Phe Val Arg Glu Ile Lys Leu Gly Lys Ile
755 760 765
Leu Lys Tyr Thr Glu Asn Leu Asn Met Phe Tyr Leu Ile Leu Lys Leu
770 775 780
Leu Asn His Lys Glu Leu Thr Asn Leu Lys Gly Ser Leu Glu Lys Tyr
785 790 795 800
Gln Ser Ala Asn Lys Glu Glu Thr Phe Ser Asp Glu Leu Glu Leu Ile
805 810 815
Asn Leu Leu Asn Leu Asp Asn Asn Arg Val Thr Glu Asp Phe Glu Leu
820 825 830
Glu Ala Asn Glu Ile Gly Lys Phe Leu Asp Phe Asn Glu Asn Lys Ile
835 840 845
Lys Asp Arg Lys Glu Leu Lys Lys Phe Asp Thr Asn Lys Ile Tyr Phe
850 855 860
Asp Gly Glu Asn Ile Ile Lys His Arg Ala Phe Tyr Asn Ile Lys Lys
865 870 875 880
Tyr Gly Met Leu Asn Leu Leu Glu Lys Ile Ala Asp Lys Ala Lys Tyr
885 890 895
Lys Ile Ser Leu Lys Glu Leu Lys Glu Tyr Ser Asn Lys Lys Asn Glu
900 905 910
Ile Glu Lys Asn Tyr Thr Met Gln Gln Asn Leu His Arg Lys Tyr Ala
915 920 925
Arg Pro Lys Lys Asp Glu Lys Phe Asn Asp Glu Asp Tyr Lys Glu Tyr
930 935 940
Glu Lys Ala Ile Gly Asn Ile Gln Lys Tyr Thr His Leu Lys Asn Lys
945 950 955 960
Val Glu Phe Asn Glu Leu Asn Leu Leu Gln Gly Leu Leu Leu Lys Ile
965 970 975
Leu His Arg Leu Val Gly Tyr Thr Ser Ile Trp Glu Arg Asp Leu Arg
980 985 990
Phe Arg Leu Lys Gly Glu Phe Pro Glu Asn His Tyr Ile Glu Glu Ile
995 1000 1005
Phe Asn Phe Asp Asn Ser Lys Asn Val Lys Tyr Lys Ser Gly Gln Ile
1010 1015 1020
Val Glu Lys Tyr Ile Asn Phe Tyr Lys Glu Leu Tyr Lys Asp Asn Val
1025 1030 1035 1040
Glu Lys Arg Ser Ile Tyr Ser Asp Lys Lys Val Lys Lys Leu Lys Gln
1045 1050 1055
Glu Lys Lys Asp Leu Tyr Ile Ala Asn Tyr Ile Ala Ala Phe Asn Tyr
1060 1065 1070
Ile Pro His Ala Glu Ile Ser Leu Leu Glu Val Leu Glu Asn Leu Arg
1075 1080 1085
Lys Leu Leu Ser Tyr Asp Arg Lys Leu Lys Asn Ala Ile Met Lys Ser
1090 1095 1100
Ile Val Asp Ile Leu Lys Glu Tyr Gly Phe Val Ala Thr Phe Lys Ile
1105 1110 1115 1120
Gly Ala Asp Lys Lys Ile Glu Ile Gln Thr Leu Glu Ser Glu Lys Ile
1125 1130 1135
Val His Leu Lys Asn Leu Lys Lys Lys Lys Leu Met Thr Asp Arg Asn
1140 1145 1150
Ser Glu Glu Leu Cys Glu Leu Val Lys Val Met Phe Glu Tyr Lys Ala
1155 1160 1165
Leu Glu Gly Leu Glu Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly
1170 1175 1180
Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly
1185 1190 1195 1200
Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp
1205 1210 1215
Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys
1220 1225 1230
Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val
1235 1240 1245
Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe
1250 1255 1260
Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe
1265 1270 1275 1280
Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly
1285 1290 1295
Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu
1300 1305 1310
Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His
1315 1320 1325
Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn
1330 1335 1340
Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp
1345 1350 1355 1360
His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro
1365 1370 1375
Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn
1380 1385 1390
Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly
1395 1400 1405
Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly
1410 1415 1420
Phe His Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys
1425 1430 1435 1440
Lys Lys Lys Gln Arg Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly
1445 1450 1455
Asp Tyr Lys Asp His Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1460 1465 1470
<210> 3
<211> 1400
<212> PRT
<213> Artificial Sequence
<400> 3
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Glu Gly Ala Leu Glu Ala Leu
1090 1095 1100
Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val
1105 1110 1115 1120
Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe
1125 1130 1135
Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr
1140 1145 1150
Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr
1155 1160 1165
Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro
1170 1175 1180
Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly
1185 1190 1195 1200
Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys
1205 1210 1215
Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile
1220 1225 1230
Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His
1235 1240 1245
Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp
1250 1255 1260
Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile
1265 1270 1275 1280
Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro
1285 1290 1295
Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr
1300 1305 1310
Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val
1315 1320 1325
Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu
1330 1335 1340
Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys Arg Pro Ala
1345 1350 1355 1360
Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg Val Gln
1365 1370 1375
Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His Asp Ile
1380 1385 1390
Asp Tyr Lys Asp Asp Asp Asp Lys
1395 1400
<210> 4
<211> 1483
<212> PRT
<213> Artificial Sequence
<400> 4
Met Pro Lys Lys Lys Arg Lys Val Thr Glu Gln Ser Glu Arg Pro Tyr
1 5 10 15
Asn Gly Thr Tyr Tyr Thr Leu Glu Asp Lys His Phe Trp Ala Ala Phe
20 25 30
Leu Asn Leu Ala Arg His Asn Ala Tyr Ile Thr Leu Thr His Ile Asp
35 40 45
Arg Gln Leu Ala Tyr Ser Lys Ala Asp Ile Thr Asn Asp Gln Asp Val
50 55 60
Leu Ser Phe Lys Ala Leu Trp Lys Asn Phe Asp Asn Asp Leu Glu Arg
65 70 75 80
Lys Ser Arg Leu Arg Ser Leu Ile Leu Lys His Phe Ser Phe Leu Glu
85 90 95
Gly Ala Ala Tyr Gly Lys Lys Leu Phe Glu Ser Lys Ser Ser Gly Asn
100 105 110
Lys Ser Ser Lys Asn Lys Glu Leu Thr Lys Lys Glu Lys Glu Glu Leu
115 120 125
Gln Ala Asn Ala Leu Ser Leu Asp Asn Leu Lys Ser Ile Leu Phe Asp
130 135 140
Phe Leu Gln Lys Leu Lys Asp Phe Arg Asn Tyr Tyr Ser Ala Tyr Arg
145 150 155 160
His Ser Gly Ser Ser Glu Leu Pro Leu Phe Asp Gly Asn Met Leu Gln
165 170 175
Arg Leu Tyr Asn Val Phe Asp Val Ser Val Gln Arg Val Lys Ile Asp
180 185 190
His Glu His Asn Asp Glu Val Asp Pro His Tyr His Phe Asn His Leu
195 200 205
Val Arg Lys Gly Lys Lys Asp Arg Tyr Gly His Asn Asp Asn Pro Ser
210 215 220
Phe Lys His His Phe Val Asp Gly Glu Gly Met Val Thr Glu Ala Gly
225 230 235 240
Leu Leu Phe Phe Val Ser Leu Phe Leu Glu Lys Arg Asp Ala Ile Trp
245 250 255
Met Gln Lys Lys Ile Arg Gly Phe Lys Gly Gly Thr Glu Thr Tyr Gln
260 265 270
Gln Met Thr Asn Glu Val Phe Cys Arg Ser Arg Ile Ser Leu Pro Lys
275 280 285
Leu Lys Leu Glu Ser Leu Arg Met Asp Asp Trp Met Leu Leu Asp Met
290 295 300
Leu Asn Glu Leu Val Arg Cys Pro Lys Pro Leu Tyr Asp Arg Leu Arg
305 310 315 320
Glu Asp Asp Arg Ala Cys Phe Arg Val Pro Val Asp Ile Leu Pro Asp
325 330 335
Glu Asp Asp Thr Asp Gly Gly Gly Glu Asp Pro Phe Lys Asn Thr Leu
340 345 350
Val Arg His Gln Asp Arg Phe Pro Tyr Phe Ala Leu Arg Tyr Phe Asp
355 360 365
Leu Lys Lys Val Phe Thr Ser Leu Arg Phe His Ile Asp Leu Gly Thr
370 375 380
Tyr His Phe Ala Ile Tyr Lys Lys Met Ile Gly Glu Gln Pro Glu Asp
385 390 395 400
Arg His Leu Thr Arg Asn Leu Tyr Gly Phe Gly Arg Ile Gln Asp Phe
405 410 415
Ala Glu Glu His Arg Pro Glu Glu Trp Lys Arg Leu Val Arg Asp Leu
420 425 430
Asp Tyr Phe Glu Thr Gly Asp Lys Pro Tyr Ile Ser Gln Thr Ser Pro
435 440 445
His Tyr His Ile Glu Lys Gly Lys Ile Gly Leu Arg Phe Met Pro Glu
450 455 460
Gly Gln His Leu Trp Pro Ser Pro Glu Val Gly Thr Thr Arg Thr Gly
465 470 475 480
Arg Ser Lys Tyr Ala Gln Asp Lys Arg Leu Thr Ala Glu Ala Phe Leu
485 490 495
Ser Val His Glu Leu Met Pro Met Met Phe Tyr Tyr Phe Leu Leu Arg
500 505 510
Glu Lys Tyr Ser Glu Glu Val Ser Ala Glu Arg Val Gln Gly Arg Ile
515 520 525
Lys Arg Val Ile Glu Asp Val Tyr Ala Val Tyr Asp Ala Phe Ala Arg
530 535 540
Asp Glu Ile Asn Thr Arg Asp Glu Leu Asp Ala Cys Leu Ala Asp Lys
545 550 555 560
Gly Ile Arg Arg Gly His Leu Pro Arg Gln Met Ile Ala Ile Leu Ser
565 570 575
Gln Glu His Lys Asp Met Glu Glu Lys Ile Arg Lys Lys Leu Gln Glu
580 585 590
Met Met Ala Asp Thr Asp His Arg Leu Asp Met Leu Asp Arg Gln Thr
595 600 605
Asp Arg Lys Ile Arg Ile Gly Arg Lys Asn Ala Gly Leu Pro Lys Ser
610 615 620
Gly Val Ile Ala Asp Trp Leu Val Arg Asp Met Met Arg Phe Gln Pro
625 630 635 640
Val Ala Lys Asp Ala Ser Gly Lys Pro Leu Asn Asn Ser Lys Ala Asn
645 650 655
Ser Thr Glu Tyr Arg Met Leu Gln Arg Ala Leu Ala Leu Phe Gly Gly
660 665 670
Glu Lys Glu Arg Leu Thr Pro Tyr Phe Arg Gln Met Asn Leu Thr Gly
675 680 685
Gly Asn Asn Pro His Pro Phe Leu His Glu Thr Arg Trp Glu Ser His
690 695 700
Thr Asn Ile Leu Ser Phe Tyr Arg Ser Tyr Leu Arg Ala Arg Lys Ala
705 710 715 720
Phe Leu Glu Arg Ile Gly Arg Ser Asp Arg Val Glu Asn Arg Pro Phe
725 730 735
Leu Leu Leu Lys Glu Pro Lys Thr Asp Arg Gln Thr Leu Val Ala Gly
740 745 750
Trp Lys Gly Glu Phe His Leu Pro Arg Gly Ile Phe Thr Glu Ala Val
755 760 765
Arg Asp Cys Leu Ile Glu Met Gly His Asp Glu Val Ala Ser Tyr Lys
770 775 780
Glu Val Gly Phe Met Ala Lys Ala Val Pro Leu Tyr Phe Glu Arg Ala
785 790 795 800
Cys Glu Asp Arg Val Gln Pro Phe Tyr Asp Ser Pro Phe Asn Val Gly
805 810 815
Asn Ser Leu Lys Pro Lys Lys Gly Arg Phe Leu Ser Lys Glu Glu Arg
820 825 830
Ala Glu Glu Trp Glu Arg Gly Lys Glu Arg Phe Arg Asp Leu Glu Ala
835 840 845
Trp Ser Tyr Ser Ala Ala Arg Arg Ile Glu Asp Ala Phe Ala Gly Ile
850 855 860
Glu Tyr Ala Ser Pro Gly Asn Lys Lys Lys Ile Glu Gln Leu Leu Arg
865 870 875 880
Asp Leu Ser Leu Trp Glu Ala Phe Glu Ser Lys Leu Lys Val Arg Ala
885 890 895
Asp Arg Ile Asn Leu Ala Lys Leu Lys Lys Glu Ile Leu Glu Ala Gln
900 905 910
Glu His Pro Tyr His Asp Phe Lys Ser Trp Gln Lys Phe Glu Arg Glu
915 920 925
Leu Arg Leu Val Lys Asn Gln Asp Ile Ile Thr Trp Met Met Cys Arg
930 935 940
Asp Leu Met Glu Glu Asn Lys Val Glu Gly Leu Asp Thr Gly Thr Leu
945 950 955 960
Tyr Leu Lys Asp Ile Arg Pro Asn Val Gln Glu Gln Gly Ser Leu Asn
965 970 975
Val Leu Asn Arg Val Lys Pro Met Arg Leu Pro Val Val Val Tyr Arg
980 985 990
Ala Asp Ser Arg Gly His Val His Lys Glu Glu Ala Pro Leu Ala Thr
995 1000 1005
Val Tyr Ile Glu Glu Arg Asp Thr Lys Leu Leu Lys Gln Gly Asn Phe
1010 1015 1020
Lys Ser Phe Val Lys Asp Arg Arg Leu Asn Gly Leu Phe Ser Phe Val
1025 1030 1035 1040
Asp Thr Gly Gly Leu Ala Met Glu Gln Tyr Pro Ile Ser Lys Leu Arg
1045 1050 1055
Val Glu Tyr Glu Leu Ala Lys Tyr Gln Thr Ala Arg Val Cys Val Phe
1060 1065 1070
Glu Leu Thr Leu Arg Leu Glu Glu Ser Leu Leu Thr Arg Tyr Pro His
1075 1080 1085
Leu Pro Asp Glu Ser Phe Arg Glu Met Leu Glu Ser Trp Ser Asp Pro
1090 1095 1100
Leu Leu Ala Lys Trp Pro Glu Leu His Gly Lys Val Arg Leu Leu Ile
1105 1110 1115 1120
Ala Val Arg Asn Ala Phe Ser Ala Asn Gln Tyr Pro Met Tyr Asp Glu
1125 1130 1135
Ala Val Phe Ser Ser Ile Arg Lys Tyr Asp Pro Ser Ser Pro Asp Ala
1140 1145 1150
Ile Glu Glu Arg Met Gly Leu Asn Ile Ala His Arg Leu Ser Glu Glu
1155 1160 1165
Val Lys Gln Ala Lys Glu Thr Val Glu Arg Ile Ile Gln Ala Ser Leu
1170 1175 1180
Glu Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
1185 1190 1195 1200
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
1205 1210 1215
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
1220 1225 1230
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
1235 1240 1245
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
1250 1255 1260
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
1265 1270 1275 1280
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
1285 1290 1295
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
1300 1305 1310
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
1315 1320 1325
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
1330 1335 1340
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
1345 1350 1355 1360
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
1365 1370 1375
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
1380 1385 1390
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
1395 1400 1405
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
1410 1415 1420
Met Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys
1425 1430 1435 1440
Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln
1445 1450 1455
Arg Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp
1460 1465 1470
His Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1475 1480
<210> 5
<211> 1403
<212> PRT
<213> Artificial Sequence
<400> 5
Met Pro Lys Lys Lys Arg Lys Val Glu Lys Pro Leu Leu Pro Asn Val
1 5 10 15
Tyr Thr Leu Lys His Lys Phe Phe Trp Gly Ala Phe Leu Asn Ile Ala
20 25 30
Arg His Asn Ala Phe Ile Thr Ile Cys His Ile Asn Glu Gln Leu Gly
35 40 45
Leu Lys Thr Pro Ser Asn Asp Asp Lys Ile Val Asp Val Val Cys Glu
50 55 60
Thr Trp Asn Asn Ile Leu Asn Asn Asp His Asp Leu Leu Lys Lys Ser
65 70 75 80
Gln Leu Thr Glu Leu Ile Leu Lys His Phe Pro Phe Leu Thr Ala Met
85 90 95
Cys Tyr His Pro Pro Lys Lys Glu Gly Lys Lys Lys Gly His Gln Lys
100 105 110
Glu Gln Gln Lys Glu Lys Glu Ser Glu Ala Gln Ser Gln Ala Glu Ala
115 120 125
Leu Asn Pro Ser Lys Leu Ile Glu Ala Leu Glu Ile Leu Val Asn Gln
130 135 140
Leu His Ser Leu Arg Asn Tyr Tyr Ser Ala Tyr Lys His Lys Lys Pro
145 150 155 160
Asp Ala Glu Lys Asp Ile Phe Lys His Leu Tyr Lys Ala Phe Asp Ala
165 170 175
Ser Leu Arg Met Val Lys Glu Asp Tyr Lys Ala His Phe Thr Val Asn
180 185 190
Leu Thr Arg Asp Phe Ala His Leu Asn Arg Lys Gly Lys Asn Lys Gln
195 200 205
Asp Asn Pro Asp Phe Asn Arg Tyr Arg Phe Glu Lys Asp Gly Phe Phe
210 215 220
Thr Glu Ser Gly Leu Leu Phe Phe Thr Asn Leu Phe Leu Asp Lys Arg
225 230 235 240
Asp Ala Tyr Trp Met Leu Lys Lys Val Ser Gly Phe Lys Ala Ser His
245 250 255
Lys Gln Arg Glu Lys Met Thr Thr Glu Val Phe Cys Arg Ser Arg Ile
260 265 270
Leu Leu Pro Lys Leu Arg Leu Glu Ser Arg Tyr Asp His Asn Gln Met
275 280 285
Leu Leu Asp Met Leu Ser Glu Leu Ser Arg Cys Pro Lys Leu Leu Tyr
290 295 300
Glu Lys Leu Ser Glu Glu Asn Lys Lys His Phe Gln Val Glu Ala Asp
305 310 315 320
Gly Phe Leu Asp Glu Ile Glu Glu Glu Gln Asn Pro Phe Lys Asp Thr
325 330 335
Leu Ile Arg His Gln Asp Arg Phe Pro Tyr Phe Ala Leu Arg Tyr Leu
340 345 350
Asp Leu Asn Glu Ser Phe Lys Ser Ile Arg Phe Gln Val Asp Leu Gly
355 360 365
Thr Tyr His Tyr Cys Ile Tyr Asp Lys Lys Ile Gly Asp Glu Gln Glu
370 375 380
Lys Arg His Leu Thr Arg Thr Leu Leu Ser Phe Gly Arg Leu Gln Asp
385 390 395 400
Phe Thr Glu Ile Asn Arg Pro Gln Glu Trp Lys Ala Leu Thr Lys Asp
405 410 415
Leu Asp Tyr Lys Glu Thr Ser Asn Gln Pro Phe Ile Ser Lys Thr Thr
420 425 430
Pro His Tyr His Ile Thr Asp Asn Lys Ile Gly Phe Arg Leu Gly Thr
435 440 445
Ser Lys Glu Leu Tyr Pro Ser Leu Glu Ile Lys Asp Gly Ala Asn Arg
450 455 460
Ile Ala Lys Tyr Pro Tyr Asn Ser Gly Phe Val Ala His Ala Phe Ile
465 470 475 480
Ser Val His Glu Leu Leu Pro Leu Met Phe Tyr Gln His Leu Thr Gly
485 490 495
Lys Ser Glu Asp Leu Leu Lys Glu Thr Val Arg His Ile Gln Arg Ile
500 505 510
Tyr Lys Asp Phe Glu Glu Glu Arg Ile Asn Thr Ile Glu Asp Leu Glu
515 520 525
Lys Ala Asn Gln Gly Arg Leu Pro Leu Gly Ala Phe Pro Lys Gln Met
530 535 540
Leu Gly Leu Leu Gln Asn Lys Gln Pro Asp Leu Ser Glu Lys Ala Lys
545 550 555 560
Ile Lys Ile Glu Lys Leu Ile Ala Glu Thr Lys Leu Leu Ser His Arg
565 570 575
Leu Asn Thr Lys Leu Lys Ser Ser Pro Lys Leu Gly Lys Arg Arg Glu
580 585 590
Lys Leu Ile Lys Thr Gly Val Leu Ala Asp Trp Leu Val Lys Asp Phe
595 600 605
Met Arg Phe Gln Pro Val Ala Tyr Asp Ala Gln Asn Gln Pro Ile Lys
610 615 620
Ser Ser Lys Ala Asn Ser Thr Glu Phe Trp Phe Ile Arg Arg Ala Leu
625 630 635 640
Ala Leu Tyr Gly Gly Glu Lys Asn Arg Leu Glu Gly Tyr Phe Lys Gln
645 650 655
Thr Asn Leu Ile Gly Asn Thr Asn Pro His Pro Phe Leu Asn Lys Phe
660 665 670
Asn Trp Lys Ala Cys Arg Asn Leu Val Asp Phe Tyr Gln Gln Tyr Leu
675 680 685
Glu Gln Arg Glu Lys Phe Leu Glu Ala Ile Lys Asn Gln Pro Trp Glu
690 695 700
Pro Tyr Gln Tyr Cys Leu Leu Leu Lys Ile Pro Lys Glu Asn Arg Lys
705 710 715 720
Asn Leu Val Lys Gly Trp Glu Gln Gly Gly Ile Ser Leu Pro Arg Gly
725 730 735
Leu Phe Thr Glu Ala Ile Arg Glu Thr Leu Ser Glu Asp Leu Met Leu
740 745 750
Ser Lys Pro Ile Arg Lys Glu Ile Lys Lys His Gly Arg Val Gly Phe
755 760 765
Ile Ser Arg Ala Ile Thr Leu Tyr Phe Lys Glu Lys Tyr Gln Asp Lys
770 775 780
His Gln Ser Phe Tyr Asn Leu Ser Tyr Lys Leu Glu Ala Lys Ala Pro
785 790 795 800
Leu Leu Lys Arg Glu Glu His Tyr Glu Tyr Trp Gln Gln Asn Lys Pro
805 810 815
Gln Ser Pro Thr Glu Ser Gln Arg Leu Glu Leu His Thr Ser Asp Arg
820 825 830
Trp Lys Asp Tyr Leu Leu Tyr Lys Arg Trp Gln His Leu Glu Lys Lys
835 840 845
Leu Arg Leu Tyr Arg Asn Gln Asp Val Met Leu Trp Leu Met Thr Leu
850 855 860
Glu Leu Thr Lys Asn His Phe Lys Glu Leu Asn Leu Asn Tyr His Gln
865 870 875 880
Leu Lys Leu Glu Asn Leu Ala Val Asn Val Gln Glu Ala Asp Ala Lys
885 890 895
Leu Asn Pro Leu Asn Gln Thr Leu Pro Met Val Leu Pro Val Lys Val
900 905 910
Tyr Pro Ala Thr Ala Phe Gly Glu Val Gln Tyr His Lys Thr Pro Ile
915 920 925
Arg Thr Val Tyr Ile Arg Glu Glu His Thr Lys Ala Leu Lys Met Gly
930 935 940
Asn Phe Lys Ala Leu Val Lys Asp Arg Arg Leu Asn Gly Leu Phe Ser
945 950 955 960
Phe Ile Lys Glu Glu Asn Asp Thr Gln Lys His Pro Ile Ser Gln Leu
965 970 975
Arg Leu Arg Arg Glu Leu Glu Ile Tyr Gln Ser Leu Arg Val Asp Ala
980 985 990
Phe Lys Glu Thr Leu Ser Leu Glu Glu Lys Leu Leu Asn Lys His Thr
995 1000 1005
Ser Leu Ser Ser Leu Glu Asn Glu Phe Arg Ala Leu Leu Glu Glu Trp
1010 1015 1020
Lys Lys Glu Tyr Ala Ala Ser Ser Met Val Thr Asp Glu His Ile Ala
1025 1030 1035 1040
Phe Ile Ala Ser Val Arg Asn Ala Phe Cys Ala Asn Gln Tyr Pro Phe
1045 1050 1055
Tyr Lys Glu Ala Leu His Ala Pro Ile Pro Leu Phe Thr Val Ala Gln
1060 1065 1070
Pro Thr Thr Glu Glu Lys Asp Gly Leu Gly Ile Ala Glu Ala Leu Leu
1075 1080 1085
Lys Val Leu Arg Glu Tyr Cys Glu Ile Val Lys Ser Gln Ile Gly Leu
1090 1095 1100
Glu Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
1105 1110 1115 1120
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
1125 1130 1135
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
1140 1145 1150
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
1155 1160 1165
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
1170 1175 1180
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
1185 1190 1195 1200
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
1205 1210 1215
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
1220 1225 1230
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
1235 1240 1245
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
1250 1255 1260
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
1265 1270 1275 1280
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
1285 1290 1295
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
1300 1305 1310
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
1315 1320 1325
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
1330 1335 1340
Met Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys
1345 1350 1355 1360
Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln
1365 1370 1375
Arg Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp
1380 1385 1390
His Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1395 1400
<210> 6
<211> 1266
<212> PRT
<213> Artificial Sequence
<400> 6
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Met Asn Asn Lys Arg Lys Thr Lys Ala Lys Ala Ala Gly
20 25 30
Leu Lys Ser Val Phe Phe Asp Gln Lys Gln Ala Val Leu Thr Thr Phe
35 40 45
Ala Lys Gly Asn Asn Ser Gln Ile Glu Lys Lys Val Val Asn Ser Glu
50 55 60
Val Lys Asp Leu Arg Gln Pro Pro Ala Phe Asp Leu Glu Leu Lys Glu
65 70 75 80
Lys Thr Phe Tyr Ile Ser Gly Lys Asn Asn Ile Asn Thr Ser Arg Glu
85 90 95
Asn Pro Leu Ala Ser Ala Ser Leu Pro Leu Ser Lys Arg Gln Arg Ile
100 105 110
Arg Ala Glu Arg Ile Lys Arg Ala Arg Glu Glu Asn Arg Pro Tyr His
115 120 125
Asn Val Lys Arg Val Gly Glu Asp Asp Leu Arg Ala Lys Ala Asp Leu
130 135 140
Glu Lys His Tyr Phe Gly Lys Glu Tyr Ser Asp Asn Leu Lys Ile Gln
145 150 155 160
Ile Ile Tyr Asn Ile Leu Asp Ile Asn Lys Ile Ile Ser Pro Tyr Ile
165 170 175
Asn Asp Ile Val Tyr Ser Met Asn Asn Leu Ala Arg Asn Asp Glu Tyr
180 185 190
Ile Asp Gly Lys Ile Asp Val Ile Gly Ser Leu Ser Ser Thr Thr Asp
195 200 205
Tyr Ser Ser Phe Met Ser Pro Asn Lys Asp Leu Glu Lys Glu Lys Lys
210 215 220
Phe Ser Phe His Arg Glu Asn Tyr Lys Lys Phe Val Glu Ala Ser Lys
225 230 235 240
Pro Tyr Met Arg Tyr Tyr Gly Lys Val Phe Ile Arg Asp Val Lys Lys
245 250 255
Ser Lys Leu Ser Thr Gly Lys Gly Glu Lys Ile Glu Val Met Tyr Arg
260 265 270
Ser Asp Glu Glu Ile Phe Thr Ile Phe Gln Ile Leu Ser Tyr Val Ala
275 280 285
Gln Ser Ile Met Ala Asn Asp Ile Gly Asn Lys Ser Ser Ile Leu Ala
290 295 300
Ile Glu Lys Tyr Pro Ala Arg Phe Val Gly Phe Leu Ser Asp Leu Leu
305 310 315 320
Lys Thr Lys Thr Asn Asp Val Asn Arg Met Phe Ile Asp Asn Asn Ser
325 330 335
Gln Thr Asn Phe Trp Val Leu Phe Ser Ile Phe Gly Leu Gln Asp His
340 345 350
Thr Ser Gly Ala Asp Lys Ile Cys Arg Asn Phe Tyr Asp Phe Val Ile
355 360 365
Lys Ala Asp Ser Lys Asn Leu Gly Phe Ser Leu Lys Lys Ile Arg Glu
370 375 380
Leu Met Leu Asp Leu Pro Asn Ala Asn Met Leu Arg Asp His Gln Phe
385 390 395 400
Asp Thr Val Arg Ser Lys Phe Tyr Thr Leu Leu Asp Phe Ile Ile Tyr
405 410 415
Gln His Tyr Leu Glu Glu Lys Ser Arg Ile Asp Asn Met Val Glu Lys
420 425 430
Leu Arg Met Thr Leu Lys Glu Glu Glu Lys Glu Val Leu Tyr Ala Ala
435 440 445
Glu Ala Lys Ile Val Trp Asn Ala Ile Gly Ala Lys Val Ile Asn Lys
450 455 460
Leu Val Pro Met Met Asn Gly Asp Ala Leu Lys Glu Ile Lys Arg Lys
465 470 475 480
Asn Arg Asp Arg Lys Leu Pro Gln Ser Val Ile Ala Thr Val Gln Val
485 490 495
Asn Ser Asp Ala Asn Val Phe Ser Gly Leu Ile Tyr Phe Leu Thr Leu
500 505 510
Phe Leu Asp Gly Lys Glu Ile Asn Glu Met Val Ser Asn Leu Ile Thr
515 520 525
Lys Phe Glu Asn Ile Asp Ser Leu Leu His Val Asp Arg Glu Ile Tyr
530 535 540
Lys Ser Asp Glu Lys Asp Leu Asp Leu Glu Ile Glu Lys Leu Ala Leu
545 550 555 560
Phe Phe Lys Gly Val Val Arg Pro Asn Ala Lys Thr Asp Thr Gly Ala
565 570 575
Gly Glu Ile Ser Lys Ser Phe Ser Ile Phe Gln Ser Ala Glu Arg Ile
580 585 590
Ile Glu Glu Leu Lys Phe Ile Lys Asn Val Thr Arg Met Asp Asn Glu
595 600 605
Ile Phe Pro Ser Glu Gly Val Phe Leu Asp Ala Ala Asn Val Leu Gly
610 615 620
Val Arg Gly Asp Asp Phe Asp Phe Ser Asn Glu Phe Val Gly Asp Asp
625 630 635 640
Leu His Ser Asp Ala Asn Lys Lys Ile Ile Asn Lys Ile Asn Gly Thr
645 650 655
Lys Glu Asp Arg Asn Leu Arg Asn Phe Ile Ile Asn Asn Val Val Lys
660 665 670
Ser Arg Arg Phe Gln Tyr Ile Ala Arg His Met Asn Thr His Tyr Val
675 680 685
Lys Gln Leu Ala Asn Asn Glu Thr Leu Asn Arg Phe Val Leu Asn Lys
690 695 700
Met Gly Asp Ala Lys Ile Ile Asn Arg Tyr Tyr Glu Ser Ile Ser Gly
705 710 715 720
Asn Thr Pro Asn Ile Glu Val Arg Ser Gln Ile Asp Tyr Leu Val Lys
725 730 735
Arg Leu Arg Ser Phe Ser Phe Glu Asp Leu Asn Asp Val Lys Gln Lys
740 745 750
Val Arg Pro Gly Thr Asn Glu Ser Ile Glu Lys Glu Lys Lys Lys Ala
755 760 765
Leu Val Gly Leu Cys Leu Thr Ile Gln Tyr Leu Val Tyr Lys Asn Leu
770 775 780
Val Asn Ile Asn Ala Arg Tyr Thr Thr Ala Phe Tyr Cys Leu Glu Arg
785 790 795 800
Asp Ser Lys Leu Lys Gly Phe Gly Val Asp Val Trp Arg Asp Phe Glu
805 810 815
Ser Tyr Thr Ala Leu Thr Asn His Phe Ile Lys Glu Gly Tyr Leu Pro
820 825 830
Val Arg Lys Ala Glu Ile Leu Arg Ala Asn Leu Lys His Leu Asp Cys
835 840 845
Glu Asp Gly Phe Lys Tyr Tyr Ala Asn Gln Val Thr Ala Leu Asn Ala
850 855 860
Ile Arg Val Ala Tyr Lys Tyr Ile Asn Glu Ile Lys Ser Val His Ser
865 870 875 880
Tyr Phe Ala Leu Tyr His Tyr Ile Met Gln Arg His Leu Tyr Asp Ser
885 890 895
Leu Gln Ala Lys Ala Lys Asp Ser Ser Gly Phe Val Ile Asp Ala Leu
900 905 910
Lys Lys Ser Phe Glu His Lys Ile Tyr Ser Lys Asp Leu Leu His Val
915 920 925
Leu His Ser Pro Phe Gly Tyr Asn Thr Ala Arg Tyr Lys Asn Leu Ser
930 935 940
Ile Glu Ala Leu Phe Asp Lys Asn Glu Ser Arg Pro Glu Val Asn Pro
945 950 955 960
Leu Ser Thr Asn Asp Ser Leu Glu Ala Leu Pro Val Ala Thr Met Val
965 970 975
Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu
980 985 990
Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly
995 1000 1005
Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr
1010 1015 1020
Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr
1025 1030 1035 1040
Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His
1045 1050 1055
Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr
1060 1065 1070
Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys
1075 1080 1085
Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp
1090 1095 1100
Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr
1105 1110 1115 1120
Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile
1125 1130 1135
Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln
1140 1145 1150
Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val
1155 1160 1165
Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys
1170 1175 1180
Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr
1185 1190 1195 1200
Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser Asn Ser
1205 1210 1215
Lys Pro Gly Phe His Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly
1220 1225 1230
Gln Ala Lys Lys Lys Lys Gln Arg Val Gln Leu Ser Asp Tyr Lys Asp
1235 1240 1245
His Asp Gly Asp Tyr Lys Asp His Asp Ile Asp Tyr Lys Asp Asp Asp
1250 1255 1260
Asp Lys
1265
<210> 7
<211> 1274
<212> PRT
<213> Artificial Sequence
<400> 7
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Met Gly Lys Lys Ile His Ala Arg Asp Leu Arg Glu Gln
20 25 30
Arg Lys Thr Asp Arg Thr Glu Lys Phe Ala Asp Gln Asn Lys Lys Arg
35 40 45
Glu Ala Glu Arg Ala Val Pro Lys Lys Asp Ala Ala Val Ser Val Lys
50 55 60
Ser Val Ser Ser Val Ser Ser Lys Lys Asp Asn Val Thr Lys Ser Met
65 70 75 80
Ala Lys Ala Ala Gly Val Lys Ser Val Phe Ala Val Gly Asn Thr Val
85 90 95
Tyr Met Thr Ser Phe Gly Arg Gly Asn Asp Ala Val Leu Glu Gln Lys
100 105 110
Ile Val Asp Thr Ser His Glu Pro Leu Asn Ile Asp Asp Pro Ala Tyr
115 120 125
Gln Leu Asn Val Val Thr Met Asn Gly Tyr Ser Val Thr Gly His Arg
130 135 140
Gly Glu Thr Val Ser Ala Val Thr Asp Asn Pro Leu Arg Arg Phe Asn
145 150 155 160
Gly Arg Lys Lys Asp Glu Pro Glu Gln Ser Val Pro Thr Asp Met Leu
165 170 175
Cys Leu Lys Pro Thr Leu Glu Lys Lys Phe Phe Gly Lys Glu Phe Asp
180 185 190
Asp Asn Ile His Ile Gln Leu Ile Tyr Asn Ile Leu Asp Ile Glu Lys
195 200 205
Ile Leu Ala Val Tyr Ser Thr Asn Ala Ile Tyr Ala Leu Asn Asn Met
210 215 220
Ser Ala Asp Glu Asn Ile Glu Asn Ser Asp Phe Phe Met Lys Arg Thr
225 230 235 240
Thr Asp Glu Thr Phe Asp Asp Phe Glu Lys Lys Lys Glu Ser Thr Asn
245 250 255
Ser Arg Glu Lys Ala Asp Phe Asp Ala Phe Glu Lys Phe Ile Gly Asn
260 265 270
Tyr Arg Leu Ala Tyr Phe Ala Asp Ala Phe Tyr Val Asn Lys Lys Asn
275 280 285
Pro Lys Gly Lys Ala Lys Asn Val Leu Arg Glu Asp Lys Glu Leu Tyr
290 295 300
Ser Val Leu Thr Leu Ile Gly Lys Leu Ala His Trp Cys Val Ala Ser
305 310 315 320
Glu Glu Gly Arg Ala Glu Phe Trp Leu Tyr Lys Leu Asp Glu Leu Lys
325 330 335
Asp Asp Phe Lys Asn Val Leu Asp Val Val Tyr Asn Arg Pro Val Glu
340 345 350
Glu Ile Asn Asn Arg Phe Ile Glu Asn Asn Lys Val Asn Ile Gln Ile
355 360 365
Leu Gly Ser Val Tyr Lys Asn Thr Asp Ile Ala Glu Leu Val Arg Ser
370 375 380
Tyr Tyr Glu Phe Leu Ile Thr Lys Lys Tyr Lys Asn Met Gly Phe Ser
385 390 395 400
Ile Lys Lys Leu Arg Glu Ser Met Leu Glu Gly Lys Gly Tyr Ala Asp
405 410 415
Lys Glu Tyr Asp Ser Val Arg Asn Lys Leu Tyr Gln Met Thr Asp Phe
420 425 430
Ile Leu Tyr Thr Gly Tyr Ile Asn Glu Asp Ser Asp Arg Ala Asp Asp
435 440 445
Leu Val Asn Thr Leu Arg Ser Ser Leu Lys Glu Asp Asp Lys Thr Thr
450 455 460
Val Tyr Cys Lys Glu Ala Asp Tyr Leu Trp Lys Lys Tyr Arg Glu Ser
465 470 475 480
Ile Arg Glu Val Ala Asp Ala Leu Asp Gly Asp Asn Ile Lys Lys Leu
485 490 495
Ser Lys Ser Asn Ile Glu Ile Gln Glu Asp Lys Leu Arg Lys Cys Phe
500 505 510
Ile Ser Tyr Ala Asp Ser Val Ser Glu Phe Thr Lys Leu Ile Tyr Leu
515 520 525
Leu Thr Arg Phe Leu Ser Gly Lys Glu Ile Asn Asp Leu Val Thr Thr
530 535 540
Leu Ile Asn Lys Phe Asp Asn Ile Arg Ser Phe Leu Glu Ile Met Asp
545 550 555 560
Glu Leu Gly Leu Asp Arg Thr Phe Thr Ala Glu Tyr Ser Phe Phe Glu
565 570 575
Gly Ser Thr Lys Tyr Leu Ala Glu Leu Val Glu Leu Asn Ser Phe Val
580 585 590
Lys Ser Cys Ser Phe Asp Ile Asn Ala Lys Arg Thr Met Tyr Arg Asp
595 600 605
Ala Leu Asp Ile Leu Gly Ile Glu Ser Asp Lys Thr Glu Glu Asp Ile
610 615 620
Glu Lys Met Ile Asp Asn Ile Leu Gln Ile Asp Ala Asn Gly Asp Lys
625 630 635 640
Lys Leu Lys Lys Asn Asn Gly Leu Arg Asn Phe Ile Ala Ser Asn Val
645 650 655
Ile Asp Ser Asn Arg Phe Lys Tyr Leu Val Arg Tyr Gly Asn Pro Lys
660 665 670
Lys Ile Arg Glu Thr Ala Lys Cys Lys Pro Ala Val Arg Phe Val Leu
675 680 685
Asn Glu Ile Pro Asp Ala Gln Ile Glu Arg Tyr Tyr Glu Ala Cys Cys
690 695 700
Pro Lys Asn Thr Ala Leu Cys Ser Ala Asn Lys Arg Arg Glu Lys Leu
705 710 715 720
Ala Asp Met Ile Ala Glu Ile Lys Phe Glu Asn Phe Ser Asp Ala Gly
725 730 735
Asn Tyr Gln Lys Ala Asn Val Thr Ser Arg Thr Ser Glu Ala Glu Ile
740 745 750
Lys Arg Lys Asn Gln Ala Ile Ile Arg Leu Tyr Leu Thr Val Met Tyr
755 760 765
Ile Met Leu Lys Asn Leu Val Asn Val Asn Ala Arg Tyr Val Ile Ala
770 775 780
Phe His Cys Val Glu Arg Asp Thr Lys Leu Tyr Ala Glu Ser Gly Leu
785 790 795 800
Glu Val Gly Asn Ile Glu Lys Asn Lys Thr Asn Leu Thr Met Ala Val
805 810 815
Met Gly Val Lys Leu Glu Asn Gly Ile Ile Lys Thr Glu Phe Asp Lys
820 825 830
Ser Phe Ala Glu Asn Ala Ala Asn Arg Tyr Leu Arg Asn Ala Arg Trp
835 840 845
Tyr Lys Leu Ile Leu Asp Asn Leu Lys Lys Ser Glu Arg Ala Val Val
850 855 860
Asn Glu Phe Ala Asn Thr Val Cys Ala Leu Asn Ala Ile Arg Asn Ile
865 870 875 880
Asn Ile Asn Ile Lys Glu Ile Lys Glu Val Glu Asn Tyr Phe Ala Leu
885 890 895
Tyr His Tyr Leu Ile Gln Lys His Leu Glu Asn Arg Phe Ala Asp Lys
900 905 910
Lys Val Glu Arg Asp Thr Gly Asp Phe Ile Ser Lys Leu Glu Glu His
915 920 925
Lys Thr Tyr Cys Lys Asp Phe Val Lys Ala Tyr Cys Thr Pro Phe Gly
930 935 940
Tyr Asn Leu Val Arg Tyr Lys Asn Leu Thr Ile Asp Gly Leu Phe Asp
945 950 955 960
Lys Asn Tyr Pro Gly Lys Asp Asp Ser Asp Glu Gln Lys Gly Leu Glu
965 970 975
Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr
980 985 990
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
995 1000 1005
Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
1010 1015 1020
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
1025 1030 1035 1040
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
1045 1050 1055
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
1060 1065 1070
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
1075 1080 1085
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
1090 1095 1100
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
1105 1110 1115 1120
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met
1125 1130 1135
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His
1140 1145 1150
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
1155 1160 1165
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
1170 1175 1180
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
1185 1190 1195 1200
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
1205 1210 1215
Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys Arg
1220 1225 1230
Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg
1235 1240 1245
Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His
1250 1255 1260
Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1265 1270
<210> 8
<211> 1286
<212> PRT
<213> Artificial Sequence
<400> 8
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Ile Glu Lys Lys Lys Ser Phe Ala Lys Gly Met Gly Val
20 25 30
Lys Ser Thr Leu Val Ser Gly Ser Lys Val Tyr Met Thr Thr Phe Ala
35 40 45
Glu Gly Ser Asp Ala Arg Leu Glu Lys Ile Val Glu Gly Asp Ser Ile
50 55 60
Arg Ser Val Asn Glu Gly Glu Ala Phe Ser Ala Glu Met Ala Asp Lys
65 70 75 80
Asn Ala Gly Tyr Lys Ile Gly Asn Ala Lys Phe Ser His Pro Lys Gly
85 90 95
Tyr Ala Val Val Ala Asn Asn Pro Leu Tyr Thr Gly Pro Val Gln Gln
100 105 110
Asp Met Leu Gly Leu Lys Glu Thr Leu Glu Lys Arg Tyr Phe Gly Glu
115 120 125
Ser Ala Asp Gly Asn Asp Asn Ile Cys Ile Gln Val Ile His Asn Ile
130 135 140
Leu Asp Ile Glu Lys Ile Leu Ala Glu Tyr Ile Thr Asn Ala Ala Tyr
145 150 155 160
Ala Val Asn Asn Ile Ser Gly Leu Asp Lys Asp Ile Ile Gly Phe Gly
165 170 175
Lys Phe Ser Thr Val Tyr Thr Tyr Asp Glu Phe Lys Asp Pro Glu His
180 185 190
His Arg Ala Ala Phe Asn Asn Asn Asp Lys Leu Ile Asn Ala Ile Lys
195 200 205
Ala Gln Tyr Asp Glu Phe Asp Asn Phe Leu Asp Asn Pro Arg Leu Gly
210 215 220
Tyr Phe Gly Gln Ala Phe Phe Ser Lys Glu Gly Arg Asn Tyr Ile Ile
225 230 235 240
Asn Tyr Gly Asn Glu Cys Tyr Asp Ile Leu Ala Leu Leu Ser Gly Leu
245 250 255
Ala His Trp Val Val Ala Asn Asn Glu Glu Glu Ser Arg Ile Ser Arg
260 265 270
Thr Trp Leu Tyr Asn Leu Asp Lys Asn Leu Asp Asn Glu Tyr Ile Ser
275 280 285
Thr Leu Asn Tyr Leu Tyr Asp Arg Ile Thr Asn Glu Leu Thr Asn Ser
290 295 300
Phe Ser Lys Asn Ser Ala Ala Asn Val Asn Tyr Ile Ala Glu Thr Leu
305 310 315 320
Gly Ile Asn Pro Ala Glu Phe Ala Glu Gln Tyr Phe Arg Phe Ser Ile
325 330 335
Met Lys Glu Gln Lys Asn Leu Gly Phe Asn Ile Thr Lys Leu Arg Glu
340 345 350
Val Met Leu Asp Arg Lys Asp Met Ser Glu Ile Arg Lys Asn His Lys
355 360 365
Val Phe Asp Ser Ile Arg Thr Lys Val Tyr Thr Met Met Asp Phe Val
370 375 380
Ile Tyr Arg Tyr Tyr Ile Glu Glu Asp Ala Lys Val Ala Ala Ala Asn
385 390 395 400
Lys Ser Leu Pro Asp Asn Glu Lys Ser Leu Ser Glu Lys Asp Ile Phe
405 410 415
Val Ile Asn Leu Arg Gly Ser Phe Asn Asp Asp Gln Lys Asp Ala Leu
420 425 430
Tyr Tyr Asp Glu Ala Asn Arg Ile Trp Arg Lys Leu Glu Asn Ile Met
435 440 445
His Asn Ile Lys Glu Phe Arg Gly Asn Lys Thr Arg Glu Tyr Lys Lys
450 455 460
Lys Asp Ala Pro Arg Leu Pro Arg Ile Leu Pro Ala Gly Arg Asp Val
465 470 475 480
Ser Ala Phe Ser Lys Leu Met Tyr Ala Leu Thr Met Phe Leu Asp Gly
485 490 495
Lys Glu Ile Asn Asp Leu Leu Thr Thr Leu Ile Asn Lys Phe Asp Asn
500 505 510
Ile Gln Ser Phe Leu Lys Val Met Pro Leu Ile Gly Val Asn Ala Lys
515 520 525
Phe Val Glu Glu Tyr Ala Phe Phe Lys Asp Ser Ala Lys Ile Ala Asp
530 535 540
Glu Leu Arg Leu Ile Lys Ser Phe Ala Arg Met Gly Glu Pro Ile Ala
545 550 555 560
Asp Ala Arg Arg Ala Met Tyr Ile Asp Ala Ile Arg Ile Leu Gly Thr
565 570 575
Asn Leu Ser Tyr Asp Glu Leu Lys Ala Leu Ala Asp Thr Phe Ser Leu
580 585 590
Asp Glu Asn Gly Asn Lys Leu Lys Lys Gly Lys His Gly Met Arg Asn
595 600 605
Phe Ile Ile Asn Asn Val Ile Ser Asn Lys Arg Phe His Tyr Leu Ile
610 615 620
Arg Tyr Gly Asp Pro Ala His Leu His Glu Ile Ala Lys Asn Glu Ala
625 630 635 640
Val Val Lys Phe Val Leu Gly Arg Ile Ala Asp Ile Gln Lys Lys Gln
645 650 655
Gly Gln Asn Gly Lys Asn Gln Ile Asp Arg Tyr Tyr Glu Thr Cys Ile
660 665 670
Gly Lys Asp Lys Gly Lys Ser Val Ser Glu Lys Val Asp Ala Leu Thr
675 680 685
Lys Ile Ile Thr Gly Met Asn Tyr Asp Gln Phe Asp Lys Lys Arg Ser
690 695 700
Val Ile Glu Asp Thr Gly Arg Glu Asn Ala Glu Arg Glu Lys Phe Lys
705 710 715 720
Lys Ile Ile Ser Leu Tyr Leu Thr Val Ile Tyr His Ile Leu Lys Asn
725 730 735
Ile Val Asn Ile Asn Ala Arg Tyr Val Ile Gly Phe His Cys Val Glu
740 745 750
Arg Asp Ala Gln Leu Tyr Lys Glu Lys Gly Tyr Asp Ile Asn Leu Lys
755 760 765
Lys Leu Glu Glu Lys Gly Phe Ser Ser Val Thr Lys Leu Cys Ala Gly
770 775 780
Ile Asp Glu Thr Ala Pro Asp Lys Arg Lys Asp Val Glu Lys Glu Met
785 790 795 800
Ala Glu Arg Ala Lys Glu Ser Ile Asp Ser Leu Glu Ser Ala Asn Pro
805 810 815
Lys Leu Tyr Ala Asn Tyr Ile Lys Tyr Ser Asp Glu Lys Lys Ala Glu
820 825 830
Glu Phe Thr Arg Gln Ile Asn Arg Glu Lys Ala Lys Thr Ala Leu Asn
835 840 845
Ala Tyr Leu Arg Asn Thr Lys Trp Asn Val Ile Ile Arg Glu Asp Leu
850 855 860
Leu Arg Ile Asp Asn Lys Thr Cys Thr Leu Phe Ala Asn Lys Ala Val
865 870 875 880
Ala Leu Glu Val Ala Arg Tyr Val His Ala Tyr Ile Asn Asp Ile Ala
885 890 895
Glu Val Asn Ser Tyr Phe Gln Leu Tyr His Tyr Ile Met Gln Arg Ile
900 905 910
Ile Met Asn Glu Arg Tyr Glu Lys Ser Ser Gly Lys Val Ser Glu Tyr
915 920 925
Phe Asp Ala Val Asn Asp Glu Lys Lys Tyr Asn Asp Arg Leu Leu Lys
930 935 940
Leu Leu Cys Val Pro Phe Gly Tyr Cys Ile Pro Arg Phe Lys Asn Leu
945 950 955 960
Ser Ile Glu Ala Leu Phe Asp Arg Asn Glu Ala Ala Lys Phe Asp Lys
965 970 975
Glu Lys Lys Lys Val Ser Gly Asn Ser Ser Leu Glu Ala Leu Pro Val
980 985 990
Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
995 1000 1005
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val
1010 1015 1020
Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys
1025 1030 1035 1040
Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
1045 1050 1055
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His
1060 1065 1070
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
1075 1080 1085
Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg
1090 1095 1100
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
1105 1110 1115 1120
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu
1125 1130 1135
Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln
1140 1145 1150
Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp
1155 1160 1165
Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
1170 1175 1180
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
1185 1190 1195 1200
Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu
1205 1210 1215
Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr
1220 1225 1230
Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys Arg Pro Ala Ala Thr
1235 1240 1245
Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg Val Gln Leu Ser
1250 1255 1260
Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His Asp Ile Asp Tyr
1265 1270 1275 1280
Lys Asp Asp Asp Asp Lys
1285
<210> 9
<211> 1369
<212> PRT
<213> Artificial Sequence
<400> 9
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu
20 25 30
Val Glu Asn Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met
35 40 45
Leu Asn Ala Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile
50 55 60
Glu Gly Glu Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val
65 70 75 80
Met Ser His Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu
85 90 95
Lys Thr Met Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu
100 105 110
Lys Ile Met Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys
115 120 125
Gln Asn Arg Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys
130 135 140
Arg Ala Phe Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr
145 150 155 160
Lys Thr Tyr Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser
165 170 175
Thr Glu Gln Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala
180 185 190
Leu Arg Asn Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala
195 200 205
Phe Ile Gln Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys
210 215 220
Lys Lys Ser Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr
225 230 235 240
Asn Gly Asp Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala
245 250 255
Leu Leu Ile Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu
260 265 270
Ser Arg Leu Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg
275 280 285
Arg Ile Ile Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys
290 295 300
Asp Arg Ile His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met
305 310 315 320
Leu Asn Glu Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser
325 330 335
Ala Glu Lys Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu
340 345 350
Val Leu Met Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln
355 360 365
Tyr Ile Asp Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn
370 375 380
Met Gly Lys Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp
385 390 395 400
Gly Gln Thr Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly
405 410 415
Arg Leu Glu Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe
420 425 430
Gly Asn Ser Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp
435 440 445
Asp Ala Asn Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His
450 455 460
Tyr Ile Leu Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu
465 470 475 480
Asp Ser Ala Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val
485 490 495
Lys Thr Ile Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met
500 505 510
Ala Phe His Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile
515 520 525
Val Asp Val His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys
530 535 540
Glu Glu Val Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser
545 550 555 560
Asp Leu Pro Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly
565 570 575
Lys Asp Val Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr
580 585 590
Asp Thr Glu Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile
595 600 605
Arg Ser Ala Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser
610 615 620
Thr Gly Lys Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln
625 630 635 640
Pro Ser Val Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg
645 650 655
Ile Met Gln Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu
660 665 670
Ala Lys Gln Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly
675 680 685
Lys Gly Thr Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg
690 695 700
Ser Ile Pro Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu
705 710 715 720
Arg Lys Phe Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn
725 730 735
Arg Val Asp Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr
740 745 750
Pro Ala Met Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val
755 760 765
Glu Leu Pro Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys
770 775 780
Ser Leu Pro Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr
785 790 795 800
Tyr Leu Ile Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln
805 810 815
Thr Phe Tyr Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys
820 825 830
Gly Glu Tyr Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val
835 840 845
Glu Glu Arg Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg
850 855 860
Tyr Arg Lys Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg
865 870 875 880
Asn Ala Ser Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser
885 890 895
Asn Ser Arg Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr
900 905 910
Arg Val Gln Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr
915 920 925
Glu Leu Ala Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met
930 935 940
Pro Asp Ala Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe
945 950 955 960
Thr Phe Glu Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met
965 970 975
Lys Leu Lys Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg
980 985 990
Ile Gly Asn Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu
995 1000 1005
Asp Ile Met Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile
1010 1015 1020
Ser Ser Ile Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro
1025 1030 1035 1040
Glu Leu Ser Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser
1045 1050 1055
Ile Leu Lys Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser
1060 1065 1070
Asp Ile Leu Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro
1075 1080 1085
Asp Lys Gly Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser
1090 1095 1100
Ile Lys Lys Ala Phe Gly Glu Tyr Ala Ile Met Lys Gly Gly Gly Ser
1105 1110 1115 1120
Gly Ser Met Arg Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile
1125 1130 1135
Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Arg
1140 1145 1150
Gly Glu Gly Glu Gly Asp Ala Thr Asn Gly Lys Leu Thr Leu Lys Phe
1155 1160 1165
Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr
1170 1175 1180
Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg Tyr Pro Asp His Met
1185 1190 1195 1200
Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln
1205 1210 1215
Glu Arg Thr Ile Ser Phe Lys Asp Asp Gly Thr Tyr Lys Thr Arg Ala
1220 1225 1230
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
1235 1240 1245
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu
1250 1255 1260
Tyr Asn Phe Asn Ser His Asn Val Tyr Ile Thr Ala Asp Lys Gln Lys
1265 1270 1275 1280
Asn Gly Ile Lys Ala Asn Phe Lys Ile Arg His Asn Val Glu Asp Gly
1285 1290 1295
Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp
1300 1305 1310
Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Val
1315 1320 1325
Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu
1330 1335 1340
Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys
1345 1350 1355 1360
Leu Glu Pro Lys Lys Lys Arg Lys Val
1365
<210> 10
<211> 1857
<212> PRT
<213> Artificial Sequence
<400> 10
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu
20 25 30
Val Glu Asn Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met
35 40 45
Leu Asn Ala Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile
50 55 60
Glu Gly Glu Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val
65 70 75 80
Met Ser His Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu
85 90 95
Lys Thr Met Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu
100 105 110
Lys Ile Met Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys
115 120 125
Gln Asn Arg Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys
130 135 140
Arg Ala Phe Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr
145 150 155 160
Lys Thr Tyr Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser
165 170 175
Thr Glu Gln Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala
180 185 190
Leu Arg Asn Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala
195 200 205
Phe Ile Gln Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys
210 215 220
Lys Lys Ser Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr
225 230 235 240
Asn Gly Asp Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala
245 250 255
Leu Leu Ile Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu
260 265 270
Ser Arg Leu Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg
275 280 285
Arg Ile Ile Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys
290 295 300
Asp Arg Ile His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met
305 310 315 320
Leu Asn Glu Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser
325 330 335
Ala Glu Lys Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu
340 345 350
Val Leu Met Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln
355 360 365
Tyr Ile Asp Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn
370 375 380
Met Gly Lys Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp
385 390 395 400
Gly Gln Thr Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly
405 410 415
Arg Leu Glu Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe
420 425 430
Gly Asn Ser Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp
435 440 445
Asp Ala Asn Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His
450 455 460
Tyr Ile Leu Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu
465 470 475 480
Asp Ser Ala Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val
485 490 495
Lys Thr Ile Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met
500 505 510
Ala Phe His Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile
515 520 525
Val Asp Val His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys
530 535 540
Glu Glu Val Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser
545 550 555 560
Asp Leu Pro Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly
565 570 575
Lys Asp Val Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr
580 585 590
Asp Thr Glu Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile
595 600 605
Arg Ser Ala Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser
610 615 620
Thr Gly Lys Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln
625 630 635 640
Pro Ser Val Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg
645 650 655
Ile Met Gln Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu
660 665 670
Ala Lys Gln Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly
675 680 685
Lys Gly Thr Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg
690 695 700
Ser Ile Pro Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu
705 710 715 720
Arg Lys Phe Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn
725 730 735
Arg Val Asp Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr
740 745 750
Pro Ala Met Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val
755 760 765
Glu Leu Pro Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys
770 775 780
Ser Leu Pro Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr
785 790 795 800
Tyr Leu Ile Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln
805 810 815
Thr Phe Tyr Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys
820 825 830
Gly Glu Tyr Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val
835 840 845
Glu Glu Arg Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg
850 855 860
Tyr Arg Lys Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg
865 870 875 880
Asn Ala Ser Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser
885 890 895
Asn Ser Arg Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr
900 905 910
Arg Val Gln Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr
915 920 925
Glu Leu Ala Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met
930 935 940
Pro Asp Ala Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe
945 950 955 960
Thr Phe Glu Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met
965 970 975
Lys Leu Lys Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg
980 985 990
Ile Gly Asn Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu
995 1000 1005
Asp Ile Met Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile
1010 1015 1020
Ser Ser Ile Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro
1025 1030 1035 1040
Glu Leu Ser Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser
1045 1050 1055
Ile Leu Lys Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser
1060 1065 1070
Asp Ile Leu Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro
1075 1080 1085
Asp Lys Gly Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser
1090 1095 1100
Ile Lys Lys Ala Phe Gly Glu Tyr Ala Ile Met Lys Gly Gly Gly Ser
1105 1110 1115 1120
Gly Ser Met Arg Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile
1125 1130 1135
Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Arg
1140 1145 1150
Gly Glu Gly Glu Gly Asp Ala Thr Asn Gly Lys Leu Thr Leu Lys Phe
1155 1160 1165
Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr
1170 1175 1180
Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg Tyr Pro Asp His Met
1185 1190 1195 1200
Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln
1205 1210 1215
Glu Arg Thr Ile Ser Phe Lys Asp Asp Gly Thr Tyr Lys Thr Arg Ala
1220 1225 1230
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
1235 1240 1245
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu
1250 1255 1260
Tyr Asn Phe Asn Ser His Asn Val Tyr Ile Thr Ala Asp Lys Gln Lys
1265 1270 1275 1280
Asn Gly Ile Lys Ala Asn Phe Lys Ile Arg His Asn Val Glu Asp Gly
1285 1290 1295
Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp
1300 1305 1310
Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Val
1315 1320 1325
Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu
1330 1335 1340
Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys
1345 1350 1355 1360
Ser Gly Gly Arg Ser Gly Met Arg Lys Gly Glu Glu Leu Phe Thr Gly
1365 1370 1375
Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys
1380 1385 1390
Phe Ser Val Arg Gly Glu Gly Glu Gly Asp Ala Thr Asn Gly Lys Leu
1395 1400 1405
Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro
1410 1415 1420
Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg Tyr
1425 1430 1435 1440
Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu
1445 1450 1455
Gly Tyr Val Gln Glu Arg Thr Ile Ser Phe Lys Asp Asp Gly Thr Tyr
1460 1465 1470
Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg
1475 1480 1485
Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly
1490 1495 1500
His Lys Leu Glu Tyr Asn Phe Asn Ser His Asn Val Tyr Ile Thr Ala
1505 1510 1515 1520
Asp Lys Gln Lys Asn Gly Ile Lys Ala Asn Phe Lys Ile Arg His Asn
1525 1530 1535
Val Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr
1540 1545 1550
Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser
1555 1560 1565
Thr Gln Ser Val Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met
1570 1575 1580
Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp
1585 1590 1595 1600
Glu Leu Tyr Lys Gly Ser Ile Asp Gly Ser Met Arg Lys Gly Glu Glu
1605 1610 1615
Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val
1620 1625 1630
Asn Gly His Lys Phe Ser Val Arg Gly Glu Gly Glu Gly Asp Ala Thr
1635 1640 1645
Asn Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro
1650 1655 1660
Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys
1665 1670 1675 1680
Phe Ala Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser
1685 1690 1695
Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Ser Phe Lys Asp
1700 1705 1710
Asp Gly Thr Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr
1715 1720 1725
Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly
1730 1735 1740
Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Phe Asn Ser His Asn Val
1745 1750 1755 1760
Tyr Ile Thr Ala Asp Lys Gln Lys Asn Gly Ile Lys Ala Asn Phe Lys
1765 1770 1775
Ile Arg His Asn Val Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr
1780 1785 1790
Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn
1795 1800 1805
His Tyr Leu Ser Thr Gln Ser Val Leu Ser Lys Asp Pro Asn Glu Lys
1810 1815 1820
Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr
1825 1830 1835 1840
His Gly Met Asp Glu Leu Tyr Lys Leu Glu Pro Lys Lys Lys Arg Lys
1845 1850 1855
Val
<210> 11
<211> 1398
<212> PRT
<213> Artificial Sequence
<400> 11
Met Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys
1 5 10 15
Lys Ala Ser Asn Ile Pro Ala Leu Val Glu Asn Gln Lys Lys Tyr Phe
20 25 30
Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala Gln Thr Val Leu Asp
35 40 45
His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu Gln Asn Glu Asn Asn
50 55 60
Glu Asn Leu Trp Phe His Pro Val Met Ser His Leu Tyr Asn Ala Lys
65 70 75 80
Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met Phe Ile Ile Glu Arg
85 90 95
Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met Ala Glu Asn Gln Arg
100 105 110
Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg Val Glu Val Asn Ser
115 120 125
Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe Gly Val Leu Lys Met
130 135 140
Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr Glu Glu Lys Leu Asn
145 150 155 160
Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln Pro Leu Ser Gly Met
165 170 175
Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn Met Asn Glu Arg Tyr
180 185 190
Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln Asp Lys Arg Phe Lys
195 200 205
Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser Gln Val Asn Thr Gly
210 215 220
Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp Thr Gln Lys Lys Leu
225 230 235 240
His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile Cys Leu Phe Leu Asp
245 250 255
Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu Pro Ile Phe Ser Ser
260 265 270
Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile Ile Arg Ser Phe Gly
275 280 285
Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile His Ser Glu Lys Ser
290 295 300
Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu Val Lys Arg Cys Pro
305 310 315 320
Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys Gln Ser Arg Phe Arg
325 330 335
Ile Ile Ser Asp Asp His Asn Glu Val Leu Met Lys Arg Ser Ser Asp
340 345 350
Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp Tyr Gly Lys Leu Phe
355 360 365
Asp His Ile Arg Phe His Val Asn Met Gly Lys Leu Arg Tyr Leu Leu
370 375 380
Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr Arg Val Arg Val Ile
385 390 395 400
Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu Glu Ala Glu Thr Met
405 410 415
Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser Gly Ile Arg Ile Arg
420 425 430
Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn Pro Ala Asn Tyr Pro
435 440 445
Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu Glu Asn Asn Lys Val
450 455 460
Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala Pro Leu Leu Pro Val
465 470 475 480
Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile Pro Ser Cys Arg Met
485 490 495
Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His Met Phe Leu Phe Gly
500 505 510
Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val His Asn Arg Tyr Lys
515 520 525
Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val Thr Ala Glu Asn Ile
530 535 540
Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro Gln Lys Ile Leu Asp
545 550 555 560
Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val Asp Ala Phe Ile Arg
565 570 575
Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu Arg Arg Ile Lys Arg
580 585 590
Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala Asp Asn Lys Met Gly
595 600 605
Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys Leu Ala Asp Phe Leu
610 615 620
Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val Asn Asp Gly Glu Asn
625 630 635 640
Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln Ser Ala Ile Ala Val
645 650 655
Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln Gln Phe Lys Leu Met
660 665 670
Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr Thr Glu Pro His Pro
675 680 685
Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro Ala Asn Ala Val Glu
690 695 700
Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe Tyr Leu Thr Gly Leu
705 710 715 720
Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp Val Pro Phe Ile Arg
725 730 735
Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met Lys Thr Leu Gly Arg
740 745 750
Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro Arg Gln Met Phe Asp
755 760 765
Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro Gln Met Glu Gly Ile
770 775 780
Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile Ala Glu Tyr Met Lys
785 790 795 800
Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr Gln Trp Asn Arg Asn
805 810 815
Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr Asp Arg Lys Gly Ser
820 825 830
Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg Glu Gly Leu Trp Lys
835 840 845
Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys Gln Ala Ser Asn Lys
850 855 860
Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser Ser Glu Glu Ile Glu
865 870 875 880
Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg Asn Glu Tyr Gln Lys
885 890 895
Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln Asp Ala Leu Leu Phe
900 905 910
Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala Asp Phe Asp Gly Glu
915 920 925
Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala Glu Lys Gly Ile Leu
930 935 940
Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu Lys Gly Gly Lys Lys
945 950 955 960
Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys Asn Tyr Gly Asp Phe
965 970 975
Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn Leu Leu Glu Leu Val
980 985 990
Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met Glu Glu Phe Asn Lys
995 1000 1005
Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile Val Phe Asn Leu Glu
1010 1015 1020
Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser Ala Arg Val Asp Arg
1025 1030 1035 1040
Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys Ile Leu Leu Asn Asn
1045 1050 1055
Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu Arg Lys Ile Arg Asn
1060 1065 1070
Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly Val Val Glu Ile Lys
1075 1080 1085
Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys Ala Phe Gly Glu Tyr
1090 1095 1100
Ala Ile Met Lys Ser Arg Val Ser Lys Gly Glu Glu Asp Asn Met Ala
1105 1110 1115 1120
Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly Ser Ile Asn Gly
1125 1130 1135
Val Asp Phe Asp Met Val Gly Gln Gly Thr Gly Asn Pro Asn Asp Gly
1140 1145 1150
Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Asp Leu Gln Phe Ser
1155 1160 1165
Pro Trp Ile Leu Val Pro His Ile Gly Tyr Gly Phe His Gln Tyr Leu
1170 1175 1180
Pro Tyr Pro Asp Gly Met Ser Pro Phe Gln Ala Ala Met Val Asp Gly
1185 1190 1195 1200
Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu Asp Gly Ala Ser
1205 1210 1215
Leu Thr Val Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys Gly
1220 1225 1230
Glu Ala Gln Val Lys Gly Thr Gly Phe Pro Ala Asp Gly Pro Val Met
1235 1240 1245
Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Arg Ser Lys Lys Thr Tyr
1250 1255 1260
Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Lys Trp Ser Tyr Thr Thr
1265 1270 1275 1280
Gly Asn Gly Lys Arg Tyr Arg Ser Thr Ala Arg Thr Thr Tyr Thr Phe
1285 1290 1295
Ala Lys Pro Met Ala Ala Asn Tyr Leu Lys Asn Gln Pro Met Tyr Val
1300 1305 1310
Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu Leu Asn Phe Lys
1315 1320 1325
Glu Trp Gln Lys Ala Phe Thr Asp Val Met Gly Met Asp Glu Leu Tyr
1330 1335 1340
Lys Ser Gly Leu Arg Ser Cys Leu His Met Lys Arg Pro Ala Ala Thr
1345 1350 1355 1360
Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg Val Gln Leu Ser
1365 1370 1375
Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His Asp Ile Asp Tyr
1380 1385 1390
Lys Asp Asp Asp Asp Lys
1395
<210> 12
<211> 1642
<212> PRT
<213> Artificial Sequence
<400> 12
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Glu Gly Ala Leu Glu Gly Thr
1090 1095 1100
Ser Gly Gly Gly Ser Met Val Ser Lys Gly Glu Glu Asp Asn Met Ala
1105 1110 1115 1120
Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly Ser Ile Asn Gly
1125 1130 1135
Val Asp Phe Asp Met Val Gly Gln Gly Thr Gly Asn Pro Asn Asp Gly
1140 1145 1150
Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Asp Leu Gln Phe Ser
1155 1160 1165
Pro Trp Ile Leu Val Pro His Ile Gly Tyr Gly Phe His Gln Tyr Leu
1170 1175 1180
Pro Tyr Pro Asp Gly Met Ser Pro Phe Gln Ala Ala Met Val Asp Gly
1185 1190 1195 1200
Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu Asp Gly Ala Ser
1205 1210 1215
Leu Thr Val Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys Gly
1220 1225 1230
Glu Ala Gln Val Lys Gly Thr Gly Phe Pro Ala Asp Gly Pro Val Met
1235 1240 1245
Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Arg Ser Lys Lys Thr Tyr
1250 1255 1260
Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Lys Trp Ser Tyr Thr Thr
1265 1270 1275 1280
Gly Asn Gly Lys Arg Tyr Arg Ser Thr Ala Arg Thr Thr Tyr Thr Phe
1285 1290 1295
Ala Lys Pro Met Ala Ala Asn Tyr Leu Lys Asn Gln Pro Met Tyr Val
1300 1305 1310
Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu Leu Asn Phe Lys
1315 1320 1325
Glu Trp Gln Lys Ala Phe Thr Asp Val Met Gly Met Asp Glu Leu Tyr
1330 1335 1340
Lys Ser Asn Ser Ala Val Asp Gly Thr Met Val Ser Lys Gly Glu Glu
1345 1350 1355 1360
Asp Asn Met Ala Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly
1365 1370 1375
Ser Ile Asn Gly Val Asp Phe Asp Met Val Gly Gln Gly Thr Gly Asn
1380 1385 1390
Pro Asn Asp Gly Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Asp
1395 1400 1405
Leu Gln Phe Ser Pro Trp Ile Leu Val Pro His Ile Gly Tyr Gly Phe
1410 1415 1420
His Gln Tyr Leu Pro Tyr Pro Asp Gly Met Ser Pro Phe Gln Ala Ala
1425 1430 1435 1440
Met Val Asp Gly Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu
1445 1450 1455
Asp Gly Ala Ser Leu Thr Val Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser
1460 1465 1470
His Ile Lys Gly Glu Ala Gln Val Lys Gly Thr Gly Phe Pro Ala Asp
1475 1480 1485
Gly Pro Val Met Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Arg Ser
1490 1495 1500
Lys Lys Thr Tyr Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Lys Trp
1505 1510 1515 1520
Ser Tyr Thr Thr Gly Asn Gly Lys Arg Tyr Arg Ser Thr Ala Arg Thr
1525 1530 1535
Thr Tyr Thr Phe Ala Lys Pro Met Ala Ala Asn Tyr Leu Lys Asn Gln
1540 1545 1550
Pro Met Tyr Val Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu
1555 1560 1565
Leu Asn Phe Lys Glu Trp Gln Lys Ala Phe Thr Asp Val Met Gly Met
1570 1575 1580
Asp Glu Leu Tyr Lys Ser Gly Leu Arg Ser Cys Leu His Met Lys Arg
1585 1590 1595 1600
Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg
1605 1610 1615
Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His
1620 1625 1630
Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1635 1640
<210> 13
<211> 1883
<212> PRT
<213> Artificial Sequence
<400> 13
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Glu Gly Ala Leu Glu Ala Leu
1090 1095 1100
Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val
1105 1110 1115 1120
Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe
1125 1130 1135
Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr
1140 1145 1150
Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr
1155 1160 1165
Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro
1170 1175 1180
Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly
1185 1190 1195 1200
Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys
1205 1210 1215
Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile
1220 1225 1230
Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His
1235 1240 1245
Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp
1250 1255 1260
Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile
1265 1270 1275 1280
Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro
1285 1290 1295
Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr
1300 1305 1310
Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val
1315 1320 1325
Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu
1330 1335 1340
Leu Tyr Lys Ser Gly Leu Arg Ser Val Ser Lys Gly Glu Glu Leu Phe
1345 1350 1355 1360
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
1365 1370 1375
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
1380 1385 1390
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
1395 1400 1405
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
1410 1415 1420
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
1425 1430 1435 1440
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
1445 1450 1455
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
1460 1465 1470
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
1475 1480 1485
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
1490 1495 1500
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
1505 1510 1515 1520
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
1525 1530 1535
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
1540 1545 1550
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
1555 1560 1565
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
1570 1575 1580
Met Asp Glu Leu Tyr Lys Lys Leu Val Ser Lys Gly Glu Glu Leu Phe
1585 1590 1595 1600
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
1605 1610 1615
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
1620 1625 1630
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
1635 1640 1645
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
1650 1655 1660
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
1665 1670 1675 1680
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
1685 1690 1695
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
1700 1705 1710
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
1715 1720 1725
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
1730 1735 1740
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
1745 1750 1755 1760
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
1765 1770 1775
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
1780 1785 1790
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
1795 1800 1805
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
1810 1815 1820
Met Asp Glu Leu Tyr Lys Ser Asn Ser Lys Pro Gly Phe His Met Lys
1825 1830 1835 1840
Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln
1845 1850 1855
Arg Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp
1860 1865 1870
His Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1875 1880
<210> 14
<211> 1838
<212> PRT
<213> Artificial Sequence
<400> 14
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Gly Gly Gly Ser Gly Ser Met
1090 1095 1100
Arg Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu
1105 1110 1115 1120
Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Arg Gly Glu Gly
1125 1130 1135
Glu Gly Asp Ala Thr Asn Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr
1140 1145 1150
Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr
1155 1160 1165
Tyr Gly Val Gln Cys Phe Ala Arg Tyr Pro Asp His Met Lys Gln His
1170 1175 1180
Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr
1185 1190 1195 1200
Ile Ser Phe Lys Asp Asp Gly Thr Tyr Lys Thr Arg Ala Glu Val Lys
1205 1210 1215
Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp
1220 1225 1230
Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Phe
1235 1240 1245
Asn Ser His Asn Val Tyr Ile Thr Ala Asp Lys Gln Lys Asn Gly Ile
1250 1255 1260
Lys Ala Asn Phe Lys Ile Arg His Asn Val Glu Asp Gly Ser Val Gln
1265 1270 1275 1280
Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val
1285 1290 1295
Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Val Leu Ser Lys
1300 1305 1310
Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr
1315 1320 1325
Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys Ser Gly Gly
1330 1335 1340
Arg Ser Gly Met Arg Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
1345 1350 1355 1360
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val
1365 1370 1375
Arg Gly Glu Gly Glu Gly Asp Ala Thr Asn Gly Lys Leu Thr Leu Lys
1380 1385 1390
Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
1395 1400 1405
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg Tyr Pro Asp His
1410 1415 1420
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
1425 1430 1435 1440
Gln Glu Arg Thr Ile Ser Phe Lys Asp Asp Gly Thr Tyr Lys Thr Arg
1445 1450 1455
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
1460 1465 1470
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu
1475 1480 1485
Glu Tyr Asn Phe Asn Ser His Asn Val Tyr Ile Thr Ala Asp Lys Gln
1490 1495 1500
Lys Asn Gly Ile Lys Ala Asn Phe Lys Ile Arg His Asn Val Glu Asp
1505 1510 1515 1520
Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
1525 1530 1535
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
1540 1545 1550
Val Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu
1555 1560 1565
Glu Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr
1570 1575 1580
Lys Gly Ser Ile Asp Gly Ser Met Arg Lys Gly Glu Glu Leu Phe Thr
1585 1590 1595 1600
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
1605 1610 1615
Lys Phe Ser Val Arg Gly Glu Gly Glu Gly Asp Ala Thr Asn Gly Lys
1620 1625 1630
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
1635 1640 1645
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg
1650 1655 1660
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
1665 1670 1675 1680
Glu Gly Tyr Val Gln Glu Arg Thr Ile Ser Phe Lys Asp Asp Gly Thr
1685 1690 1695
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
1700 1705 1710
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
1715 1720 1725
Gly His Lys Leu Glu Tyr Asn Phe Asn Ser His Asn Val Tyr Ile Thr
1730 1735 1740
Ala Asp Lys Gln Lys Asn Gly Ile Lys Ala Asn Phe Lys Ile Arg His
1745 1750 1755 1760
Asn Val Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
1765 1770 1775
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
1780 1785 1790
Ser Thr Gln Ser Val Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
1795 1800 1805
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr His Gly Met
1810 1815 1820
Asp Glu Leu Tyr Lys Leu Glu Pro Lys Lys Lys Arg Lys Val
1825 1830 1835
<210> 15
<211> 1625
<212> PRT
<213> Artificial Sequence
<400> 15
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Glu Gly Ala Leu Glu Gly Thr
1090 1095 1100
Ser Gly Gly Gly Ser Met Val Ser Lys Gly Glu Glu Asp Asn Met Ala
1105 1110 1115 1120
Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly Ser Ile Asn Gly
1125 1130 1135
Val Asp Phe Asp Met Val Gly Gln Gly Thr Gly Asn Pro Asn Asp Gly
1140 1145 1150
Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Asp Leu Gln Phe Ser
1155 1160 1165
Pro Trp Ile Leu Val Pro His Ile Gly Tyr Gly Phe His Gln Tyr Leu
1170 1175 1180
Pro Tyr Pro Asp Gly Met Ser Pro Phe Gln Ala Ala Met Val Asp Gly
1185 1190 1195 1200
Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu Asp Gly Ala Ser
1205 1210 1215
Leu Thr Val Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser His Ile Lys Gly
1220 1225 1230
Glu Ala Gln Val Lys Gly Thr Gly Phe Pro Ala Asp Gly Pro Val Met
1235 1240 1245
Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Arg Ser Lys Lys Thr Tyr
1250 1255 1260
Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Lys Trp Ser Tyr Thr Thr
1265 1270 1275 1280
Gly Asn Gly Lys Arg Tyr Arg Ser Thr Ala Arg Thr Thr Tyr Thr Phe
1285 1290 1295
Ala Lys Pro Met Ala Ala Asn Tyr Leu Lys Asn Gln Pro Met Tyr Val
1300 1305 1310
Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu Leu Asn Phe Lys
1315 1320 1325
Glu Trp Gln Lys Ala Phe Thr Asp Val Met Gly Met Asp Glu Leu Tyr
1330 1335 1340
Lys Ser Asn Ser Ala Val Asp Gly Thr Met Val Ser Lys Gly Glu Glu
1345 1350 1355 1360
Asp Asn Met Ala Ser Leu Pro Ala Thr His Glu Leu His Ile Phe Gly
1365 1370 1375
Ser Ile Asn Gly Val Asp Phe Asp Met Val Gly Gln Gly Thr Gly Asn
1380 1385 1390
Pro Asn Asp Gly Tyr Glu Glu Leu Asn Leu Lys Ser Thr Lys Gly Asp
1395 1400 1405
Leu Gln Phe Ser Pro Trp Ile Leu Val Pro His Ile Gly Tyr Gly Phe
1410 1415 1420
His Gln Tyr Leu Pro Tyr Pro Asp Gly Met Ser Pro Phe Gln Ala Ala
1425 1430 1435 1440
Met Val Asp Gly Ser Gly Tyr Gln Val His Arg Thr Met Gln Phe Glu
1445 1450 1455
Asp Gly Ala Ser Leu Thr Val Asn Tyr Arg Tyr Thr Tyr Glu Gly Ser
1460 1465 1470
His Ile Lys Gly Glu Ala Gln Val Lys Gly Thr Gly Phe Pro Ala Asp
1475 1480 1485
Gly Pro Val Met Thr Asn Ser Leu Thr Ala Ala Asp Trp Cys Arg Ser
1490 1495 1500
Lys Lys Thr Tyr Pro Asn Asp Lys Thr Ile Ile Ser Thr Phe Lys Trp
1505 1510 1515 1520
Ser Tyr Thr Thr Gly Asn Gly Lys Arg Tyr Arg Ser Thr Ala Arg Thr
1525 1530 1535
Thr Tyr Thr Phe Ala Lys Pro Met Ala Ala Asn Tyr Leu Lys Asn Gln
1540 1545 1550
Pro Met Tyr Val Phe Arg Lys Thr Glu Leu Lys His Ser Lys Thr Glu
1555 1560 1565
Leu Asn Phe Lys Glu Trp Gln Lys Ala Phe Thr Asp Val Met Gly Met
1570 1575 1580
Asp Glu Leu Tyr Lys Ser Gly Leu Arg Ser Cys Leu Glu Gln Arg Val
1585 1590 1595 1600
Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His Asp
1605 1610 1615
Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1620 1625
<210> 16
<211> 1934
<212> PRT
<213> Artificial Sequence
<400> 16
Met Pro Lys Lys Lys Arg Lys Val Thr Glu Gln Ser Glu Arg Pro Tyr
1 5 10 15
Asn Gly Thr Tyr Tyr Thr Leu Glu Asp Lys His Phe Trp Ala Ala Phe
20 25 30
Leu Asn Leu Ala Arg His Asn Ala Tyr Ile Thr Leu Thr His Ile Asp
35 40 45
Arg Gln Leu Ala Tyr Ser Lys Ala Asp Ile Thr Asn Asp Gln Asp Val
50 55 60
Leu Ser Phe Lys Ala Leu Trp Lys Asn Phe Asp Asn Asp Leu Glu Arg
65 70 75 80
Lys Ser Arg Leu Arg Ser Leu Ile Leu Lys His Phe Ser Phe Leu Glu
85 90 95
Gly Ala Ala Tyr Gly Lys Lys Leu Phe Glu Ser Lys Ser Ser Gly Asn
100 105 110
Lys Ser Ser Lys Asn Lys Glu Leu Thr Lys Lys Glu Lys Glu Glu Leu
115 120 125
Gln Ala Asn Ala Leu Ser Leu Asp Asn Leu Lys Ser Ile Leu Phe Asp
130 135 140
Phe Leu Gln Lys Leu Lys Asp Phe Arg Asn Tyr Tyr Ser Ala Tyr Arg
145 150 155 160
His Ser Gly Ser Ser Glu Leu Pro Leu Phe Asp Gly Asn Met Leu Gln
165 170 175
Arg Leu Tyr Asn Val Phe Asp Val Ser Val Gln Arg Val Lys Ile Asp
180 185 190
His Glu His Asn Asp Glu Val Asp Pro His Tyr His Phe Asn His Leu
195 200 205
Val Arg Lys Gly Lys Lys Asp Arg Tyr Gly His Asn Asp Asn Pro Ser
210 215 220
Phe Lys His His Phe Val Asp Gly Glu Gly Met Val Thr Glu Ala Gly
225 230 235 240
Leu Leu Phe Phe Val Ser Leu Phe Leu Glu Lys Arg Asp Ala Ile Trp
245 250 255
Met Gln Lys Lys Ile Arg Gly Phe Lys Gly Gly Thr Glu Thr Tyr Gln
260 265 270
Gln Met Thr Asn Glu Val Phe Cys Arg Ser Arg Ile Ser Leu Pro Lys
275 280 285
Leu Lys Leu Glu Ser Leu Arg Met Asp Asp Trp Met Leu Leu Asp Met
290 295 300
Leu Asn Glu Leu Val Arg Cys Pro Lys Pro Leu Tyr Asp Arg Leu Arg
305 310 315 320
Glu Asp Asp Arg Ala Cys Phe Arg Val Pro Val Asp Ile Leu Pro Asp
325 330 335
Glu Asp Asp Thr Asp Gly Gly Gly Glu Asp Pro Phe Lys Asn Thr Leu
340 345 350
Val Arg His Gln Asp Arg Phe Pro Tyr Phe Ala Leu Arg Tyr Phe Asp
355 360 365
Leu Lys Lys Val Phe Thr Ser Leu Arg Phe His Ile Asp Leu Gly Thr
370 375 380
Tyr His Phe Ala Ile Tyr Lys Lys Met Ile Gly Glu Gln Pro Glu Asp
385 390 395 400
Arg His Leu Thr Arg Asn Leu Tyr Gly Phe Gly Arg Ile Gln Asp Phe
405 410 415
Ala Glu Glu His Arg Pro Glu Glu Trp Lys Arg Leu Val Arg Asp Leu
420 425 430
Asp Tyr Phe Glu Thr Gly Asp Lys Pro Tyr Ile Ser Gln Thr Ser Pro
435 440 445
His Tyr His Ile Glu Lys Gly Lys Ile Gly Leu Arg Phe Met Pro Glu
450 455 460
Gly Gln His Leu Trp Pro Ser Pro Glu Val Gly Thr Thr Arg Thr Gly
465 470 475 480
Arg Ser Lys Tyr Ala Gln Asp Lys Arg Leu Thr Ala Glu Ala Phe Leu
485 490 495
Ser Val His Glu Leu Met Pro Met Met Phe Tyr Tyr Phe Leu Leu Arg
500 505 510
Glu Lys Tyr Ser Glu Glu Val Ser Ala Glu Arg Val Gln Gly Arg Ile
515 520 525
Lys Arg Val Ile Glu Asp Val Tyr Ala Val Tyr Asp Ala Phe Ala Arg
530 535 540
Asp Glu Ile Asn Thr Arg Asp Glu Leu Asp Ala Cys Leu Ala Asp Lys
545 550 555 560
Gly Ile Arg Arg Gly His Leu Pro Arg Gln Met Ile Ala Ile Leu Ser
565 570 575
Gln Glu His Lys Asp Met Glu Glu Lys Ile Arg Lys Lys Leu Gln Glu
580 585 590
Met Met Ala Asp Thr Asp His Arg Leu Asp Met Leu Asp Arg Gln Thr
595 600 605
Asp Arg Lys Ile Arg Ile Gly Arg Lys Asn Ala Gly Leu Pro Lys Ser
610 615 620
Gly Val Ile Ala Asp Trp Leu Val Arg Asp Met Met Arg Phe Gln Pro
625 630 635 640
Val Ala Lys Asp Ala Ser Gly Lys Pro Leu Asn Asn Ser Lys Ala Asn
645 650 655
Ser Thr Glu Tyr Arg Met Leu Gln Arg Ala Leu Ala Leu Phe Gly Gly
660 665 670
Glu Lys Glu Arg Leu Thr Pro Tyr Phe Arg Gln Met Asn Leu Thr Gly
675 680 685
Gly Asn Asn Pro His Pro Phe Leu His Glu Thr Arg Trp Glu Ser His
690 695 700
Thr Asn Ile Leu Ser Phe Tyr Arg Ser Tyr Leu Arg Ala Arg Lys Ala
705 710 715 720
Phe Leu Glu Arg Ile Gly Arg Ser Asp Arg Val Glu Asn Arg Pro Phe
725 730 735
Leu Leu Leu Lys Glu Pro Lys Thr Asp Arg Gln Thr Leu Val Ala Gly
740 745 750
Trp Lys Gly Glu Phe His Leu Pro Arg Gly Ile Phe Thr Glu Ala Val
755 760 765
Arg Asp Cys Leu Ile Glu Met Gly His Asp Glu Val Ala Ser Tyr Lys
770 775 780
Glu Val Gly Phe Met Ala Lys Ala Val Pro Leu Tyr Phe Glu Arg Ala
785 790 795 800
Cys Glu Asp Arg Val Gln Pro Phe Tyr Asp Ser Pro Phe Asn Val Gly
805 810 815
Asn Ser Leu Lys Pro Lys Lys Gly Arg Phe Leu Ser Lys Glu Glu Arg
820 825 830
Ala Glu Glu Trp Glu Arg Gly Lys Glu Arg Phe Arg Asp Leu Glu Ala
835 840 845
Trp Ser Tyr Ser Ala Ala Arg Arg Ile Glu Asp Ala Phe Ala Gly Ile
850 855 860
Glu Tyr Ala Ser Pro Gly Asn Lys Lys Lys Ile Glu Gln Leu Leu Arg
865 870 875 880
Asp Leu Ser Leu Trp Glu Ala Phe Glu Ser Lys Leu Lys Val Arg Ala
885 890 895
Asp Arg Ile Asn Leu Ala Lys Leu Lys Lys Glu Ile Leu Glu Ala Gln
900 905 910
Glu His Pro Tyr His Asp Phe Lys Ser Trp Gln Lys Phe Glu Arg Glu
915 920 925
Leu Arg Leu Val Lys Asn Gln Asp Ile Ile Thr Trp Met Met Cys Arg
930 935 940
Asp Leu Met Glu Glu Asn Lys Val Glu Gly Leu Asp Thr Gly Thr Leu
945 950 955 960
Tyr Leu Lys Asp Ile Arg Pro Asn Val Gln Glu Gln Gly Ser Leu Asn
965 970 975
Val Leu Asn Arg Val Lys Pro Met Arg Leu Pro Val Val Val Tyr Arg
980 985 990
Ala Asp Ser Arg Gly His Val His Lys Glu Glu Ala Pro Leu Ala Thr
995 1000 1005
Val Tyr Ile Glu Glu Arg Asp Thr Lys Leu Leu Lys Gln Gly Asn Phe
1010 1015 1020
Lys Ser Phe Val Lys Asp Arg Arg Leu Asn Gly Leu Phe Ser Phe Val
1025 1030 1035 1040
Asp Thr Gly Gly Leu Ala Met Glu Gln Tyr Pro Ile Ser Lys Leu Arg
1045 1050 1055
Val Glu Tyr Glu Leu Ala Lys Tyr Gln Thr Ala Arg Val Cys Val Phe
1060 1065 1070
Glu Leu Thr Leu Arg Leu Glu Glu Ser Leu Leu Thr Arg Tyr Pro His
1075 1080 1085
Leu Pro Asp Glu Ser Phe Arg Glu Met Leu Glu Ser Trp Ser Asp Pro
1090 1095 1100
Leu Leu Ala Lys Trp Pro Glu Leu His Gly Lys Val Arg Leu Leu Ile
1105 1110 1115 1120
Ala Val Arg Asn Ala Phe Ser Ala Asn Gln Tyr Pro Met Tyr Asp Glu
1125 1130 1135
Ala Val Phe Ser Ser Ile Arg Lys Tyr Asp Pro Ser Ser Pro Asp Ala
1140 1145 1150
Ile Glu Glu Arg Met Gly Leu Asn Ile Ala His Arg Leu Ser Glu Glu
1155 1160 1165
Val Lys Gln Ala Lys Glu Thr Val Glu Arg Ile Ile Gln Ala Ser Leu
1170 1175 1180
Glu Ala Leu Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Ile
1185 1190 1195 1200
Lys Glu Asn Met Arg Met Lys Val Val Met Glu Gly Ser Val Asn Gly
1205 1210 1215
His Gln Phe Lys Cys Thr Gly Glu Gly Glu Gly Arg Pro Tyr Glu Gly
1220 1225 1230
Val Gln Thr Met Arg Ile Lys Val Ile Glu Gly Gly Pro Leu Pro Phe
1235 1240 1245
Ala Phe Asp Ile Leu Ala Thr Ser Phe Met Tyr Gly Ser Arg Thr Phe
1250 1255 1260
Ile Lys Tyr Pro Ala Asp Ile Pro Asp Phe Phe Lys Gln Ser Phe Pro
1265 1270 1275 1280
Glu Gly Phe Thr Trp Glu Arg Val Thr Arg Tyr Glu Asp Gly Gly Val
1285 1290 1295
Val Thr Val Thr Gln Asp Thr Ser Leu Glu Asp Gly Glu Leu Val Tyr
1300 1305 1310
Asn Val Lys Val Arg Gly Val Asn Phe Pro Ser Asn Gly Pro Val Met
1315 1320 1325
Gln Lys Lys Thr Lys Gly Trp Glu Pro Asn Thr Glu Met Met Tyr Pro
1330 1335 1340
Ala Asp Gly Gly Leu Arg Gly Tyr Thr Asp Ile Ala Leu Lys Val Asp
1345 1350 1355 1360
Gly Gly Gly His Leu His Cys Asn Phe Val Thr Thr Tyr Arg Ser Lys
1365 1370 1375
Lys Thr Val Gly Asn Ile Lys Met Pro Gly Val His Ala Val Asp His
1380 1385 1390
Arg Leu Glu Arg Ile Glu Glu Ser Asp Asn Glu Thr Tyr Val Val Gln
1395 1400 1405
Arg Glu Val Ala Val Ala Lys Tyr Ser Asn Leu Gly Gly Gly Met Asp
1410 1415 1420
Glu Leu Tyr Lys Ser Gly Leu Arg Ser Val Ser Lys Gly Glu Glu Leu
1425 1430 1435 1440
Ile Lys Glu Asn Met Arg Met Lys Val Val Met Glu Gly Ser Val Asn
1445 1450 1455
Gly His Gln Phe Lys Cys Thr Gly Glu Gly Glu Gly Arg Pro Tyr Glu
1460 1465 1470
Gly Val Gln Thr Met Arg Ile Lys Val Ile Glu Gly Gly Pro Leu Pro
1475 1480 1485
Phe Ala Phe Asp Ile Leu Ala Thr Ser Phe Met Tyr Gly Ser Arg Thr
1490 1495 1500
Phe Ile Lys Tyr Pro Ala Asp Ile Pro Asp Phe Phe Lys Gln Ser Phe
1505 1510 1515 1520
Pro Glu Gly Phe Thr Trp Glu Arg Val Thr Arg Tyr Glu Asp Gly Gly
1525 1530 1535
Val Val Thr Val Thr Gln Asp Thr Ser Leu Glu Asp Gly Glu Leu Val
1540 1545 1550
Tyr Asn Val Lys Val Arg Gly Val Asn Phe Pro Ser Asn Gly Pro Val
1555 1560 1565
Met Gln Lys Lys Thr Lys Gly Trp Glu Pro Asn Thr Glu Met Met Tyr
1570 1575 1580
Pro Ala Asp Gly Gly Leu Arg Gly Tyr Thr Asp Ile Ala Leu Lys Val
1585 1590 1595 1600
Asp Gly Gly Gly His Leu His Cys Asn Phe Val Thr Thr Tyr Arg Ser
1605 1610 1615
Lys Lys Thr Val Gly Asn Ile Lys Met Pro Gly Val His Ala Val Asp
1620 1625 1630
His Arg Leu Glu Arg Ile Glu Glu Ser Asp Asn Glu Thr Tyr Val Val
1635 1640 1645
Gln Arg Glu Val Ala Val Ala Lys Tyr Ser Asn Leu Gly Gly Gly Met
1650 1655 1660
Asp Glu Leu Tyr Lys Lys Leu Val Ser Lys Gly Glu Glu Leu Ile Lys
1665 1670 1675 1680
Glu Asn Met Arg Met Lys Val Val Met Glu Gly Ser Val Asn Gly His
1685 1690 1695
Gln Phe Lys Cys Thr Gly Glu Gly Glu Gly Arg Pro Tyr Glu Gly Val
1700 1705 1710
Gln Thr Met Arg Ile Lys Val Ile Glu Gly Gly Pro Leu Pro Phe Ala
1715 1720 1725
Phe Asp Ile Leu Ala Thr Ser Phe Met Tyr Gly Ser Arg Thr Phe Ile
1730 1735 1740
Lys Tyr Pro Ala Asp Ile Pro Asp Phe Phe Lys Gln Ser Phe Pro Glu
1745 1750 1755 1760
Gly Phe Thr Trp Glu Arg Val Thr Arg Tyr Glu Asp Gly Gly Val Val
1765 1770 1775
Thr Val Thr Gln Asp Thr Ser Leu Glu Asp Gly Glu Leu Val Tyr Asn
1780 1785 1790
Val Lys Val Arg Gly Val Asn Phe Pro Ser Asn Gly Pro Val Met Gln
1795 1800 1805
Lys Lys Thr Lys Gly Trp Glu Pro Asn Thr Glu Met Met Tyr Pro Ala
1810 1815 1820
Asp Gly Gly Leu Arg Gly Tyr Thr Asp Ile Ala Leu Lys Val Asp Gly
1825 1830 1835 1840
Gly Gly His Leu His Cys Asn Phe Val Thr Thr Tyr Arg Ser Lys Lys
1845 1850 1855
Thr Val Gly Asn Ile Lys Met Pro Gly Val His Ala Val Asp His Arg
1860 1865 1870
Leu Glu Arg Ile Glu Glu Ser Asp Asn Glu Thr Tyr Val Val Gln Arg
1875 1880 1885
Glu Val Ala Val Ala Lys Tyr Ser Asn Leu Gly Gly Gly Met Asp Glu
1890 1895 1900
Leu Tyr Lys Ser Gly Leu Arg Ser Arg Arg Tyr Arg His Met Lys Arg
1905 1910 1915 1920
Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys
1925 1930
<210> 17
<211> 1386
<212> PRT
<213> Artificial Sequence
<400> 17
Met Pro Lys Lys Lys Arg Lys Val Asn Ile Pro Ala Leu Val Glu Asn
1 5 10 15
Gln Lys Lys Tyr Phe Gly Thr Tyr Ser Val Met Ala Met Leu Asn Ala
20 25 30
Gln Thr Val Leu Asp His Ile Gln Lys Val Ala Asp Ile Glu Gly Glu
35 40 45
Gln Asn Glu Asn Asn Glu Asn Leu Trp Phe His Pro Val Met Ser His
50 55 60
Leu Tyr Asn Ala Lys Asn Gly Tyr Asp Lys Gln Pro Glu Lys Thr Met
65 70 75 80
Phe Ile Ile Glu Arg Leu Gln Ser Tyr Phe Pro Phe Leu Lys Ile Met
85 90 95
Ala Glu Asn Gln Arg Glu Tyr Ser Asn Gly Lys Tyr Lys Gln Asn Arg
100 105 110
Val Glu Val Asn Ser Asn Asp Ile Phe Glu Val Leu Lys Arg Ala Phe
115 120 125
Gly Val Leu Lys Met Tyr Arg Asp Leu Thr Asn Ala Tyr Lys Thr Tyr
130 135 140
Glu Glu Lys Leu Asn Asp Gly Cys Glu Phe Leu Thr Ser Thr Glu Gln
145 150 155 160
Pro Leu Ser Gly Met Ile Asn Asn Tyr Tyr Thr Val Ala Leu Arg Asn
165 170 175
Met Asn Glu Arg Tyr Gly Tyr Lys Thr Glu Asp Leu Ala Phe Ile Gln
180 185 190
Asp Lys Arg Phe Lys Phe Val Lys Asp Ala Tyr Gly Lys Lys Lys Ser
195 200 205
Gln Val Asn Thr Gly Phe Phe Leu Ser Leu Gln Asp Tyr Asn Gly Asp
210 215 220
Thr Gln Lys Lys Leu His Leu Ser Gly Val Gly Ile Ala Leu Leu Ile
225 230 235 240
Cys Leu Phe Leu Asp Lys Gln Tyr Ile Asn Ile Phe Leu Ser Arg Leu
245 250 255
Pro Ile Phe Ser Ser Tyr Asn Ala Gln Ser Glu Glu Arg Arg Ile Ile
260 265 270
Ile Arg Ser Phe Gly Ile Asn Ser Ile Lys Leu Pro Lys Asp Arg Ile
275 280 285
His Ser Glu Lys Ser Asn Lys Ser Val Ala Met Asp Met Leu Asn Glu
290 295 300
Val Lys Arg Cys Pro Asp Glu Leu Phe Thr Thr Leu Ser Ala Glu Lys
305 310 315 320
Gln Ser Arg Phe Arg Ile Ile Ser Asp Asp His Asn Glu Val Leu Met
325 330 335
Lys Arg Ser Ser Asp Arg Phe Val Pro Leu Leu Leu Gln Tyr Ile Asp
340 345 350
Tyr Gly Lys Leu Phe Asp His Ile Arg Phe His Val Asn Met Gly Lys
355 360 365
Leu Arg Tyr Leu Leu Lys Ala Asp Lys Thr Cys Ile Asp Gly Gln Thr
370 375 380
Arg Val Arg Val Ile Glu Gln Pro Leu Asn Gly Phe Gly Arg Leu Glu
385 390 395 400
Glu Ala Glu Thr Met Arg Lys Gln Glu Asn Gly Thr Phe Gly Asn Ser
405 410 415
Gly Ile Arg Ile Arg Asp Phe Glu Asn Met Lys Arg Asp Asp Ala Asn
420 425 430
Pro Ala Asn Tyr Pro Tyr Ile Val Asp Thr Tyr Thr His Tyr Ile Leu
435 440 445
Glu Asn Asn Lys Val Glu Met Phe Ile Asn Asp Lys Glu Asp Ser Ala
450 455 460
Pro Leu Leu Pro Val Ile Glu Asp Asp Arg Tyr Val Val Lys Thr Ile
465 470 475 480
Pro Ser Cys Arg Met Ser Thr Leu Glu Ile Pro Ala Met Ala Phe His
485 490 495
Met Phe Leu Phe Gly Ser Lys Lys Thr Glu Lys Leu Ile Val Asp Val
500 505 510
His Asn Arg Tyr Lys Arg Leu Phe Gln Ala Met Gln Lys Glu Glu Val
515 520 525
Thr Ala Glu Asn Ile Ala Ser Phe Gly Ile Ala Glu Ser Asp Leu Pro
530 535 540
Gln Lys Ile Leu Asp Leu Ile Ser Gly Asn Ala His Gly Lys Asp Val
545 550 555 560
Asp Ala Phe Ile Arg Leu Thr Val Asp Asp Met Leu Thr Asp Thr Glu
565 570 575
Arg Arg Ile Lys Arg Phe Lys Asp Asp Arg Lys Ser Ile Arg Ser Ala
580 585 590
Asp Asn Lys Met Gly Lys Arg Gly Phe Lys Gln Ile Ser Thr Gly Lys
595 600 605
Leu Ala Asp Phe Leu Ala Lys Asp Ile Val Leu Phe Gln Pro Ser Val
610 615 620
Asn Asp Gly Glu Asn Lys Ile Thr Gly Leu Asn Tyr Arg Ile Met Gln
625 630 635 640
Ser Ala Ile Ala Val Tyr Asp Ser Gly Asp Asp Tyr Glu Ala Lys Gln
645 650 655
Gln Phe Lys Leu Met Phe Glu Lys Ala Arg Leu Ile Gly Lys Gly Thr
660 665 670
Thr Glu Pro His Pro Phe Leu Tyr Lys Val Phe Ala Arg Ser Ile Pro
675 680 685
Ala Asn Ala Val Glu Phe Tyr Glu Arg Tyr Leu Ile Glu Arg Lys Phe
690 695 700
Tyr Leu Thr Gly Leu Ser Asn Glu Ile Lys Lys Gly Asn Arg Val Asp
705 710 715 720
Val Pro Phe Ile Arg Arg Asp Gln Asn Lys Trp Lys Thr Pro Ala Met
725 730 735
Lys Thr Leu Gly Arg Ile Tyr Ser Glu Asp Leu Pro Val Glu Leu Pro
740 745 750
Arg Gln Met Phe Asp Asn Glu Ile Lys Ser His Leu Lys Ser Leu Pro
755 760 765
Gln Met Glu Gly Ile Asp Phe Asn Asn Ala Asn Val Thr Tyr Leu Ile
770 775 780
Ala Glu Tyr Met Lys Arg Val Leu Asp Asp Asp Phe Gln Thr Phe Tyr
785 790 795 800
Gln Trp Asn Arg Asn Tyr Arg Tyr Met Asp Met Leu Lys Gly Glu Tyr
805 810 815
Asp Arg Lys Gly Ser Leu Gln His Cys Phe Thr Ser Val Glu Glu Arg
820 825 830
Glu Gly Leu Trp Lys Glu Arg Ala Ser Arg Thr Glu Arg Tyr Arg Lys
835 840 845
Gln Ala Ser Asn Lys Ile Arg Ser Asn Arg Gln Met Arg Asn Ala Ser
850 855 860
Ser Glu Glu Ile Glu Thr Ile Leu Asp Lys Arg Leu Ser Asn Ser Arg
865 870 875 880
Asn Glu Tyr Gln Lys Ser Glu Lys Val Ile Arg Arg Tyr Arg Val Gln
885 890 895
Asp Ala Leu Leu Phe Leu Leu Ala Lys Lys Thr Leu Thr Glu Leu Ala
900 905 910
Asp Phe Asp Gly Glu Arg Phe Lys Leu Lys Glu Ile Met Pro Asp Ala
915 920 925
Glu Lys Gly Ile Leu Ser Glu Ile Met Pro Met Ser Phe Thr Phe Glu
930 935 940
Lys Gly Gly Lys Lys Tyr Thr Ile Thr Ser Glu Gly Met Lys Leu Lys
945 950 955 960
Asn Tyr Gly Asp Phe Phe Val Leu Ala Ser Asp Lys Arg Ile Gly Asn
965 970 975
Leu Leu Glu Leu Val Gly Ser Asp Ile Val Ser Lys Glu Asp Ile Met
980 985 990
Glu Glu Phe Asn Lys Tyr Asp Gln Cys Arg Pro Glu Ile Ser Ser Ile
995 1000 1005
Val Phe Asn Leu Glu Lys Trp Ala Phe Asp Thr Tyr Pro Glu Leu Ser
1010 1015 1020
Ala Arg Val Asp Arg Glu Glu Lys Val Asp Phe Lys Ser Ile Leu Lys
1025 1030 1035 1040
Ile Leu Leu Asn Asn Lys Asn Ile Asn Lys Glu Gln Ser Asp Ile Leu
1045 1050 1055
Arg Lys Ile Arg Asn Ala Phe Asp Ala Asn Asn Tyr Pro Asp Lys Gly
1060 1065 1070
Val Val Glu Ile Lys Ala Leu Pro Glu Ile Ala Met Ser Ile Lys Lys
1075 1080 1085
Ala Phe Gly Glu Tyr Ala Ile Met Lys Glu Gly Ala Leu Glu Gly Ser
1090 1095 1100
Val Ser Lys Gly Glu Ala Val Ile Lys Glu Phe Met Arg Phe Lys Val
1105 1110 1115 1120
His Met Glu Gly Ser Met Asn Gly His Glu Phe Glu Ile Glu Gly Glu
1125 1130 1135
Gly Glu Gly Arg Pro Tyr Glu Gly Thr Gln Thr Ala Lys Leu Lys Val
1140 1145 1150
Thr Lys Gly Gly Pro Leu Pro Phe Ser Trp Asp Ile Leu Ser Pro Gln
1155 1160 1165
Phe Met Tyr Gly Ser Arg Ala Phe Thr Lys His Pro Ala Asp Ile Pro
1170 1175 1180
Asp Tyr Tyr Lys Gln Ser Phe Pro Glu Gly Phe Lys Trp Glu Arg Val
1185 1190 1195 1200
Met Asn Phe Glu Asp Gly Gly Ala Val Thr Val Thr Gln Asp Thr Ser
1205 1210 1215
Leu Glu Asp Gly Thr Leu Ile Tyr Lys Val Lys Leu Arg Gly Thr Asn
1220 1225 1230
Phe Pro Pro Asp Gly Pro Val Met Gln Lys Lys Thr Met Gly Trp Glu
1235 1240 1245
Ala Ser Thr Glu Arg Leu Tyr Pro Glu Asp Gly Val Leu Lys Gly Asp
1250 1255 1260
Ile Lys Met Ala Leu Arg Leu Lys Asp Gly Gly Arg Tyr Leu Ala Asp
1265 1270 1275 1280
Phe Lys Thr Thr Tyr Lys Ala Lys Lys Pro Val Gln Met Pro Gly Ala
1285 1290 1295
Tyr Asn Val Asp Arg Lys Leu Asp Ile Thr Ser His Asn Glu Asp Tyr
1300 1305 1310
Thr Val Val Glu Gln Tyr Glu Arg Ser Glu Gly Arg His Ser Thr Gly
1315 1320 1325
Gly Met Asp Glu Leu Tyr Lys Ser Gly Leu Arg Ser His Met Lys Arg
1330 1335 1340
Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys Gln Arg
1345 1350 1355 1360
Val Gln Leu Ser Asp Tyr Lys Asp His Asp Gly Asp Tyr Lys Asp His
1365 1370 1375
Asp Ile Asp Tyr Lys Asp Asp Asp Asp Lys
1380 1385
<210> 18
<211> 1637
<212> PRT
<213> Artificial Sequence
<400> 18
Met Ala Pro Lys Lys Lys Arg Lys Val Gly Ile His Gly Val Pro Ala
1 5 10 15
Ala Asp Lys Lys Tyr Ser Ile Gly Leu Ala Ile Gly Thr Asn Ser Val
20 25 30
Gly Trp Ala Val Ile Thr Asp Glu Tyr Lys Val Pro Ser Lys Lys Phe
35 40 45
Lys Val Leu Gly Asn Thr Asp Arg His Ser Ile Lys Lys Asn Leu Ile
50 55 60
Gly Ala Leu Leu Phe Asp Ser Gly Glu Thr Ala Glu Ala Thr Arg Leu
65 70 75 80
Lys Arg Thr Ala Arg Arg Arg Tyr Thr Arg Arg Lys Asn Arg Ile Cys
85 90 95
Tyr Leu Gln Glu Ile Phe Ser Asn Glu Met Ala Lys Val Asp Asp Ser
100 105 110
Phe Phe His Arg Leu Glu Glu Ser Phe Leu Val Glu Glu Asp Lys Lys
115 120 125
His Glu Arg His Pro Ile Phe Gly Asn Ile Val Asp Glu Val Ala Tyr
130 135 140
His Glu Lys Tyr Pro Thr Ile Tyr His Leu Arg Lys Lys Leu Val Asp
145 150 155 160
Ser Thr Asp Lys Ala Asp Leu Arg Leu Ile Tyr Leu Ala Leu Ala His
165 170 175
Met Ile Lys Phe Arg Gly His Phe Leu Ile Glu Gly Asp Leu Asn Pro
180 185 190
Asp Asn Ser Asp Val Asp Lys Leu Phe Ile Gln Leu Val Gln Thr Tyr
195 200 205
Asn Gln Leu Phe Glu Glu Asn Pro Ile Asn Ala Ser Gly Val Asp Ala
210 215 220
Lys Ala Ile Leu Ser Ala Arg Leu Ser Lys Ser Arg Arg Leu Glu Asn
225 230 235 240
Leu Ile Ala Gln Leu Pro Gly Glu Lys Lys Asn Gly Leu Phe Gly Asn
245 250 255
Leu Ile Ala Leu Ser Leu Gly Leu Thr Pro Asn Phe Lys Ser Asn Phe
260 265 270
Asp Leu Ala Glu Asp Ala Lys Leu Gln Leu Ser Lys Asp Thr Tyr Asp
275 280 285
Asp Asp Leu Asp Asn Leu Leu Ala Gln Ile Gly Asp Gln Tyr Ala Asp
290 295 300
Leu Phe Leu Ala Ala Lys Asn Leu Ser Asp Ala Ile Leu Leu Ser Asp
305 310 315 320
Ile Leu Arg Val Asn Thr Glu Ile Thr Lys Ala Pro Leu Ser Ala Ser
325 330 335
Met Ile Lys Arg Tyr Asp Glu His His Gln Asp Leu Thr Leu Leu Lys
340 345 350
Ala Leu Val Arg Gln Gln Leu Pro Glu Lys Tyr Lys Glu Ile Phe Phe
355 360 365
Asp Gln Ser Lys Asn Gly Tyr Ala Gly Tyr Ile Asp Gly Gly Ala Ser
370 375 380
Gln Glu Glu Phe Tyr Lys Phe Ile Lys Pro Ile Leu Glu Lys Met Asp
385 390 395 400
Gly Thr Glu Glu Leu Leu Val Lys Leu Asn Arg Glu Asp Leu Leu Arg
405 410 415
Lys Gln Arg Thr Phe Asp Asn Gly Ser Ile Pro His Gln Ile His Leu
420 425 430
Gly Glu Leu His Ala Ile Leu Arg Arg Gln Glu Asp Phe Tyr Pro Phe
435 440 445
Leu Lys Asp Asn Arg Glu Lys Ile Glu Lys Ile Leu Thr Phe Arg Ile
450 455 460
Pro Tyr Tyr Val Gly Pro Leu Ala Arg Gly Asn Ser Arg Phe Ala Trp
465 470 475 480
Met Thr Arg Lys Ser Glu Glu Thr Ile Thr Pro Trp Asn Phe Glu Glu
485 490 495
Val Val Asp Lys Gly Ala Ser Ala Gln Ser Phe Ile Glu Arg Met Thr
500 505 510
Asn Phe Asp Lys Asn Leu Pro Asn Glu Lys Val Leu Pro Lys His Ser
515 520 525
Leu Leu Tyr Glu Tyr Phe Thr Val Tyr Asn Glu Leu Thr Lys Val Lys
530 535 540
Tyr Val Thr Glu Gly Met Arg Lys Pro Ala Phe Leu Ser Gly Glu Gln
545 550 555 560
Lys Lys Ala Ile Val Asp Leu Leu Phe Lys Thr Asn Arg Lys Val Thr
565 570 575
Val Lys Gln Leu Lys Glu Asp Tyr Phe Lys Lys Ile Glu Cys Phe Asp
580 585 590
Ser Val Glu Ile Ser Gly Val Glu Asp Arg Phe Asn Ala Ser Leu Gly
595 600 605
Thr Tyr His Asp Leu Leu Lys Ile Ile Lys Asp Lys Asp Phe Leu Asp
610 615 620
Asn Glu Glu Asn Glu Asp Ile Leu Glu Asp Ile Val Leu Thr Leu Thr
625 630 635 640
Leu Phe Glu Asp Arg Glu Met Ile Glu Glu Arg Leu Lys Thr Tyr Ala
645 650 655
His Leu Phe Asp Asp Lys Val Met Lys Gln Leu Lys Arg Arg Arg Tyr
660 665 670
Thr Gly Trp Gly Arg Leu Ser Arg Lys Leu Ile Asn Gly Ile Arg Asp
675 680 685
Lys Gln Ser Gly Lys Thr Ile Leu Asp Phe Leu Lys Ser Asp Gly Phe
690 695 700
Ala Asn Arg Asn Phe Met Gln Leu Ile His Asp Asp Ser Leu Thr Phe
705 710 715 720
Lys Glu Asp Ile Gln Lys Ala Gln Val Ser Gly Gln Gly Asp Ser Leu
725 730 735
His Glu His Ile Ala Asn Leu Ala Gly Ser Pro Ala Ile Lys Lys Gly
740 745 750
Ile Leu Gln Thr Val Lys Val Val Asp Glu Leu Val Lys Val Met Gly
755 760 765
Arg His Lys Pro Glu Asn Ile Val Ile Glu Met Ala Arg Glu Asn Gln
770 775 780
Thr Thr Gln Lys Gly Gln Lys Asn Ser Arg Glu Arg Met Lys Arg Ile
785 790 795 800
Glu Glu Gly Ile Lys Glu Leu Gly Ser Gln Ile Leu Lys Glu His Pro
805 810 815
Val Glu Asn Thr Gln Leu Gln Asn Glu Lys Leu Tyr Leu Tyr Tyr Leu
820 825 830
Gln Asn Gly Arg Asp Met Tyr Val Asp Gln Glu Leu Asp Ile Asn Arg
835 840 845
Leu Ser Asp Tyr Asp Val Asp Ala Ile Val Pro Gln Ser Phe Leu Lys
850 855 860
Asp Asp Ser Ile Asp Asn Lys Val Leu Thr Arg Ser Asp Lys Asn Arg
865 870 875 880
Gly Lys Ser Asp Asn Val Pro Ser Glu Glu Val Val Lys Lys Met Lys
885 890 895
Asn Tyr Trp Arg Gln Leu Leu Asn Ala Lys Leu Ile Thr Gln Arg Lys
900 905 910
Phe Asp Asn Leu Thr Lys Ala Glu Arg Gly Gly Leu Ser Glu Leu Asp
915 920 925
Lys Ala Gly Phe Ile Lys Arg Gln Leu Val Glu Thr Arg Gln Ile Thr
930 935 940
Lys His Val Ala Gln Ile Leu Asp Ser Arg Met Asn Thr Lys Tyr Asp
945 950 955 960
Glu Asn Asp Lys Leu Ile Arg Glu Val Lys Val Ile Thr Leu Lys Ser
965 970 975
Lys Leu Val Ser Asp Phe Arg Lys Asp Phe Gln Phe Tyr Lys Val Arg
980 985 990
Glu Ile Asn Asn Tyr His His Ala His Asp Ala Tyr Leu Asn Ala Val
995 1000 1005
Val Gly Thr Ala Leu Ile Lys Lys Tyr Pro Lys Leu Glu Ser Glu Phe
1010 1015 1020
Val Tyr Gly Asp Tyr Lys Val Tyr Asp Val Arg Lys Met Ile Ala Lys
1025 1030 1035 1040
Ser Glu Gln Glu Ile Gly Lys Ala Thr Ala Lys Tyr Phe Phe Tyr Ser
1045 1050 1055
Asn Ile Met Asn Phe Phe Lys Thr Glu Ile Thr Leu Ala Asn Gly Glu
1060 1065 1070
Ile Arg Lys Arg Pro Leu Ile Glu Thr Asn Gly Glu Thr Gly Glu Ile
1075 1080 1085
Val Trp Asp Lys Gly Arg Asp Phe Ala Thr Val Arg Lys Val Leu Ser
1090 1095 1100
Met Pro Gln Val Asn Ile Val Lys Lys Thr Glu Val Gln Thr Gly Gly
1105 1110 1115 1120
Phe Ser Lys Glu Ser Ile Leu Pro Lys Arg Asn Ser Asp Lys Leu Ile
1125 1130 1135
Ala Arg Lys Lys Asp Trp Asp Pro Lys Lys Tyr Gly Gly Phe Asp Ser
1140 1145 1150
Pro Thr Val Ala Tyr Ser Val Leu Val Val Ala Lys Val Glu Lys Gly
1155 1160 1165
Lys Ser Lys Lys Leu Lys Ser Val Lys Glu Leu Leu Gly Ile Thr Ile
1170 1175 1180
Met Glu Arg Ser Ser Phe Glu Lys Asn Pro Ile Asp Phe Leu Glu Ala
1185 1190 1195 1200
Lys Gly Tyr Lys Glu Val Lys Lys Asp Leu Ile Ile Lys Leu Pro Lys
1205 1210 1215
Tyr Ser Leu Phe Glu Leu Glu Asn Gly Arg Lys Arg Met Leu Ala Ser
1220 1225 1230
Ala Gly Glu Leu Gln Lys Gly Asn Glu Leu Ala Leu Pro Ser Lys Tyr
1235 1240 1245
Val Asn Phe Leu Tyr Leu Ala Ser His Tyr Glu Lys Leu Lys Gly Ser
1250 1255 1260
Pro Glu Asp Asn Glu Gln Lys Gln Leu Phe Val Glu Gln His Lys His
1265 1270 1275 1280
Tyr Leu Asp Glu Ile Ile Glu Gln Ile Ser Glu Phe Ser Lys Arg Val
1285 1290 1295
Ile Leu Ala Asp Ala Asn Leu Asp Lys Val Leu Ser Ala Tyr Asn Lys
1300 1305 1310
His Arg Asp Lys Pro Ile Arg Glu Gln Ala Glu Asn Ile Ile His Leu
1315 1320 1325
Phe Thr Leu Thr Asn Leu Gly Ala Pro Ala Ala Phe Lys Tyr Phe Asp
1330 1335 1340
Thr Thr Ile Asp Arg Lys Arg Tyr Thr Ser Thr Lys Glu Val Leu Asp
1345 1350 1355 1360
Ala Thr Leu Ile His Gln Ser Ile Thr Gly Leu Tyr Glu Thr Arg Ile
1365 1370 1375
Asp Leu Ser Gln Leu Gly Gly Asp Gly Ser Thr Ser Gly Ser Pro Lys
1380 1385 1390
Lys Lys Arg Lys Val Ser Arg Val Ser Lys Gly Glu Glu Leu Phe Thr
1395 1400 1405
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
1410 1415 1420
Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
1425 1430 1435 1440
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
1445 1450 1455
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ala Arg
1460 1465 1470
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
1475 1480 1485
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
1490 1495 1500
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
1505 1510 1515 1520
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
1525 1530 1535
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Lys Val Tyr Ile Thr
1540 1545 1550
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Thr Arg His
1555 1560 1565
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
1570 1575 1580
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
1585 1590 1595 1600
Ser Thr Gln Ser Lys Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
1605 1610 1615
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
1620 1625 1630
Asp Glu Leu Tyr Lys
1635
<210> 19
<211> 65
<212> DNA
<213> Artificial Sequence
<400> 19
gctggagaag atagcccaag aaagagggca ataacggttt tcagatcaca catgtagtaa 60
aggca 65
<210> 20
<211> 65
<212> DNA
<213> Artificial Sequence
<400> 20
gctggagaag atagcccaag aaagagggca ataacaattg tttgcatcat ccccaagtca 60
ttggt 65
<210> 21
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 21
gatttagact accccaaaaa cgaaggggac taaaacggtt ttcagatcac acatgtagta 60
aaggca 66
<210> 22
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 22
gatttagact accccaaaaa cgaaggggac taaaacaatt gtttgcatca tccccaagtc 60
attggt 66
<210> 23
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 23
ggttttcaga tcacacatgt agtaaaggca gttgtggaag gtccagtttt gaggggctat 60
tacaac 66
<210> 24
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 24
aattgtttgc atcatcccca agtcattggt gttgtggaag gtccagtttt gaggggctat 60
tacaac 66
<210> 25
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 25
ggttttcaga tcacacatgt agtaaaggca gttggatcta ccctctattt gaagggtaca 60
cacaac 66
<210> 26
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 26
aattgtttgc atcatcccca agtcattggt gttggatcta ccctctattt gaagggtaca 60
cacaac 66
<210> 27
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 27
ggttttcaga tcacacatgt agtaaaggca gttgggactg ctctcacttt gaagggtatt 60
cacaac 66
<210> 28
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 28
aattgtttgc atcatcccca agtcattggt gttgggactg ctctcacttt gaagggtatt 60
cacaac 66
<210> 29
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 29
gcacctctgc aaaactgcag gggtctaaaa cggttttcag atcacacatg tagtaaaggc 60
a 61
<210> 30
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 30
gcacctctgc aaaactgcag gggtctaaaa caattgtttg catcatcccc aagtcattgg 60
t 61
<210> 31
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 31
gcacccgtgc aaaaatgcag gggtctaaaa cggttttcag atcacacatg tagtaaaggc 60
a 61
<210> 32
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 32
gcacccgtgc aaaaatgcag gggtctaaaa caattgtttg catcatcccc aagtcattgg 60
t 61
<210> 33
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 33
gaacccctac caactggtcg gggtttgaaa cggttttcag atcacacatg tagtaaaggc 60
a 61
<210> 34
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 34
gaacccctac caactggtcg gggtttgaaa caattgtttg catcatcccc aagtcattgg 60
t 61
<210> 35
<211> 66
<212> DNA
<213> Artificial Sequence
<400> 35
gttgaatcca ttccattgca ttccattcat gttgtggaag gtccagtttt gaggggctat 60
tacaac 66
<210> 36
<211> 59
<212> DNA
<213> Artificial Sequence
<400> 36
gattccaatc catgccattc cacgttgtgg aaggtccagt tttgaggggc tattacaac 59
<210> 37
<211> 59
<212> DNA
<213> Artificial Sequence
<400> 37
gattccaatc catgccattc cacgttgtgg aaggtccagt tttgaggggc tattacaac 59
<210> 38
<211> 56
<212> DNA
<213> Artificial Sequence
<400> 38
gtgacctgtg gatgctgagg gttgtggaag gtccagtttt gaggggctat tacaac 56
<210> 39
<211> 57
<212> DNA
<213> Artificial Sequence
<400> 39
gacctgtgga tgctgaggaa ggttgtggaa ggtccagttt tgaggggcta ttacaac 57
<210> 40
<211> 59
<212> DNA
<213> Artificial Sequence
<400> 40
gcagttcttc tccactgcca gaagttgtgg aaggtccagt tttgaggggc tattacaac 59
<210> 41
<211> 59
<212> DNA
<213> Artificial Sequence
<400> 41
gcagttcttc tccactgcca gaagttgtgg aaggtccagt tttgaggggc tattacaac 59
<210> 42
<211> 57
<212> DNA
<213> Artificial Sequence
<400> 42
gctacctcat tttccaggtg ggttgtggaa ggtccagttt tgaggggcta ttacaac 57
<210> 43
<211> 57
<212> DNA
<213> Artificial Sequence
<400> 43
gaagaactgc tttcaaagaa ttaccacctg gaaaatgagg tagctagact gaaaaag 57
<210> 44
<211> 142
<212> DNA
<213> Artificial Sequence
<400> 44
ggcgtgacct gtggatgctg gtttgagagc taccggagca gacgatatgg cgtcgctccg 60
gtagcaagtt caaataaggc tagtccgtta tcaacttgga gcagacgata tggcgtcgct 120
ccaagtggca ccgagtcggt gc 142
<210> 45
<211> 142
<212> DNA
<213> Artificial Sequence
<400> 45
aatggaatca acccgagtac gtttgagagc taccggagca gacgatatgg cgtcgctccg 60
gtagcaagtt caaataaggc tagtccgtta tcaacttgga gcagacgata tggcgtcgct 120
ccaagtggca ccgagtcggt gc 142
<210> 46
<211> 4224
<212> DNA
<213> Artificial Sequence
<400> 46
atgcccaaaa agaagaggaa agtgaacatc cccgctctgg tggaaaacca gaagaagtac 60
tttggcacct acagcgtgat ggccatgctg aacgctcaga ccgtgctgga ccacatccag 120
aaggtggccg atattgaggg cgagcagaac gagaacaacg agaatctgtg gtttcacccc 180
gtgatgagcc acctgtacaa cgccaagaac ggctacgaca agcagcccga gaaaaccatg 240
ttcatcatcg agcggctgca gagctacttc ccattcctga agatcatggc cgagaaccag 300
agagagtaca gcaacggcaa gtacaagcag aaccgcgtgg aagtgaacag caacgacatc 360
ttcgaggtgc tgaagcgcgc cttcggcgtg ctgaagatgt acagggacct gaccaacgcc 420
tacaagacct acgaggaaaa gctgaacgac ggctgcgagt tcctgaccag cacagagcaa 480
cctctgagcg gcatgatcaa caactactac acagtggccc tgcggaacat gaacgagaga 540
tacggctaca agacagagga cctggccttc atccaggaca agcggttcaa gttcgtgaag 600
gacgcctacg gcaagaaaaa gtcccaagtg aataccggat tcttcctgag cctgcaggac 660
tacaacggcg acacacagaa gaagctgcac ctgagcggag tgggaatcgc cctgctgatc 720
tgcctgttcc tggacaagca gtacatcaac atctttctga gcaggctgcc catcttctcc 780
agctacaatg cccagagcga ggaacggcgg atcatcatca gatccttcgg catcaacagc 840
atcaagctgc ccaaggaccg gatccacagc gagaagtcca acaagagcgt ggccatggat 900
atgctcaacg aagtgaagcg gtgccccgac gagctgttca caacactgtc tgccgagaag 960
cagtcccggt tcagaatcat cagcgacgac cacaatgaag tgctgatgaa gcggagcagc 1020
gacagattcg tgcctctgct gctgcagtat atcgattacg gcaagctgtt cgaccacatc 1080
aggttccacg tgaacatggg caagctgaga tacctgctga aggccgacaa gacctgcatc 1140
gacggccaga ccagagtcag agtgatcgag cagcccctga acggcttcgg cagactggaa 1200
gaggccgaga caatgcggaa gcaagagaac ggcaccttcg gcaacagcgg catccggatc 1260
agagacttcg agaacatgaa gcgggacgac gccaatcctg ccaactatcc ctacatcgtg 1320
gacacctaca cacactacat cctggaaaac aacaaggtcg agatgtttat caacgacaaa 1380
gaggacagcg ccccactgct gcccgtgatc gaggatgata gatacgtggt caagacaatc 1440
cccagctgcc ggatgagcac cctggaaatt ccagccatgg ccttccacat gtttctgttc 1500
ggcagcaaga aaaccgagaa gctgatcgtg gacgtgcaca accggtacaa gagactgttc 1560
caggccatgc agaaagaaga agtgaccgcc gagaatatcg ccagcttcgg aatcgccgag 1620
agcgacctgc ctcagaagat cctggatctg atcagcggca atgcccacgg caaggatgtg 1680
gacgccttca tcagactgac cgtggacgac atgctgaccg acaccgagcg gagaatcaag 1740
agattcaagg acgaccggaa gtccattcgg agcgccgaca acaagatggg aaagagaggc 1800
ttcaagcaga tctccacagg caagctggcc gacttcctgg ccaaggacat cgtgctgttt 1860
cagcccagcg tgaacgatgg cgagaacaag atcaccggcc tgaactaccg gatcatgcag 1920
agcgccattg ccgtgtacga tagcggcgac gattacgagg ccaagcagca gttcaagctg 1980
atgttcgaga aggcccggct gatcggcaag ggcacaacag agcctcatcc atttctgtac 2040
aaggtgttcg cccgcagcat ccccgccaat gccgtcgagt tctacgagcg ctacctgatc 2100
gagcggaagt tctacctgac cggcctgtcc aacgagatca agaaaggcaa cagagtggat 2160
gtgcccttca tccggcggga ccagaacaag tggaaaacac ccgccatgaa gaccctgggc 2220
agaatctaca gcgaggatct gcccgtggaa ctgcccagac agatgttcga caatgagatc 2280
aagtcccacc tgaagtccct gccacagatg gaaggcatcg acttcaacaa tgccaacgtg 2340
acctatctga tcgccgagta catgaagaga gtgctggacg acgacttcca gaccttctac 2400
cagtggaacc gcaactaccg gtacatggac atgcttaagg gcgagtacga cagaaagggc 2460
tccctgcagc actgcttcac cagcgtggaa gagagagaag gcctctggaa agagcgggcc 2520
tccagaacag agcggtacag aaagcaggcc agcaacaaga tccgcagcaa ccggcagatg 2580
agaaacgcca gcagcgaaga gatcgagaca atcctggata agcggctgag caacagccgg 2640
aacgagtacc agaaaagcga gaaagtgatc cggcgctaca gagtgcagga tgccctgctg 2700
tttctgctgg ccaaaaagac cctgaccgaa ctggccgatt tcgacggcga gaggttcaaa 2760
ctgaaagaaa tcatgcccga cgccgagaag ggaatcctga gcgagatcat gcccatgagc 2820
ttcaccttcg agaaaggcgg caagaagtac accatcacca gcgagggcat gaagctgaag 2880
aactacggcg acttctttgt gctggctagc gacaagagga tcggcaacct gctggaactc 2940
gtgggcagcg acatcgtgtc caaagaggat atcatggaag agttcaacaa atacgaccag 3000
tgcaggcccg agatcagctc catcgtgttc aacctggaaa agtgggcctt cgacacatac 3060
cccgagctgt ctgccagagt ggaccgggaa gagaaggtgg acttcaagag catcctgaaa 3120
atcctgctga acaacaagaa catcaacaaa gagcagagcg acatcctgcg gaagatccgg 3180
aacgccttcg atgccaacaa ttaccccgac aaaggcgtgg tggaaatcaa ggccctgcct 3240
gagatcgcca tgagcatcaa gaaggccttt ggggagtacg ccatcatgaa ggagggagct 3300
ctagaggcgc taccggtcgc caccatggtg agcaagggcg aggagctgtt caccggggtg 3360
gtgcccatcc tggtcgagct ggacggcgac gtaaacggcc acaagttcag cgtgtccggc 3420
gagggcgagg gcgatgccac ctacggcaag ctgaccctga agttcatctg caccaccggc 3480
aagctgcccg tgccctggcc caccctcgtg accaccctga cctacggcgt gcagtgcttc 3540
agccgctacc ccgaccacat gaagcagcac gacttcttca agtccgccat gcccgaaggc 3600
tacgtccagg agcgcaccat cttcttcaag gacgacggca actacaagac ccgcgccgag 3660
gtgaagttcg agggcgacac cctggtgaac cgcatcgagc tgaagggcat cgacttcaag 3720
gaggacggca acatcctggg gcacaagctg gagtacaact acaacagcca caacgtctat 3780
atcatggccg acaagcagaa gaacggcatc aaggtgaact tcaagatccg ccacaacatc 3840
gaggacggca gcgtgcagct cgccgaccac taccagcaga acacccccat cggcgacggc 3900
cccgtgctgc tgcccgacaa ccactacctg agcacccagt ccgccctgag caaagacccc 3960
aacgagaagc gcgatcacat ggtcctgctg gagttcgtga ccgccgccgg gatcactctc 4020
ggcatggacg agctgtacaa gtccggactc agatctaagc tttcgaattc taagccagga 4080
ttccatatga agcgacctgc cgccacaaag aaggctggac aggctaagaa gaagaaacaa 4140
cgcgtgcagc taagcgacta caaagaccat gacggtgatt ataaagatca tgacatcgat 4200
tacaaggatg acgatgacaa gtaa 4224

Claims (16)

1. A fusion protein comprising a dCas protein having a deleted or reduced RNA nuclease activity, which dCas protein is a dCas13 protein, one or more marker sequences and optionally one or more nuclear localization signals, the sequence of the dCas13 protein being selected from any one of: positions 9-1089 of SEQ ID NO.3 and positions 9-1183 of SEQ ID NO.4, wherein the sequence of the nuclear localization signal is selected from one or more of the following sequences: positions 2-17 of SEQ ID NO.1 and positions 1363-1369 of SEQ ID NO. 9.
2. The fusion protein of claim 1, wherein the fusion protein has one or more characteristics selected from the group consisting of:
the dCas protein is located at the N-terminus of the marker sequence,
the fusion protein comprises a plurality of marker sequences,
the marker sequence is a fluorescent protein,
the nuclear localization signal is located at the N-terminus of dCas and/or at the C-terminus of the marker sequence.
3. The fusion protein of claim 1 or 2, wherein the fusion protein has, from N-terminus to C-terminus, one or more nuclear localization signals, dCas protein, one or more marker sequences, and one or more nuclear localization signals.
4. The fusion protein of claim 1 or 2, wherein the sequence of the fusion protein is selected from any one of SEQ ID NOs 3-4 and 9-18.
5. A polynucleotide selected from the group consisting of:
(1) A polynucleotide encoding the fusion protein of any one of claims 1-4; and
(2) (1) the complementary sequence of said polynucleotide.
6. A nucleic acid construct comprising the polynucleotide of claim 5.
7. The nucleic acid construct of claim 6, wherein said nucleic acid construct is a cloning vector or an expression vector.
8. A host cell, wherein said host cell
(1) Expressing the fusion protein of any one of claims 1-4;
(2) Comprising the polynucleotide of claim 5; or
(3) Comprising the nucleic acid construct of claim 6 or 7.
9. A detection kit comprises
(1) The fusion protein of any one of claims 1 to 4, the polynucleotide of claim 5, the nucleic acid construct of claim 6 or 7 and/or the cell of claim 8, and
(2) Reagents for detecting the marker sequence.
10. The detection kit of claim 9, further comprising a gRNA directed to a target that is a target RNA that recognizes dCas13 in the target RNA and the fusion protein, or a nucleic acid construct comprising the gRNA or a complementary sequence thereof.
11. The kit of claim 9 or 10, further comprising an agent for introducing said fusion protein, polynucleotide or nucleic acid construct into a cell, and optionally instructions.
12. Use of the fusion protein of any one of claims 1-4, the polynucleotide of claim 5, the nucleic acid construct of claim 6 or 7, or the cell of claim 8 in the preparation of a kit for detecting a target, said target being a target RNA.
13. A method of detecting a target comprising (1) incubating cells that express the fusion protein of any one of claims 1-4 and comprise grnas for the target, which are target RNAs that recognize dCas13 in the target RNA and the fusion protein, and (2) detecting the marker sequence, the method being for non-disease diagnostic and therapeutic purposes.
14. The method of claim 13, wherein the marker sequence is a fluorescent protein.
15. A method of localizing a target within a cell, comprising, (1) incubating a cell that expresses the fusion protein of any one of claims 1-4 and comprises a gRNA directed against the target, which is a target RNA, and (2) detecting the location of a marker sequence in the cell, the gRNA recognizing dCas13 in the target RNA and the fusion protein.
16. The method of claim 15, wherein the marker sequence is a fluorescent protein.
CN201911127456.3A 2019-11-18 2019-11-18 Fusion protein for live cell RNA marking and application Active CN112813049B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911127456.3A CN112813049B (en) 2019-11-18 2019-11-18 Fusion protein for live cell RNA marking and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911127456.3A CN112813049B (en) 2019-11-18 2019-11-18 Fusion protein for live cell RNA marking and application

Publications (2)

Publication Number Publication Date
CN112813049A CN112813049A (en) 2021-05-18
CN112813049B true CN112813049B (en) 2023-02-17

Family

ID=75852342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911127456.3A Active CN112813049B (en) 2019-11-18 2019-11-18 Fusion protein for live cell RNA marking and application

Country Status (1)

Country Link
CN (1) CN112813049B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115369124A (en) * 2021-05-21 2022-11-22 中国农业大学 Screening method and application of single-point mutant gene transcript for efficiently and specifically knocking down sgRNA
CN114540419A (en) * 2022-03-04 2022-05-27 中国人民解放军军事科学院军事医学研究院 Three-function report system for analyzing fusion efficiency of enveloped virus membrane

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107406838A (en) * 2014-11-06 2017-11-28 纳幕尔杜邦公司 Peptide-mediated delivering of the endonuclease of RNA guiding into cell
CN109804066A (en) * 2016-08-09 2019-05-24 哈佛大学的校长及成员们 Programmable CAS9- recombination enzyme fusion proteins and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2947904A1 (en) * 2015-11-12 2017-05-12 Pfizer Inc. Tissue-specific genome engineering using crispr-cas9

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107406838A (en) * 2014-11-06 2017-11-28 纳幕尔杜邦公司 Peptide-mediated delivering of the endonuclease of RNA guiding into cell
CN109804066A (en) * 2016-08-09 2019-05-24 哈佛大学的校长及成员们 Programmable CAS9- recombination enzyme fusion proteins and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"CRISPR/Cas13 as a Tool for RNA Interference";Zahir Ali et al.;《Trends in Plant Science》;20180531;第23卷(第5期);第376页图1G和第377页右栏第1段 *
"CRISPR-Cas13系统与活细胞RNA标记";杨良中 等;《生命的化学》;20201231;第40卷(第1期);第1-7页 *
"Dynamic imaging of RNA in living cells by CRISPR-Cas13 systems ";Liang-Zhong Yang et al.;《中国生物化学与分子生物学会2019年全国学术会议暨学会成立四十周年论文集》;20191031;第101页 *
"Targeted Cleavage and Polyadenylation of RNA by CRISPR-Cas13";Kelly M. Anderson et al.;《bioRxiv》;20190126;第4页第1段,第16页图1附图注释,第19页图1a *
"Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities";Liang Liu et al.;《Cell》;20170112;第121-134页 *

Also Published As

Publication number Publication date
CN112813049A (en) 2021-05-18

Similar Documents

Publication Publication Date Title
WO2017215619A1 (en) Fusion protein producing point mutation in cell, and preparation and use thereof
US7803920B2 (en) ECAT16 gene expressed specifically in ES cells and utilization of the same
US20210214708A1 (en) Engineered promiscuous biotin ligases for efficient proximity labeling
US9115364B2 (en) Protein expression system
CN112813049B (en) Fusion protein for live cell RNA marking and application
JP7521028B2 (en) Method for selecting cells based on CRISPR/Cas-controlled incorporation of a detectable tag into a target protein
US20100184619A1 (en) Method for analyzing organelle-localized protein and material for analysis
CN111856024B (en) Method for detecting interaction between biological membrane proteins and kit used in method
CN114560915A (en) Modified high-titer SARS-CoV-2 pseudovirus
JP2011211983A (en) Protein molecule pair, gene encoding protein molecule pair, and cell producing gene transfer vector and protein molecule pair
WO2010096594A2 (en) Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
EP3037534B1 (en) Polypeptide exhibiting fluorescent properties, and utilization of same
CN112162096A (en) Double-fluorescent protein positioning detection system for detecting cell mitochondrion autophagy and application
US9611486B2 (en) Constructs and method for regulating gene expression or for detecting and controlling a DNA locus in eukaryotes
CN112877309B (en) N-terminal extended PTEN subtype PTEN zeta protein and coding gene and application thereof
JPWO2002036823A1 (en) A method for searching for a gene encoding a nuclear localization protein
CN114057861A (en) Bio-PROTAC artificial protein targeting UBE2C
EP3954699A1 (en) Nucleic acid binding protein
US20240279646A1 (en) Peptide
O'Brien Cloning and Expression of Hydra Innexin 2, a Gap Junction Protein Required for Coordinated Contraction of the Body Column
CN114606208A (en) High-reliability rapid adjacent protein labeling system ScPhastID and labeling method
CN117165613A (en) Expression vector and construction method and application thereof
Lee et al. Eastern Staining: A Simple Recombinant Protein Detection Technology Using a Small Peptide Tag and Its Counter Partner Which is a Fluorescent Compound
KR20060035632A (en) Protein expression system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant